var title_f9_15_9456="Funnel plots";
var content_f9_15_9456=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F65012&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F65012&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Funnel plots",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 265px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The above graphs represent funnel plots. In each figure, the x-axis represents the magnitude of the effect and the y-axis the \"precision.\" The dotted line on the x-axis represents \"no effect\"; to the right of this line, the effect favors the control group while to the left the effect favors the intervention. Circles represent individual studies. Generally, larger studies have higher precision.",
"    <br>",
"     The funnel plot on the left shows several smaller studies symmetrically clustered around the \"no effect\" line. In contrast, the funnel plot on the right appears to be missing smaller studies that favored the control arm, suggesting that there may have been publication bias in favor of studies where the intervention succeeded.",
"     <br>",
"      Unfortunately, the graphical depiction of studies using this approach is subject to variable interpretation among raters, particularly when there are relatively few studies. Thus, funnel plots are not always a reliable method to clarify whether there is publication bias.",
"      <div class=\"footnotes\">",
"      </div>",
"      <div class=\"reference\">",
"       Figure courtesy of Gordon Guyatt, MD.",
"      </div>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9456=[""].join("\n");
var outline_f9_15_9456=null;
var title_f9_15_9457="Nerve root lymphoma";
var content_f9_15_9457=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F60419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F60419&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 471px\">",
"   <div class=\"ttl\">",
"    Lymphomatous nerve root involvement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 451px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This coronal T1-weighted MRI of the lumbar spine shows diffuse thickening of the nerve roots (arrows) suggestive of lymphomatous involvement.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9457=[""].join("\n");
var outline_f9_15_9457=null;
var title_f9_15_9458="CDC weight for length girls 0 to 36 months";
var content_f9_15_9458=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F74789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F74789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 553px\">",
"   <div class=\"ttl\">",
"    Weight-for-length percentiles, girls, birth to 36 months, CDC growth charts: United States",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 533px; height: 672px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Developed by the National Center for Health Statistics in collaboration with the National Center for Chronic Disease Prevention and Health Promotion (2000).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9458=[""].join("\n");
var outline_f9_15_9458=null;
var title_f9_15_9459="Straight leg raise patella fracture";
var content_f9_15_9459=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F64621&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F64621&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 499px\">",
"   <div class=\"ttl\">",
"    Straight leg raise for patella fracture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 479px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    To perform the straight leg raise, elevate the&nbsp;leg to 20 to 25 degrees, hold for a few seconds, and return to the starting position. Repeat for a total of 10 repetitions per set.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jim Blount, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9459=[""].join("\n");
var outline_f9_15_9459=null;
var title_f9_15_9460="Apraclonidine: Patient drug information";
var content_f9_15_9460=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Apraclonidine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/28/36291?source=see_link\">",
"     see \"Apraclonidine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F136267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Iopidine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F136268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Iopidine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015266\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower high eye pressure.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015265\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701841",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to clonidine, apraclonidine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697708",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use this drug only for less than 1 month.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698504",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your eye pressure checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015271\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Short-term pain after use.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015273\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015268\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695783",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take out contact lenses before using this drug. Lenses may be put back in 15 minutes after this drug is given. Do not put contacts back in if your eyes are irritated or infected.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015269\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696485",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not use 2 doses or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015274\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015275\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10955 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-52D7E7C181-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9460=[""].join("\n");
var outline_f9_15_9460=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136267\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F136268\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015266\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015265\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015270\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015271\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015273\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015268\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015269\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015274\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015275\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?35/28/36291?source=related_link\">",
"      Apraclonidine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_15_9461="Cavernous sinus anatomy";
var content_f9_15_9461=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F65634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F65634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 588px\">",
"   <div class=\"ttl\">",
"    Anatomy of the cavernous sinus and surrounding nerves and vessels",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 568px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CN: Cranial nerve",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9461=[""].join("\n");
var outline_f9_15_9461=null;
var title_f9_15_9462="Metabolism of vitamin D";
var content_f9_15_9462=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Metabolism of vitamin D",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/15/9462/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9462/contributors\">",
"     Zalman S Agus, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/15/9462/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9462/contributors\">",
"     Marc K Drezner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/15/9462/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9462/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/15/9462/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vitamin D from the diet or dermal synthesis is biologically inactive and requires enzymatic conversion to active metabolites. Vitamin D is converted to 25-hydroxyvitamin D, the major circulating form of vitamin D, and then to 1,25-dihydroxyvitamin D, the active form of vitamin D, by enzymes in the liver and kidney. 1,25-dihydroxyvitamin D binds to the intracellular vitamin D receptor to activate vitamin D response elements within target genes. The half-life of 1,25-dihydroxyvitamin D is four to six hours, compared with two to three weeks for 25-hydroxyvitamin D and 24 hours for parent vitamin D.",
"   </p>",
"   <p>",
"    The production and metabolism of vitamin D will be reviewed here. The causes and treatment of vitamin D deficiency are reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/3/39990?source=see_link\">",
"     \"Overview of vitamin D\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/18/38184?source=see_link\">",
"     \"Causes of vitamin D deficiency and resistance\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28266?source=see_link\">",
"     \"Vitamin D insufficiency and deficiency in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/21/3417?source=see_link\">",
"     \"Treatment of vitamin D deficiency in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28248?source=see_link\">",
"     \"Etiology and treatment of calcipenic rickets in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5192386\">",
"    <span class=\"h1\">",
"     PRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Very few foods contain vitamin D (fatty fish livers are the exception) and dermal synthesis is the major natural source of the vitamin. Previtamin D3 is synthesized nonenzymatically in skin from 7-dehydrocholesterol during exposure to the ultraviolet rays in sunlight. Previtamin D3 undergoes a temperature dependent rearrangement to form vitamin D3 (cholecalciferol). This system is exceedingly efficient, and it is estimated that brief casual exposure of the arms and face is equivalent to ingestion of 200 International Units per day [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/1\">",
"     1",
"    </a>",
"    ]. However, the length of daily exposure required to obtain the sunlight equivalent of oral vitamin D supplementation is difficult to predict on an individual basis and varies with the skin type, latitude, season, and time of day [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Prolonged exposure of the skin to sunlight does not produce toxic amounts of vitamin D3 because of photoconversion of previtamin D3 and vitamin D3 to inactive metabolites (lumisterol, tachysterol, 5,6-transvitamin D, and suprasterol 1 and 2) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In addition, sunlight-induces production of melanin, which reduces production of vitamin D3 in the skin.",
"   </p>",
"   <p>",
"    Infants, disabled persons and the elderly may have inadequate sun exposure, while the skin of those older than 70 years of age also does not convert vitamin D effectively. In addition, at northern latitudes, there is not enough radiation to convert vitamin D, particularly during the winter. For these reasons (in the United States), milk, infant formula, breakfast cereals, and some other foods have been fortified with synthetic vitamin D2 (ergocalciferol, which is derived from irradiation of ergosterol found in plants, the mold ergot, and plankton) or vitamin D3.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     METABOLISM OF VITAMIN D",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6107214\">",
"    <span class=\"h2\">",
"     Hepatic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dietary vitamin D is fat soluble and is absorbed in the small intestine incorporated into chylomicrons. Dietary vitamin D travels to the liver, bound to vitamin D&ndash;binding protein and in continued association with chylomicrons and lipoproteins, where it and endogenously synthesized vitamin D3 are metabolized [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The hepatic enzyme 25&ndash;hydroxylase places a hydroxyl group in the 25 position of the vitamin D molecule, resulting in the formation of 25-hydroxyvitamin D or calcidiol&nbsp;(",
"    <a class=\"graphic graphic_figure graphicRef65360 \" href=\"UTD.htm?20/23/20862\">",
"     figure 1",
"    </a>",
"    ). The association of oral vitamin D with chylomicra and lipoproteins permits more rapid hepatic delivery when compared with endogenously synthesized or parenterally administered hormone, which circulates exclusively on vitamin D-binding protein. This difference results in a rapid but less sustained increase in plasma 25-hydroxyvitamin D (25OHD) levels obtained with oral as opposed to parenteral administration or endogenous synthesis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    25-hydroxyvitamin D2 has a lower affinity than 25-hydroxyvitamin D3 for vitamin D-binding protein. Thus, 25-hydroxyvitamin D2 has a shorter half-life than 25OHD3, and treatment with vitamin D2 may not increase serum total 25OHD levels as efficiently as vitamin D3. The treatment of vitamin D deficiency is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/21/3417?source=see_link&amp;anchor=H8#H8\">",
"     \"Treatment of vitamin D deficiency in adults\", section on 'Preparations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is some feedback regulation of the hepatic 25-hydroxylase, but it is insufficient to prevent vitamin D intoxication following the ingestion of large amounts of vitamin D. The liver is the usual storage system for vitamin D. When large amounts of vitamin D are ingested, much of the excess vitamin D is stored in adipose tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/9\">",
"     9",
"    </a>",
"    ]. As these sites become saturated, the vitamin D remains in serum and is converted to toxic levels of 25-hydroxyvitamin D [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/10\">",
"     10",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/22/28007?source=see_link&amp;anchor=H12#H12\">",
"     \"Etiology of hypercalcemia\", section on 'Hypervitaminosis D'",
"    </a>",
"    .) The liver has the capacity to metabolize 25-hydroxyvitamin D to inactive metabolites. This is accomplished by the P-450 system and is enhanced by alcohol, barbiturates, and phenytoin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6107221\">",
"    <span class=\"h2\">",
"     Renal",
"    </span>",
"    &nbsp;&mdash;&nbsp;25-hydroxyvitamin D2 and D3 (25OHD) produced by the liver enters the circulation and travels to the kidney, again bound to vitamin D binding protein. This protein has a single binding site, which binds vitamin D and all of its metabolites. Only 3 to 5 percent of the total circulating binding sites are normally occupied; as a result, this protein is not rate-limiting in vitamin D metabolism unless large amounts are lost in the urine as in the nephrotic syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/11\">",
"     11",
"    </a>",
"    ]. In the renal tubule, entry of the filtered 25OHD-vitamin D binding protein complex into the cells is facilitated by receptor-mediated endocytosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/12\">",
"     12",
"    </a>",
"    ]. At least two proteins working in tandem are involved in this process: cubilin and megalin [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Cubilin and megalin, expressed in the renal proximal tubule, are multiligand receptors the facilitate uptake of extracellular ligands. Deficiency of either of these proteins results in increased 25OHD excretion in the urine and, at least in experimental models, 1,25-dihydroxyvitamin D deficiency and bone disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/12-14\">",
"     12-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Within the tubular cell, 25OHD is released from the binding protein. The renal tubular cells contain two enzymes (1-alpha-hydroxylase [CYP27B1] and 24-alpha-hydroxylase [CYP24]) that can further hydroxylate 25OHD, producing 1,25-dihydroxyvitamin D, the most active form of vitamin D, or 24,25-dihydroxyvitamin D, an inactive metabolite (",
"    <a class=\"graphic graphic_figure graphicRef65360 \" href=\"UTD.htm?20/23/20862\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. Both enzymes are members of the P-450 system [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/18\">",
"     18",
"    </a>",
"    ]. Studies in vitamin D-deficient animals suggest that the proximal tubule is the important site of synthesis. In contrast, studies in the normal human kidney indicate that the distal nephron is the predominant site of 1-alpha-hydroxylase expression under conditions of vitamin D sufficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/17\">",
"     17",
"    </a>",
"    ]. The 1-alpha hydroxylase enzyme is also expressed at extrarenal sites, including the gastrointestinal tract, skin, vasculature, mammary epithelial cells, and in osteoblasts and osteoclasts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H19171518\">",
"     'Extrarenal 1-alpha hydroxylase'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The plasma 1,25-dihydroxyvitamin D concentration is a function both of the availability of 25OHD and of the activities of the renal enzymes 1-alpha-hydroxylase and 24-alpha-hydroxylase. The renal 1-alpha-hydroxylase enzyme is primarily regulated by the following factors [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/7,18\">",
"     7,18",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Parathyroid hormone (PTH)",
"     </li>",
"     <li>",
"      Serum calcium and phosphate concentrations",
"     </li>",
"     <li>",
"      Fibroblast growth factor 23 (FGF23)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Increased PTH secretion (most often due to a fall in the plasma calcium concentration) and hypophosphatemia stimulate the enzyme and enhance 1,25 dihydroxyvitamin D production [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/21\">",
"     21",
"    </a>",
"    ]. 1,25-dihydroxyvitamin D, in turn, inhibits the synthesis and secretion of PTH, providing negative feedback regulation of 1,25-diydroxyvitamin D production. 1,25-dihydroxyvitamin D synthesis may also be modulated by vitamin D receptors on the cell surface; downregulation of these receptors may play an important role in regulating vitamin D activation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    FGF23 inhibits renal production of 1,25-dihydroxyvitamin D by inhibiting mRNA expression of 1-alpha-hydroxylase in the renal proximal tubule and by simultaneously increasing expression of 24-alpha-hydroxylase and production of 24,25-dihydroxyvitamin D (an inactive metabolite) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/23\">",
"     23",
"    </a>",
"    ]. 1,25-dihydroxyvitamin D stimulates fibroblast growth factor 23 (FGF23), a phosphaturic hormone, creating a feedback loop. Experimental data suggest that FGF23 decreases renal reabsorption of phosphate, and thereby, counteracts the increased gastrointestinal phosphate reabsorption induced by 1,25-dihydroxyvitamin D, maintaining phosphate homeostasis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Impaired degradation of FGF23 results in the abnormalities associated with autosomal dominant hypophosphatemic rickets. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/45/21209?source=see_link\">",
"     \"Hereditary hypophosphatemic rickets and tumor-induced osteomalacia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Both 1,25-dihydroxyvitamin D and 25-hydroxyvtaimn D are degraded in part by being hydroxylated at the 24-position by a 24-hydroxylase [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/7,16\">",
"     7,16",
"    </a>",
"    ]. The activity of the 24-hydroxylase gene is increased by 1,25-dihydroxyvitamin D (which therefore promotes its own inactivation) and reduced by PTH (thereby allowing more active hormone to be formed) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19171518\">",
"    <span class=\"h2\">",
"     Extrarenal 1-alpha hydroxylase",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most widely recognized manifestation of extrarenal synthesis of 1,25-dihydroxyvitamin D is hypercalcemia and hypercalciuria found in patients with granulomatous diseases, such as sarcoid. In this setting, PTH-independent extrarenal production of 1,25-dihydroxyvitamin D from 25-hydroxyvitamin D by activated macrophages in the lung and lymph nodes. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/16/2310?source=see_link&amp;anchor=H2#H2\">",
"     \"Hypercalcemia in granulomatous diseases\", section on 'Sarcoidosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 1-alpha hydroxylase enzyme is also expressed at other extrarenal sites, including the gastrointestinal tract, skin, vasculature, mammary epithelial cells, and in osteoblasts and osteoclasts [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. The physiologic significance of extrarenal production of 1,25-dihydroxyvitamin D remains uncertain. It is hypothesized that extrarenal 1,25-dihydroxyvitamin D functions in a tissue specific manner to regulate cellular proliferation and differentiation, hormone secretion, and immune function [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ACTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;1,25-dihydroxyvitamin D binds to intracellular receptors in target tissues and regulates gene transcription [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/26\">",
"     26",
"    </a>",
"    ]. It appears to function through a single vitamin D receptor (VDR), which is nearly universally expressed in nucleated cells. The receptor is a member of the class II steroid hormone receptor, and is closely related to the retinoic acid receptor and the thyroid hormone receptor [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9462/abstract/10\">",
"     10",
"    </a>",
"    ]. Its most important biological action is to promote enterocyte differentiation and the intestinal absorption of calcium. Other effects include a lesser stimulation of intestinal phosphate absorption, direct suppression of PTH release from the parathyroid gland, regulation of osteoblast function, and permissively allowing PTH-induced osteoclast activation and bone resorption (",
"    <a class=\"graphic graphic_figure graphicRef65360 \" href=\"UTD.htm?20/23/20862\">",
"     figure 1",
"    </a>",
"    ). Through these actions, calcitriol contributes to the maintenance of normal plasma concentrations of calcium and phosphate, thereby allowing mineralization of newly formed bone to take place and preventing symptomatic hypocalcemia or hypophosphatemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/50/18218?source=see_link\">",
"     \"Pathogenesis of renal osteodystrophy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The importance of 1,25 dihydroxyvitamin D in mineral metabolism is illustrated by the findings that can occur in hypervitaminosis D (hypercalcemia) and vitamin D deficiency (hypocalcemia, hypophosphatemia, and rickets or osteomalacia). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/22/28007?source=see_link\">",
"     \"Etiology of hypercalcemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24984?source=see_link\">",
"     \"Etiology of hypocalcemia in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/25/15767?source=see_link\">",
"     \"Causes of hypophosphatemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/54/27494?source=see_link\">",
"     \"Epidemiology and etiology of osteomalacia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to its role in calcium and bone homeostasis, 1,25-dihydroxyvitamin D potentially regulates many other cellular functions. Its effect on muscle function, cancer, and on the immune, cardiovascular, and metabolic system is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31193?source=see_link\">",
"     \"Vitamin D and extraskeletal health\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    25-hydroxyvitamin D is the major circulating form of vitamin D. It has a half-life of two to three weeks, shorter than that of vitamin D3 and similar to that of vitamin D2. It has activity at bone and intestine, but is less than 1 percent as potent as 1,25-dihydroxyvitamin D.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/45/10962?source=see_link\">",
"       \"Patient information: Vitamin D deficiency (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/12/36034?source=see_link\">",
"       \"Patient information: Calcium and vitamin D for bone health (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?14/62/15331?source=see_link\">",
"       \"Patient information: Vitamin D deficiency (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=see_link\">",
"       \"Patient information: Calcium and vitamin D for bone health (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6106984\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Very few foods contain vitamin D and dermal synthesis is the major source of the vitamin. Prolonged exposure of the skin to sunlight does not produce toxic amounts of vitamin D3 (cholecalciferol) because of photoconversion of previtamin D3 and vitamin D3 to inactive metabolites. In addition, sunlight-induces production of melanin, which reduces production of vitamin D3 in the skin. (See",
"      <a class=\"local\" href=\"#H5192386\">",
"       'Production'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Vitamin D2 and D3 are converted to 25-hydroxyvitamin D, the major circulating form of vitamin D, and then to 1,25-dihydroxyvitamin D, the active form of vitamin D, by enzymes in the liver and kidney. The enzymes are regulated by 1,25-dihyroxyvitamin D, parathyroid hormone (through changes in serum calcium concentration), and fibroblast growth factor (FGF) 23. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Metabolism of vitamin D'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most important biological action of 1,25-dihydroxyvitamin D is regulation of calcium and bone homeostasis. In addition, it potentially regulates many other cellular functions. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Actions'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31193?source=see_link\">",
"       \"Vitamin D and extraskeletal health\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/1\">",
"      Haddad JG. Vitamin D--solar rays, the Milky Way, or both? N Engl J Med 1992; 326:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/2\">",
"      Terushkin V, Bender A, Psaty EL, et al. Estimated equivalency of vitamin D production from natural sun exposure versus oral vitamin D supplementation across seasons at two US latitudes. J Am Acad Dermatol 2010; 62:929.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/3\">",
"      Binkley N, Novotny R, Krueger D, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab 2007; 92:2130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/4\">",
"      Holick MF. Vitamin D: A millenium perspective. J Cell Biochem 2003; 88:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/5\">",
"      Holick MF, MacLaughlin JA, Doppelt SH. Regulation of cutaneous previtamin D3 photosynthesis in man: skin pigment is not an essential regulator. Science 1981; 211:590.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/6\">",
"      Brown AJ. Regulation of vitamin D action. Nephrol Dial Transplant 1999; 14:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/7\">",
"      Christakos S, Ajibade DV, Dhawan P, et al. Vitamin D: metabolism. Endocrinol Metab Clin North Am 2010; 39:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/8\">",
"      Haddad JG, Matsuoka LY, Hollis BW, et al. Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest 1993; 91:2552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/9\">",
"      Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/10\">",
"      DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004; 80:1689S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/11\">",
"      Vaziri ND. Endocrinological consequences of the nephrotic syndrome. Am J Nephrol 1993; 13:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/12\">",
"      Nykjaer A, Dragun D, Walther D, et al. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 1999; 96:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/13\">",
"      Nykjaer A, Fyfe JC, Kozyraki R, et al. Cubilin dysfunction causes abnormal metabolism of the steroid hormone 25(OH) vitamin D(3). Proc Natl Acad Sci U S A 2001; 98:13895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/14\">",
"      Negri AL. Proximal tubule endocytic apparatus as the specific renal uptake mechanism for vitamin D-binding protein/25-(OH)D3 complex. Nephrology (Carlton) 2006; 11:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/15\">",
"      Kawashima H, Torikai S, Kurokawa K. Localization of 25-hydroxyvitamin D3 1 alpha-hydroxylase and 24-hydroxylase along the rat nephron. Proc Natl Acad Sci U S A 1981; 78:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/16\">",
"      Zierold C, Darwish HM, DeLuca HF. Identification of a vitamin D-response element in the rat calcidiol (25-hydroxyvitamin D3) 24-hydroxylase gene. Proc Natl Acad Sci U S A 1994; 91:900.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/17\">",
"      Zehnder D, Bland R, Walker EA, et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol 1999; 10:2465.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/18\">",
"      Takeyama K, Kitanaka S, Sato T, et al. 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 1997; 277:1827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/19\">",
"      van Driel M, Koedam M, Buurman CJ, et al. Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization. J Cell Biochem 2006; 99:922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/20\">",
"      Hewison M, Burke F, Evans KN, et al. Extra-renal 25-hydroxyvitamin D3-1alpha-hydroxylase in human health and disease. J Steroid Biochem Mol Biol 2007; 103:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/21\">",
"      Portale AA, Halloran BP, Morris RC Jr. Physiologic regulation of the serum concentration of 1,25-dihydroxyvitamin D by phosphorus in normal men. J Clin Invest 1989; 83:1494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/22\">",
"      Iida K, Shinki T, Yamaguchi A, et al. A possible role of vitamin D receptors in regulating vitamin D activation in the kidney. Proc Natl Acad Sci U S A 1995; 92:6112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/23\">",
"      Pri&eacute; D, Friedlander G. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system. Clin J Am Soc Nephrol 2010; 5:1717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/24\">",
"      Liu S, Tang W, Zhou J, et al. Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 2006; 17:1305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/25\">",
"      Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab 2009; 94:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9462/abstract/26\">",
"      Lowe KE, Maiyar AC, Norman AW. Vitamin D-mediated gene expression. Crit Rev Eukaryot Gene Expr 1992; 2:65.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2021 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-222.190.118.195-3C09538E6E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9462=[""].join("\n");
var outline_f9_15_9462=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H6106984\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5192386\">",
"      PRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      METABOLISM OF VITAMIN D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6107214\">",
"      Hepatic",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6107221\">",
"      Renal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19171518\">",
"      Extrarenal 1-alpha hydroxylase",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ACTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6106984\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/2021\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/2021|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/23/20862\" title=\"figure 1\">",
"      Vit D metabolism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/25/15767?source=related_link\">",
"      Causes of hypophosphatemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/18/38184?source=related_link\">",
"      Causes of vitamin D deficiency and resistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/54/27494?source=related_link\">",
"      Epidemiology and etiology of osteomalacia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/37/28248?source=related_link\">",
"      Etiology and treatment of calcipenic rickets in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/22/28007?source=related_link\">",
"      Etiology of hypercalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/25/24984?source=related_link\">",
"      Etiology of hypocalcemia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/45/21209?source=related_link\">",
"      Hereditary hypophosphatemic rickets and tumor-induced osteomalacia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/16/2310?source=related_link\">",
"      Hypercalcemia in granulomatous diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/3/39990?source=related_link\">",
"      Overview of vitamin D",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/50/18218?source=related_link\">",
"      Pathogenesis of renal osteodystrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/12/36034?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?14/62/15331?source=related_link\">",
"      Patient information: Vitamin D deficiency (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/45/10962?source=related_link\">",
"      Patient information: Vitamin D deficiency (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/21/3417?source=related_link\">",
"      Treatment of vitamin D deficiency in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/29/31193?source=related_link\">",
"      Vitamin D and extraskeletal health",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/38/28266?source=related_link\">",
"      Vitamin D insufficiency and deficiency in children and adolescents",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_15_9463="Calculator: Blood pressure percentiles for boys (2 to 17 years)";
var content_f9_15_9463=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"BloodPressurePercentBoys_form\" name=\"BloodPressurePercentBoys_form\" onkeydown=\"clrResults();\" onkeyup=\"BloodPressurePercentBoys_fx();\" onreset=\"rrclr();\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: Blood pressure percentiles for boys (2 to 17 years)",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_main\">",
"     <center>",
"      <table cellpadding=\"6\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"95%\">",
"       <tr>",
"        <td align=\"right\" width=\"50%\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Input:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Age",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Age_param\" onblur=\"BloodPressurePercentBoys_fx(); minMaxCheck();\" onchange=\"BloodPressurePercentBoys_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Age_unit\" onchange=\"BloodPressurePercentBoys_fx();\" style=\"width:105px;\">",
"              <option value=\"0.0833333333333333|0|mo\">",
"               mo",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|yr\">",
"               yr",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Height",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Height_param\" onblur=\"BloodPressurePercentBoys_fx(); minMaxCheck();\" onchange=\"BloodPressurePercentBoys_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Height_unit\" onchange=\"BloodPressurePercentBoys_fx();\" style=\"width:105px;\">",
"              <option selected=\"selected\" value=\"1|0|cm\">",
"               cm",
"              </option>",
"              <option value=\"2.54|0|in\">",
"               in",
"              </option>",
"              <option value=\"100|0|m\">",
"               m",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Systolic BP",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Systolic_BP_param\" onblur=\"BloodPressurePercentBoys_fx(); minMaxCheck();\" onchange=\"BloodPressurePercentBoys_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Systolic_BP_unit\" onchange=\"BloodPressurePercentBoys_fx();\" style=\"width:105px;\">",
"              <option value=\"10|0|cmHg\">",
"               cmHg",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|mmHg\">",
"               mmHg",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\" width=\"42%\">",
"             <span class=\"medCalcFontOneBold\">",
"              Diastolic BP",
"             </span>",
"            </td>",
"            <td align=\"left\" nowrap=\"nowrap\" valign=\"top\" width=\"5%\">",
"             &nbsp;",
"             <input name=\"Diastolic_BP_param\" onblur=\"BloodPressurePercentBoys_fx(); minMaxCheck();\" onchange=\"BloodPressurePercentBoys_fx();\" size=\"6\" type=\"text\" value=\"\"/>",
"            </td>",
"            <td align=\"left\" valign=\"top\" width=\"115\">",
"             <select class=\"medCalcFontSelect\" name=\"Diastolic_BP_unit\" onchange=\"BloodPressurePercentBoys_fx();\" style=\"width:105px;\">",
"              <option value=\"10|0|cmHg\">",
"               cmHg",
"              </option>",
"              <option selected=\"selected\" value=\"1|0|mmHg\">",
"               mmHg",
"              </option>",
"             </select>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"        </td>",
"        <td align=\"left\" bgcolor=\"#eeeeee\">",
"         <center>",
"          <span class=\"medCalcFontIO\">",
"           Results:",
"          </span>",
"          <br/>",
"          &nbsp;",
"          <br/>",
"          <table bgcolor=\"#eeeeee\" cellspacing=\"4\" summary=\"MedCalc 3000 Table\">",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Height Percentile",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Height_Percentile_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"2\">",
"             &nbsp;",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Systolic BP Percentile",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Systolic_BP_Percentile_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              Diastolic BP Percentile",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"Diastolic_BP_Percentile_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"2\">",
"             &nbsp;",
"             <br/>",
"             <center>",
"              <span class=\"medCalcFontIO2\">",
"               Threshold for Stage II hypertension*",
"               <br/>",
"               (defined as 99th percentile plus 5 mmHg)",
"              </span>",
"             </center>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              SBP Threshold",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"SBP_Threshold_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td align=\"right\">",
"             <span class=\"medCalcFontOneBold\">",
"              DBP Threshold",
"             </span>",
"            </td>",
"            <td nowrap=\"nowrap\" valign=\"top\">",
"             &nbsp;",
"             <input name=\"DBP_Threshold_param\" onfocus=\"blur();\" size=\"6\" type=\"text\"/>",
"            </td>",
"           </tr>",
"           <tr>",
"            <td colspan=\"3\">",
"             &nbsp;",
"             <br/>",
"            </td>",
"           </tr>",
"          </table>",
"         </center>",
"         <br/>",
"         &nbsp;",
"         <br/>",
"         <center>",
"          <span class=\"medCalcFontOne\">",
"           <input name=\"reset\" type=\"reset\" value=\"Reset form\"/>",
"          </span>",
"         </center>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"70%\">",
"      <tr>",
"       <td bgcolor=\"#eeeeee\" width=\"1%\">",
"        <br/>",
"       </td>",
"       <td align=\"left\" bgcolor=\"#eeeeee\">",
"        <span class=\"medCalcFontTitleBox\">",
"         Systolic BP Percentile Interpretation",
"        </span>",
"       </td>",
"      </tr>",
"     </table>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <center>",
"      <table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" summary=\"RRTable\">",
"       <tr id=\"rr1_1\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          Percentile &lt; 90:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Normal Systolic Blood Pressure",
"         </span>",
"        </td>",
"       </tr>",
"       <tr id=\"rr1_2\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          Percentile &gt;= 90 and &lt; 95:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Prehypertensive Systolic Blood Pressure",
"         </span>",
"        </td>",
"       </tr>",
"       <tr id=\"rr1_3\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          Percentile &gt;= 95:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Hypertensive Systolic Blood Pressure",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"70%\">",
"      <tr>",
"       <td bgcolor=\"#eeeeee\" width=\"1%\">",
"        <br/>",
"       </td>",
"       <td align=\"left\" bgcolor=\"#eeeeee\">",
"        <span class=\"medCalcFontTitleBox\">",
"         Diastolic BP Percentile Interpretation",
"        </span>",
"       </td>",
"      </tr>",
"     </table>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <center>",
"      <table border=\"1\" cellpadding=\"4\" cellspacing=\"0\" summary=\"RRTable\">",
"       <tr id=\"rr2_1\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          Percentile &lt; 90:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Normal Diastolic Blood Pressure",
"         </span>",
"        </td>",
"       </tr>",
"       <tr id=\"rr2_2\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          Percentile &gt;= 90 and &lt; 95:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Prehypertensive Diastolic Blood Pressure",
"         </span>",
"        </td>",
"       </tr>",
"       <tr id=\"rr2_3\">",
"        <td align=\"right\" nowrap=\"nowrap\" style=\"border-right: 0px\">",
"         <span class=\"medCalcFontOneBold\">",
"          Percentile &gt;= 95:",
"         </span>",
"        </td>",
"        <td align=\"left\" style=\"border-left: 0px;\">",
"         <span class=\"medCalcFontOne\">",
"          Hypertensive Diastolic Blood Pressure",
"         </span>",
"        </td>",
"       </tr>",
"      </table>",
"     </center>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOne\">",
"      Prehypertension is defined as Systolic and/or Diastolic BP &gt;= 90th percentile but &lt; 95th percentile, OR if BP exceeds 120/80 mmHg even if &lt; 90th percentile.",
"      <br/>",
"      &nbsp;",
"      <br/>",
"      Hypertension is defined as either systolic and/or diastolic BP &gt;= 95th percentile measured upon three or more occasions.",
"The cuff size should be carefully matched to the size of the patient's arm to avoid inaccurate measurements.",
"      <br/>",
"      &nbsp;",
"      <br/>",
"      <font color=\"#aa0000\">",
"       * To facilitate staging of hypertension for this patient, the calculated threshold for stage II hypertension is displayed above.",
"      </font>",
"     </span>",
"     <ul class=\"medCalcFontOne\">",
"      <li>",
"       Stage I hypertension is defined as either Systolic BP or Diastolic BP between the 95th percentile and the 99th percentile plus 5 mmHg.",
"      </li>",
"      <li>",
"       Stage II hypertension is defined as either Systolic BP or Diastolic BP greater than the 99th percentile plus 5 mmHg.",
"      </li>",
"     </ul>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <span class=\"medCalcFontOne\">",
"      Children and adolescents whose BP exceeds 120/80 mmHg are considered prehypertensive even if the blood pressure",
"is &lt; 90th percentile",
"      <sup>",
"       1",
"      </sup>",
"      .",
"      <br/>",
"      &nbsp;",
"      <br/>",
"      In this calculator, the subject's blood pressure percentiles are based on age and height percentile.",
"     </span>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.",
"        <i>",
"         Pediatrics",
"        </i>",
"        . 2004 Aug;114(2 Suppl 4th Report):555-76.",
"       </span>",
"      </li>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Percentile conversion from Z-Score is done by table look-up in the standard Normal Table. Percentiles are provided for Z Scores between -3.09 and 3.09.  Values beyond these extremes return percentiles of 0.1 and 99.9 respectively.",
"       </span>",
"      </li>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        LMS Parameters for Boys: Height for Age. National health and nutrition survey (NHANES), CDC/National Center for Health Statistics.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9463=[" ",
"",
"",
"function log(i){",
"return Math.log(i) * Math.LOG10E;   ",
"}",
"",
"function ln(i){",
"return Math.log(i);",
"}",
"",
"function sq(i){",
"return i * i;",
"}",
"",
"function sqr(i){",
"return Math.sqrt(i);",
"}",
"",
"",
"function power(x,y){",
"return Math.pow(x,y);",
"}",
"",
"function eTo(x){",
"return Math.exp(x);",
"}",
"",
"",
"function fixDP(r, dps) {",
"if (isNaN(r)) return \"NaN\";",
"var msign = '';",
"if (r < 0) msign = '-';",
"x = Math.abs(r);",
"if (x > Math.pow(10, 21)) return msign + x.toString();",
"var m = Math.round(x * Math.pow(10, dps)).toString();",
"if (dps == 0) return msign + m;",
"while (m.length <= dps) m = \"0\" + m;",
"return msign + m.substring(0, m.length - dps) + \".\" + m.substring(m.length - dps);",
"}",
"",
"var currenttimeout;",
"",
"n = new Array;",
"var L = 0;",
"var M = 0;",
"var S = 0;",
"",
"n[0] = 50;",
"n[1] = 50.399;",
"n[2] = 50.798;",
"n[3] = 51.197;",
"n[4] = 51.595;",
"n[5] = 51.994;",
"n[6] = 52.392;",
"n[7] = 52.79;",
"n[8] = 53.188;",
"n[9] = 53.586;",
"n[10] = 53.983;",
"n[11] = 54.38;",
"n[12] = 54.776;",
"n[13] = 55.172;",
"n[14] = 55.567;",
"n[15] = 55.962;",
"n[16] = 56.356;",
"n[17] = 56.749;",
"n[18] = 57.142;",
"n[19] = 57.535;",
"n[20] = 57.926;",
"n[21] = 58.317;",
"n[22] = 58.706;",
"n[23] = 59.095;",
"n[24] = 59.483;",
"n[25] = 59.871;",
"n[26] = 60.257;",
"n[27] = 60.642;",
"n[28] = 61.026;",
"n[29] = 61.409;",
"n[30] = 61.791;",
"n[31] = 62.172;",
"n[32] = 62.552;",
"n[33] = 62.93;",
"n[34] = 63.307;",
"n[35] = 63.683;",
"n[36] = 64.058;",
"n[37] = 64.431;",
"n[38] = 64.803;",
"n[39] = 65.173;",
"n[40] = 65.542;",
"n[41] = 65.91;",
"n[42] = 66.276;",
"n[43] = 66.64;",
"n[44] = 67.003;",
"n[45] = 67.364;",
"n[46] = 67.724;",
"n[47] = 68.082;",
"n[48] = 68.439;",
"n[49] = 68.793;",
"n[50] = 69.146;",
"n[51] = 69.497;",
"n[52] = 69.847;",
"n[53] = 70.194;",
"n[54] = 70.54;",
"n[55] = 70.884;",
"n[56] = 71.226;",
"n[57] = 71.566;",
"n[58] = 71.904;",
"n[59] = 72.24;",
"n[60] = 72.575;",
"n[61] = 72.907;",
"n[62] = 73.237;",
"n[63] = 73.565;",
"n[64] = 73.891;",
"n[65] = 74.215;",
"n[66] = 74.537;",
"n[67] = 74.857;",
"n[68] = 75.175;",
"n[69] = 75.49;",
"n[70] = 75.804;",
"n[71] = 76.115;",
"n[72] = 76.424;",
"n[73] = 76.73;",
"n[74] = 77.035;",
"n[75] = 77.337;",
"n[76] = 77.637;",
"n[77] = 77.935;",
"n[78] = 78.23;",
"n[79] = 78.524;",
"n[80] = 78.814;",
"n[81] = 79.103;",
"n[82] = 79.389;",
"n[83] = 79.673;",
"n[84] = 79.955;",
"n[85] = 80.234;",
"n[86] = 80.511;",
"n[87] = 80.785;",
"n[88] = 81.057;",
"n[89] = 81.327;",
"n[90] = 81.594;",
"n[91] = 81.859;",
"n[92] = 82.121;",
"n[93] = 82.381;",
"n[94] = 82.639;",
"n[95] = 82.894;",
"n[96] = 83.147;",
"n[97] = 83.398;",
"n[98] = 83.646;",
"n[99] = 83.891;",
"n[100] = 84.134;",
"n[101] = 84.375;",
"n[102] = 84.614;",
"n[103] = 84.849;",
"n[104] = 85.083;",
"n[105] = 85.314;",
"n[106] = 85.543;",
"n[107] = 85.769;",
"n[108] = 85.993;",
"n[109] = 86.214;",
"n[110] = 86.433;",
"n[111] = 86.65;",
"n[112] = 86.864;",
"n[113] = 87.076;",
"n[114] = 87.286;",
"n[115] = 87.493;",
"n[116] = 87.698;",
"n[117] = 87.9;",
"n[118] = 88.1;",
"n[119] = 88.298;",
"n[120] = 88.493;",
"n[121] = 88.686;",
"n[122] = 88.877;",
"n[123] = 89.065;",
"n[124] = 89.251;",
"n[125] = 89.435;",
"n[126] = 89.617;",
"n[127] = 89.796;",
"n[128] = 89.973;",
"n[129] = 90.147;",
"n[130] = 90.32;",
"n[131] = 90.49;",
"n[132] = 90.658;",
"n[133] = 90.824;",
"n[134] = 90.988;",
"n[135] = 91.149;",
"n[136] = 91.308;",
"n[137] = 91.466;",
"n[138] = 91.621;",
"n[139] = 91.774;",
"n[140] = 91.924;",
"n[141] = 92.073;",
"n[142] = 92.22;",
"n[143] = 92.364;",
"n[144] = 92.507;",
"n[145] = 92.647;",
"n[146] = 92.785;",
"n[147] = 92.922;",
"n[148] = 93.056;",
"n[149] = 93.189;",
"n[150] = 93.319;",
"n[151] = 93.448;",
"n[152] = 93.574;",
"n[153] = 93.699;",
"n[154] = 93.822;",
"n[155] = 93.943;",
"n[156] = 94.062;",
"n[157] = 94.179;",
"n[158] = 94.295;",
"n[159] = 94.408;",
"n[160] = 94.52;",
"n[161] = 94.63;",
"n[162] = 94.738;",
"n[163] = 94.845;",
"n[164] = 94.95;",
"n[165] = 95.053;",
"n[166] = 95.154;",
"n[167] = 95.254;",
"n[168] = 95.352;",
"n[169] = 95.449;",
"n[170] = 95.543;",
"n[171] = 95.637;",
"n[172] = 95.728;",
"n[173] = 95.818;",
"n[174] = 95.907;",
"n[175] = 95.994;",
"n[176] = 96.08;",
"n[177] = 96.164;",
"n[178] = 96.246;",
"n[179] = 96.327;",
"n[180] = 96.407;",
"n[181] = 96.485;",
"n[182] = 96.562;",
"n[183] = 96.638;",
"n[184] = 96.712;",
"n[185] = 96.784;",
"n[186] = 96.856;",
"n[187] = 96.926;",
"n[188] = 96.995;",
"n[189] = 97.062;",
"n[190] = 97.128;",
"n[191] = 97.193;",
"n[192] = 97.257;",
"n[193] = 97.32;",
"n[194] = 97.381;",
"n[195] = 97.441;",
"n[196] = 97.5;",
"n[197] = 97.558;",
"n[198] = 97.615;",
"n[199] = 97.67;",
"n[200] = 97.725;",
"n[201] = 97.778;",
"n[202] = 97.831;",
"n[203] = 97.882;",
"n[204] = 97.932;",
"n[205] = 97.982;",
"n[206] = 98.03;",
"n[207] = 98.077;",
"n[208] = 98.124;",
"n[209] = 98.169;",
"n[210] = 98.214;",
"n[211] = 98.257;",
"n[212] = 98.3;",
"n[213] = 98.341;",
"n[214] = 98.382;",
"n[215] = 98.422;",
"n[216] = 98.461;",
"n[217] = 98.5;",
"n[218] = 98.537;",
"n[219] = 98.574;",
"n[220] = 98.61;",
"n[221] = 98.645;",
"n[222] = 98.679;",
"n[223] = 98.713;",
"n[224] = 98.745;",
"n[225] = 98.778;",
"n[226] = 98.809;",
"n[227] = 98.84;",
"n[228] = 98.87;",
"n[229] = 98.899;",
"n[230] = 98.928;",
"n[231] = 98.956;",
"n[232] = 98.983;",
"n[233] = 99.01;",
"n[234] = 99.036;",
"n[235] = 99.061;",
"n[236] = 99.086;",
"n[237] = 99.111;",
"n[238] = 99.134;",
"n[239] = 99.158;",
"n[240] = 99.18;",
"n[241] = 99.202;",
"n[242] = 99.224;",
"n[243] = 99.245;",
"n[244] = 99.266;",
"n[245] = 99.286;",
"n[246] = 99.305;",
"n[247] = 99.324;",
"n[248] = 99.343;",
"n[249] = 99.361;",
"n[250] = 99.379;",
"n[251] = 99.396;",
"n[252] = 99.413;",
"n[253] = 99.43;",
"n[254] = 99.446;",
"n[255] = 99.461;",
"n[256] = 99.477;",
"n[257] = 99.492;",
"n[258] = 99.506;",
"n[259] = 99.52;",
"n[260] = 99.534;",
"n[261] = 99.547;",
"n[262] = 99.56;",
"n[263] = 99.573;",
"n[264] = 99.585;",
"n[265] = 99.598;",
"n[266] = 99.609;",
"n[267] = 99.621;",
"n[268] = 99.632;",
"n[269] = 99.643;",
"n[270] = 99.653;",
"n[271] = 99.664;",
"n[272] = 99.674;",
"n[273] = 99.683;",
"n[274] = 99.693;",
"n[275] = 99.702;",
"n[276] = 99.711;",
"n[277] = 99.72;",
"n[278] = 99.728;",
"n[279] = 99.736;",
"n[280] = 99.744;",
"n[281] = 99.752;",
"n[282] = 99.76;",
"n[283] = 99.767;",
"n[284] = 99.774;",
"n[285] = 99.781;",
"n[286] = 99.788;",
"n[287] = 99.795;",
"n[288] = 99.801;",
"n[289] = 99.807;",
"n[290] = 99.813;",
"n[291] = 99.819;",
"n[292] = 99.825;",
"n[293] = 99.831;",
"n[294] = 99.836;",
"n[295] = 99.841;",
"n[296] = 99.846;",
"n[297] = 99.851;",
"n[298] = 99.856;",
"n[299] = 99.861;",
"n[300] = 99.865;",
"n[301] = 99.869;",
"n[302] = 99.874;",
"n[303] = 99.878;",
"n[304] = 99.882;",
"n[305] = 99.886;",
"n[306] = 99.889;",
"n[307] = 99.893;",
"n[308] = 99.896;",
"n[309] = 99.9;",
"",
"function ZtoPercentile(z){",
"with (document.BloodPressurePercentBoys_form){",
"az = Math.abs(z);",
"if (z < -3.09) return 0.1;",
"if (z > 3.09) return 99.9;",
"thispercentile = n[Math.round(az * 100)];",
"if (z >= 0) { return thispercentile }",
"else { return 100 - thispercentile }",
"}}",
"",
"var calctxt = ''; ",
"var xmltxt = ''; ",
"var htmtxt = ''; ",
"",
"",
"",
"function BloodPressurePercentBoys_fx() {",
"",
"currenttimeout = self.setTimeout('minMaxCheck();', 3000);",
"",
"with(document.BloodPressurePercentBoys_form){",
"",
"",
"doCalc = true;",
"if (Age_param.value.indexOf(',') >= 0){ Age_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Age_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Age_unit.options[Age_unit.selectedIndex].value.split('|');",
"Age = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Height_param.value.indexOf(',') >= 0){ Height_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Height_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Height_unit.options[Height_unit.selectedIndex].value.split('|');",
"Height = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Systolic_BP_param.value.indexOf(',') >= 0){ Systolic_BP_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Systolic_BP_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Systolic_BP_unit.options[Systolic_BP_unit.selectedIndex].value.split('|');",
"Systolic_BP = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"if (Diastolic_BP_param.value.indexOf(',') >= 0){ Diastolic_BP_param.value = ''; doCalc = false; alert('Comma character not allowed'); }",
"param_value = parseFloat(Diastolic_BP_param.value);",
"if (isNaN(param_value)){param_value = \"\"; doCalc = false;}",
"unit_parts = Diastolic_BP_unit.options[Diastolic_BP_unit.selectedIndex].value.split('|');",
"Diastolic_BP = param_value * parseFloat(unit_parts[0]) + parseFloat(unit_parts[1]);",
"dp = 0;",
"Age_Months =  Age * 12;",
"",
"if(Age_Months >= 24 && Age_Months < 25){L = 1.00720807; M = 86.86160934; S = 0.040395626;};",
"if(Age_Months >= 25 && Age_Months < 26){L = 0.837251351; M = 87.65247282; S = 0.040577525;};",
"if(Age_Months >= 26 && Age_Months < 27){L = 0.681492975; M = 88.42326434; S = 0.040723122;};",
"if(Age_Months >= 27 && Age_Months < 28){L = 0.538779654; M = 89.17549228; S = 0.040833194;};",
"if(Age_Months >= 28 && Age_Months < 29){L = 0.407697153; M = 89.91040853; S = 0.040909059;};",
"if(Age_Months >= 29 && Age_Months < 30){L = 0.286762453; M = 90.62907762; S = 0.040952433;};",
"if(Age_Months >= 30 && Age_Months < 31){L = 0.174489485; M = 91.33242379; S = 0.04096533;};",
"if(Age_Months >= 31 && Age_Months < 32){L = 0.069444521; M = 92.02127167; S = 0.040949976;};",
"if(Age_Months >= 32 && Age_Months < 33){L = -0.029720564; M = 92.69637946; S = 0.040908737;};",
"if(Age_Months >= 33 && Age_Months < 34){L = -0.124251789; M = 93.35846546; S = 0.040844062;};",
"if(Age_Months >= 34 && Age_Months < 35){L = -0.215288396; M = 94.00822923; S = 0.040758431;};",
"if(Age_Months >= 35 && Age_Months < 36){L = -0.30385434; M = 94.64636981; S = 0.040654312;};",
"if(Age_Months >= 36 && Age_Months < 37){L = -0.390918369; M = 95.27359106; S = 0.04053412;};",
"if(Age_Months >= 37 && Age_Months < 38){L = -0.254801167; M = 95.91474929; S = 0.040572876;};",
"if(Age_Months >= 38 && Age_Months < 39){L = -0.125654535; M = 96.54734328; S = 0.04061691;};",
"if(Age_Months >= 39 && Age_Months < 40){L = -0.00316735; M = 97.17191309; S = 0.040666414;};",
"if(Age_Months >= 40 && Age_Months < 41){L = 0.11291221; M = 97.78897727; S = 0.040721467;};",
"if(Age_Months >= 41 && Age_Months < 42){L = 0.222754969; M = 98.3990283; S = 0.040782045;};",
"if(Age_Months >= 42 && Age_Months < 43){L = 0.326530126; M = 99.00254338; S = 0.040848042;};",
"if(Age_Months >= 43 && Age_Months < 44){L = 0.42436156; M = 99.599977; S = 0.040919281;};",
"if(Age_Months >= 44 && Age_Months < 45){L = 0.516353108; M = 100.191764; S = 0.040995524;};",
"if(Age_Months >= 45 && Age_Months < 46){L = 0.602595306; M = 100.7783198; S = 0.041076485;};",
"if(Age_Months >= 46 && Age_Months < 47){L = 0.683170764; M = 101.3600411; S = 0.041161838;};",
"if(Age_Months >= 47 && Age_Months < 48){L = 0.758158406; M = 101.9373058; S = 0.041251224;};",
"if(Age_Months >= 48 && Age_Months < 49){L = 0.827636736; M = 102.5104735; S = 0.041344257;};",
"if(Age_Months >= 49 && Age_Months < 50){L = 0.891686306; M = 103.0798852; S = 0.041440534;};",
"if(Age_Months >= 50 && Age_Months < 51){L = 0.95039153; M = 103.645864; S = 0.041539635;};",
"if(Age_Months >= 51 && Age_Months < 52){L = 1.003830006; M = 104.208713; S = 0.041641136;};",
"if(Age_Months >= 52 && Age_Months < 53){L = 1.05213569; M = 104.7687256; S = 0.041744602;};",
"if(Age_Months >= 53 && Age_Months < 54){L = 1.0953669; M = 105.3261638; S = 0.041849607;};",
"if(Age_Months >= 54 && Age_Months < 55){L = 1.133652119; M = 105.8812823; S = 0.041955723;};",
"if(Age_Months >= 55 && Age_Months < 56){L = 1.167104213; M = 106.4343146; S = 0.042062532;};",
"if(Age_Months >= 56 && Age_Months < 57){L = 1.195845353; M = 106.9854769; S = 0.042169628;};",
"if(Age_Months >= 57 && Age_Months < 58){L = 1.220004233; M = 107.534968; S = 0.042276619;};",
"if(Age_Months >= 58 && Age_Months < 59){L = 1.239715856; M = 108.0829695; S = 0.042383129;};",
"if(Age_Months >= 59 && Age_Months < 60){L = 1.255121285; M = 108.6296457; S = 0.042488804;};",
"if(Age_Months >= 60 && Age_Months < 61){L = 1.266367398; M = 109.1751441; S = 0.042593311;};",
"if(Age_Months >= 61 && Age_Months < 62){L = 1.273606657; M = 109.7195954; S = 0.042696342;};",
"if(Age_Months >= 62 && Age_Months < 63){L = 1.276996893; M = 110.2631136; S = 0.042797615;};",
"if(Age_Months >= 63 && Age_Months < 64){L = 1.276701119; M = 110.8057967; S = 0.042896877;};",
"if(Age_Months >= 64 && Age_Months < 65){L = 1.272887366; M = 111.3477265; S = 0.042993904;};",
"if(Age_Months >= 65 && Age_Months < 66){L = 1.265728536; M = 111.8889694; S = 0.043088503;};",
"if(Age_Months >= 66 && Age_Months < 67){L = 1.255402281; M = 112.4295761; S = 0.043180513;};",
"if(Age_Months >= 67 && Age_Months < 68){L = 1.242090871; M = 112.9695827; S = 0.043269806;};",
"if(Age_Months >= 68 && Age_Months < 69){L = 1.225981067; M = 113.5090108; S = 0.043356287;};",
"if(Age_Months >= 69 && Age_Months < 70){L = 1.207263978; M = 114.0478678; S = 0.043439893;};",
"if(Age_Months >= 70 && Age_Months < 71){L = 1.186140222; M = 114.5861486; S = 0.043520597;};",
"if(Age_Months >= 71 && Age_Months < 72){L = 1.162796198; M = 115.1238315; S = 0.043598407;};",
"if(Age_Months >= 72 && Age_Months < 73){L = 1.137442868; M = 115.6608862; S = 0.043673359;};",
"if(Age_Months >= 73 && Age_Months < 74){L = 1.110286487; M = 116.1972691; S = 0.043745523;};",
"if(Age_Months >= 74 && Age_Months < 75){L = 1.081536236; M = 116.732925; S = 0.043815003;};",
"if(Age_Months >= 75 && Age_Months < 76){L = 1.05140374; M = 117.2677879; S = 0.043881929;};",
"if(Age_Months >= 76 && Age_Months < 77){L = 1.020102497; M = 117.8017819; S = 0.043946461;};",
"if(Age_Months >= 77 && Age_Months < 78){L = 0.987847213; M = 118.3348215; S = 0.044008785;};",
"if(Age_Months >= 78 && Age_Months < 79){L = 0.954853043; M = 118.8668123; S = 0.044069112;};",
"if(Age_Months >= 79 && Age_Months < 80){L = 0.921334742; M = 119.397652; S = 0.044127675;};",
"if(Age_Months >= 80 && Age_Months < 81){L = 0.887505723; M = 119.9272309; S = 0.044184725;};",
"if(Age_Months >= 81 && Age_Months < 82){L = 0.85357703; M = 120.455433; S = 0.044240532;};",
"if(Age_Months >= 82 && Age_Months < 83){L = 0.819756239; M = 120.9821362; S = 0.044295379;};",
"if(Age_Months >= 83 && Age_Months < 84){L = 0.786246296; M = 121.5072136; S = 0.044349559;};",
"if(Age_Months >= 84 && Age_Months < 85){L = 0.753244292; M = 122.0305342; S = 0.044403374;};",
"if(Age_Months >= 85 && Age_Months < 86){L = 0.720940222; M = 122.5519634; S = 0.04445713;};",
"if(Age_Months >= 86 && Age_Months < 87){L = 0.689515708; M = 123.0713645; S = 0.044511135;};",
"if(Age_Months >= 87 && Age_Months < 88){L = 0.659142731; M = 123.588599; S = 0.044565693;};",
"if(Age_Months >= 88 && Age_Months < 89){L = 0.629997853; M = 124.1035312; S = 0.044621104;};",
"if(Age_Months >= 89 && Age_Months < 90){L = 0.602203984; M = 124.6160161; S = 0.044677662;};",
"if(Age_Months >= 90 && Age_Months < 91){L = 0.575908038; M = 125.1259182; S = 0.044735646;};",
"if(Age_Months >= 91 && Age_Months < 92){L = 0.55123134; M = 125.6331012; S = 0.044795322;};",
"if(Age_Months >= 92 && Age_Months < 93){L = 0.528279901; M = 126.1374319; S = 0.044856941;};",
"if(Age_Months >= 93 && Age_Months < 94){L = 0.507143576; M = 126.6387804; S = 0.04492073;};",
"if(Age_Months >= 94 && Age_Months < 95){L = 0.487895344; M = 127.1370217; S = 0.044986899;};",
"if(Age_Months >= 95 && Age_Months < 96){L = 0.470590753; M = 127.6320362; S = 0.045055632;};",
"if(Age_Months >= 96 && Age_Months < 97){L = 0.455267507; M = 128.1237104; S = 0.045127088;};",
"if(Age_Months >= 97 && Age_Months < 98){L = 0.441945241; M = 128.6119383; S = 0.045201399;};",
"if(Age_Months >= 98 && Age_Months < 99){L = 0.430625458; M = 129.096622; S = 0.045278671;};",
"if(Age_Months >= 99 && Age_Months < 100){L = 0.421291648; M = 129.5776723; S = 0.045358979;};",
"if(Age_Months >= 100 && Age_Months < 101){L = 0.413909588; M = 130.0550101; S = 0.045442372;};",
"if(Age_Months >= 101 && Age_Months < 102){L = 0.408427813; M = 130.5285669; S = 0.045528869;};",
"if(Age_Months >= 102 && Age_Months < 103){L = 0.404778262; M = 130.9982857; S = 0.045618459;};",
"if(Age_Months >= 103 && Age_Months < 104){L = 0.402877077; M = 131.4641218; S = 0.045711105;};",
"if(Age_Months >= 104 && Age_Months < 105){L = 0.402625561; M = 131.9260439; S = 0.045806742;};",
"if(Age_Months >= 105 && Age_Months < 106){L = 0.40391127; M = 132.3840348; S = 0.045905281;};",
"if(Age_Months >= 106 && Age_Months < 107){L = 0.406609232; M = 132.838092; S = 0.046006604;};",
"if(Age_Months >= 107 && Age_Months < 108){L = 0.410583274; M = 133.2882291; S = 0.046110573;};",
"if(Age_Months >= 108 && Age_Months < 109){L = 0.415687443; M = 133.7344759; S = 0.046217028;};",
"if(Age_Months >= 109 && Age_Months < 110){L = 0.421767514; M = 134.1768801; S = 0.04632579;};",
"if(Age_Months >= 110 && Age_Months < 111){L = 0.428662551; M = 134.6155076; S = 0.046436662;};",
"if(Age_Months >= 111 && Age_Months < 112){L = 0.436206531; M = 135.0504433; S = 0.04654943;};",
"if(Age_Months >= 112 && Age_Months < 113){L = 0.44423; M = 135.4817925; S = 0.046663871;};",
"if(Age_Months >= 113 && Age_Months < 114){L = 0.45256176; M = 135.9096813; S = 0.046779748;};",
"if(Age_Months >= 114 && Age_Months < 115){L = 0.461030578; M = 136.3342577; S = 0.046896817;};",
"if(Age_Months >= 115 && Age_Months < 116){L = 0.469466904; M = 136.7556923; S = 0.047014827;};",
"if(Age_Months >= 116 && Age_Months < 117){L = 0.477704608; M = 137.1741794; S = 0.047133525;};",
"if(Age_Months >= 117 && Age_Months < 118){L = 0.48558272; M = 137.5899378; S = 0.047252654;};",
"if(Age_Months >= 118 && Age_Months < 119){L = 0.492947182; M = 138.0032114; S = 0.047371961;};",
"if(Age_Months >= 119 && Age_Months < 120){L = 0.499652617; M = 138.4142703; S = 0.047491194;};",
"if(Age_Months >= 120 && Age_Months < 121){L = 0.505564115; M = 138.8234114; S = 0.047610108;};",
"if(Age_Months >= 121 && Age_Months < 122){L = 0.510559047; M = 139.2309592; S = 0.047728463;};",
"if(Age_Months >= 122 && Age_Months < 123){L = 0.514528903; M = 139.6372663; S = 0.04784603;};",
"if(Age_Months >= 123 && Age_Months < 124){L = 0.517381177; M = 140.042714; S = 0.047962592;};",
"if(Age_Months >= 124 && Age_Months < 125){L = 0.519041285; M = 140.4477127; S = 0.048077942;};",
"if(Age_Months >= 125 && Age_Months < 126){L = 0.519454524; M = 140.8527022; S = 0.048191889;};",
"if(Age_Months >= 126 && Age_Months < 127){L = 0.518588072; M = 141.2581515; S = 0.048304259;};",
"if(Age_Months >= 127 && Age_Months < 128){L = 0.516433004; M = 141.6645592; S = 0.048414893;};",
"if(Age_Months >= 128 && Age_Months < 129){L = 0.513006312; M = 142.072452; S = 0.048523648;};",
"if(Age_Months >= 129 && Age_Months < 130){L = 0.508352901; M = 142.4823852; S = 0.048630402;};",
"if(Age_Months >= 130 && Age_Months < 131){L = 0.502547502; M = 142.8949403; S = 0.04873505;};",
"if(Age_Months >= 131 && Age_Months < 132){L = 0.495696454; M = 143.3107241; S = 0.048837504;};",
"if(Age_Months >= 132 && Age_Months < 133){L = 0.487939275; M = 143.7303663; S = 0.048937694;};",
"if(Age_Months >= 133 && Age_Months < 134){L = 0.479449924; M = 144.1545167; S = 0.049035564;};",
"if(Age_Months >= 134 && Age_Months < 135){L = 0.470437652; M = 144.5838414; S = 0.049131073;};",
"if(Age_Months >= 135 && Age_Months < 136){L = 0.461147305; M = 145.0190192; S = 0.049224189;};",
"if(Age_Months >= 136 && Age_Months < 137){L = 0.451858946; M = 145.4607359; S = 0.049314887;};",
"if(Age_Months >= 137 && Age_Months < 138){L = 0.442886661; M = 145.9096784; S = 0.049403145;};",
"if(Age_Months >= 138 && Age_Months < 139){L = 0.434576385; M = 146.3665278; S = 0.049488934;};",
"if(Age_Months >= 139 && Age_Months < 140){L = 0.427302633; M = 146.8319513; S = 0.049572216;};",
"if(Age_Months >= 140 && Age_Months < 141){L = 0.421464027; M = 147.3065929; S = 0.049652935;};",
"if(Age_Months >= 141 && Age_Months < 142){L = 0.417477538; M = 147.7910635; S = 0.049731004;};",
"if(Age_Months >= 142 && Age_Months < 143){L = 0.415771438; M = 148.2859294; S = 0.0498063;};",
"if(Age_Months >= 143 && Age_Months < 144){L = 0.416777012; M = 148.7917006; S = 0.04987865;};",
"if(Age_Months >= 144 && Age_Months < 145){L = 0.420919142; M = 149.3088178; S = 0.049947823;};",
"if(Age_Months >= 145 && Age_Months < 146){L = 0.428606007; M = 149.8376391; S = 0.050013518;};",
"if(Age_Months >= 146 && Age_Months < 147){L = 0.440218167; M = 150.3784267; S = 0.050075353;};",
"if(Age_Months >= 147 && Age_Months < 148){L = 0.456097443; M = 150.9313331; S = 0.050132858;};",
"if(Age_Months >= 148 && Age_Months < 149){L = 0.476536014; M = 151.4963887; S = 0.050185471;};",
"if(Age_Months >= 149 && Age_Months < 150){L = 0.501766234; M = 152.0734897; S = 0.050232532;};",
"if(Age_Months >= 150 && Age_Months < 151){L = 0.531951655; M = 152.6623878; S = 0.050273285;};",
"if(Age_Months >= 151 && Age_Months < 152){L = 0.567179725; M = 153.2626819; S = 0.050306885;};",
"if(Age_Months >= 152 && Age_Months < 153){L = 0.607456565; M = 153.8738124; S = 0.050332406;};",
"if(Age_Months >= 153 && Age_Months < 154){L = 0.652704121; M = 154.495058; S = 0.05034886;};",
"if(Age_Months >= 154 && Age_Months < 155){L = 0.702759868; M = 155.1255365; S = 0.050355216;};",
"if(Age_Months >= 155 && Age_Months < 156){L = 0.757379106; M = 155.7642086; S = 0.050350423;};",
"if(Age_Months >= 156 && Age_Months < 157){L = 0.816239713; M = 156.4098858; S = 0.050333444;};",
"if(Age_Months >= 157 && Age_Months < 158){L = 0.878947416; M = 157.0612415; S = 0.050303283;};",
"if(Age_Months >= 158 && Age_Months < 159){L = 0.945053486; M = 157.7168289; S = 0.050259018;};",
"if(Age_Months >= 159 && Age_Months < 160){L = 1.014046108; M = 158.3750929; S = 0.050199837;};",
"if(Age_Months >= 160 && Age_Months < 161){L = 1.085383319; M = 159.034399; S = 0.050125062;};",
"if(Age_Months >= 161 && Age_Months < 162){L = 1.158487278; M = 159.6930501; S = 0.05003418;};",
"if(Age_Months >= 162 && Age_Months < 163){L = 1.232768816; M = 160.3493168; S = 0.049926861;};",
"if(Age_Months >= 163 && Age_Months < 164){L = 1.307628899; M = 161.0014586; S = 0.049802977;};",
"if(Age_Months >= 164 && Age_Months < 165){L = 1.382473225; M = 161.6477515; S = 0.04966261;};",
"if(Age_Months >= 165 && Age_Months < 166){L = 1.456720479; M = 162.2865119; S = 0.049506051;};",
"if(Age_Months >= 166 && Age_Months < 167){L = 1.529810247; M = 162.9161202; S = 0.049333801;};",
"if(Age_Months >= 167 && Age_Months < 168){L = 1.601219573; M = 163.535045; S = 0.049146553;};",
"if(Age_Months >= 168 && Age_Months < 169){L = 1.670433444; M = 164.1418486; S = 0.04894519;};",
"if(Age_Months >= 169 && Age_Months < 170){L = 1.736995571; M = 164.7352199; S = 0.048730749;};",
"if(Age_Months >= 170 && Age_Months < 171){L = 1.800483802; M = 165.3139755; S = 0.048504404;};",
"if(Age_Months >= 171 && Age_Months < 172){L = 1.860518777; M = 165.8770715; S = 0.048267442;};",
"if(Age_Months >= 172 && Age_Months < 173){L = 1.916765525; M = 166.4236087; S = 0.04802123;};",
"if(Age_Months >= 173 && Age_Months < 174){L = 1.968934444; M = 166.9528354; S = 0.047767192;};",
"if(Age_Months >= 174 && Age_Months < 175){L = 2.016781776; M = 167.4641466; S = 0.047506783;};",
"if(Age_Months >= 175 && Age_Months < 176){L = 2.060109658; M = 167.9570814; S = 0.047241456;};",
"if(Age_Months >= 176 && Age_Months < 177){L = 2.098765817; M = 168.4313175; S = 0.04697265;};",
"if(Age_Months >= 177 && Age_Months < 178){L = 2.132642948; M = 168.8866644; S = 0.046701759;};",
"if(Age_Months >= 178 && Age_Months < 179){L = 2.16167779; M = 169.3230548; S = 0.046430122;};",
"if(Age_Months >= 179 && Age_Months < 180){L = 2.185849904; M = 169.7405351; S = 0.046159004;};",
"if(Age_Months >= 180 && Age_Months < 181){L = 2.205180153; M = 170.139255; S = 0.045889585;};",
"if(Age_Months >= 181 && Age_Months < 182){L = 2.219728869; M = 170.5194567; S = 0.045622955;};",
"if(Age_Months >= 182 && Age_Months < 183){L = 2.2295937; M = 170.881464; S = 0.045360101;};",
"if(Age_Months >= 183 && Age_Months < 184){L = 2.234907144; M = 171.2256717; S = 0.045101913;};",
"if(Age_Months >= 184 && Age_Months < 185){L = 2.235833767; M = 171.5525345; S = 0.044849174;};",
"if(Age_Months >= 185 && Age_Months < 186){L = 2.232567138; M = 171.8625576; S = 0.044602566;};",
"if(Age_Months >= 186 && Age_Months < 187){L = 2.2253265; M = 172.1562865; S = 0.044362674;};",
"if(Age_Months >= 187 && Age_Months < 188){L = 2.214353232; M = 172.4342983; S = 0.044129985;};",
"if(Age_Months >= 188 && Age_Months < 189){L = 2.199905902; M = 172.6971935; S = 0.043904897;};",
"if(Age_Months >= 189 && Age_Months < 190){L = 2.182262864; M = 172.9455898; S = 0.043687723;};",
"if(Age_Months >= 190 && Age_Months < 191){L = 2.161704969; M = 173.180112; S = 0.043478698;};",
"if(Age_Months >= 191 && Age_Months < 192){L = 2.138524662; M = 173.4013896; S = 0.043277987;};",
"if(Age_Months >= 192 && Age_Months < 193){L = 2.113023423; M = 173.6100518; S = 0.043085685;};",
"if(Age_Months >= 193 && Age_Months < 194){L = 2.085490286; M = 173.8067179; S = 0.042901835;};",
"if(Age_Months >= 194 && Age_Months < 195){L = 2.0562195; M = 173.9919998; S = 0.042726424;};",
"if(Age_Months >= 195 && Age_Months < 196){L = 2.025496648; M = 174.1664951; S = 0.042559396;};",
"if(Age_Months >= 196 && Age_Months < 197){L = 1.993598182; M = 174.3307855; S = 0.042400652;};",
"if(Age_Months >= 197 && Age_Months < 198){L = 1.960789092; M = 174.4854344; S = 0.042250063;};",
"if(Age_Months >= 198 && Age_Months < 199){L = 1.927320937; M = 174.6309856; S = 0.042107465;};",
"if(Age_Months >= 199 && Age_Months < 200){L = 1.89343024; M = 174.7679617; S = 0.041972676;};",
"if(Age_Months >= 200 && Age_Months < 201){L = 1.859337259; M = 174.8968634; S = 0.041845488;};",
"if(Age_Months >= 201 && Age_Months < 202){L = 1.825245107; M = 175.0181691; S = 0.041725679;};",
"if(Age_Months >= 202 && Age_Months < 203){L = 1.791339209; M = 175.1323345; S = 0.041613015;};",
"if(Age_Months >= 203 && Age_Months < 204){L = 1.757787065; M = 175.2397926; S = 0.041507249;};",
"if(Age_Months >= 204 && Age_Months < 205){L = 1.724738292; M = 175.340954; S = 0.041408129;};",
"if(Age_Months >= 205 && Age_Months < 206){L = 1.692324905; M = 175.4362071; S = 0.041315398;};",
"if(Age_Months >= 206 && Age_Months < 207){L = 1.660661815; M = 175.5259191; S = 0.041228796;};",
"if(Age_Months >= 207 && Age_Months < 208){L = 1.629847495; M = 175.6104358; S = 0.04114806;};",
"if(Age_Months >= 208 && Age_Months < 209){L = 1.599964788; M = 175.690083; S = 0.041072931;};",
"if(Age_Months >= 209 && Age_Months < 210){L = 1.571081817; M = 175.7651671; S = 0.04100315;};",
"if(Age_Months >= 210 && Age_Months < 211){L = 1.543252982; M = 175.8359757; S = 0.040938463;};",
"if(Age_Months >= 211 && Age_Months < 212){L = 1.516519998; M = 175.9027788; S = 0.040878617;};",
"if(Age_Months >= 212 && Age_Months < 213){L = 1.490912963; M = 175.9658293; S = 0.040823368;};",
"if(Age_Months >= 213 && Age_Months < 214){L = 1.466451429; M = 176.0253641; S = 0.040772475;};",
"if(Age_Months >= 214 && Age_Months < 215){L = 1.44314546; M = 176.081605; S = 0.040725706;};",
"if(Age_Months >= 215 && Age_Months < 216){L = 1.420996665; M = 176.1347593; S = 0.040682834;};",
"if(Age_Months >= 216 && Age_Months < 217){L = 1.399999187; M = 176.1850208; S = 0.04064364;};",
"if(Age_Months >= 217 && Age_Months < 218){L = 1.380140651; M = 176.2325707; S = 0.040607913;};",
"if(Age_Months >= 218 && Age_Months < 219){L = 1.361403047; M = 176.2775781; S = 0.040575448;};",
"if(Age_Months >= 219 && Age_Months < 220){L = 1.343763564; M = 176.3202008; S = 0.040546051;};",
"if(Age_Months >= 220 && Age_Months < 221){L = 1.327195355; M = 176.3605864; S = 0.040519532;};",
"if(Age_Months >= 221 && Age_Months < 222){L = 1.311668242; M = 176.3988725; S = 0.040495713;};",
"if(Age_Months >= 222 && Age_Months < 223){L = 1.297149359; M = 176.4351874; S = 0.040474421;};",
"if(Age_Months >= 223 && Age_Months < 224){L = 1.283603728; M = 176.469651; S = 0.040455493;};",
"if(Age_Months >= 224 && Age_Months < 225){L = 1.270994782; M = 176.5023751; S = 0.040438773;};",
"if(Age_Months >= 225 && Age_Months < 226){L = 1.25928483; M = 176.533464; S = 0.040424111;};",
"if(Age_Months >= 226 && Age_Months < 227){L = 1.248435461; M = 176.5630153; S = 0.040411366;};",
"if(Age_Months >= 227 && Age_Months < 228){L = 1.23840791; M = 176.5911197; S = 0.040400405;};",
"if(Age_Months >= 228 && Age_Months < 229){L = 1.229163362; M = 176.6178621; S = 0.040391101;};",
"if(Age_Months >= 229 && Age_Months < 230){L = 1.220663228; M = 176.6433219; S = 0.040383334;};",
"if(Age_Months >= 230 && Age_Months < 231){L = 1.212869374; M = 176.6675729; S = 0.04037699;};",
"if(Age_Months >= 231 && Age_Months < 232){L = 1.20574431; M = 176.6906844; S = 0.040371962;};",
"if(Age_Months >= 232 && Age_Months < 233){L = 1.199251356; M = 176.712721; S = 0.040368149;};",
"if(Age_Months >= 233 && Age_Months < 234){L = 1.19335477; M = 176.733743; S = 0.040365456;};",
"if(Age_Months >= 234 && Age_Months < 235){L = 1.188019859; M = 176.753807; S = 0.040363795;};",
"if(Age_Months >= 235 && Age_Months < 236){L = 1.183213059; M = 176.7729657; S = 0.04036308;};",
"if(Age_Months >= 236 && Age_Months < 237){L = 1.178901998; M = 176.7912687; S = 0.040363233;};",
"if(Age_Months >= 237 && Age_Months < 238){L = 1.175055543; M = 176.8087622; S = 0.040364179;};",
"if(Age_Months >= 238 && Age_Months < 239){L = 1.171643828; M = 176.8254895; S = 0.04036585;};",
"if(Age_Months >= 239 && Age_Months < 240){L = 1.16863827; M = 176.8414914; S = 0.04036818;};",
"Height_Z =  (power((Height / M), L) - 1) / (L * S);",
"",
"Height_Percentile =  ZtoPercentile(Height_Z);",
"",
"if (doCalc) Height_Percentile_param.value = fixDP(Height_Percentile, dp);",
"",
"",
"",
"Age_Factor =  Age - 10;",
"",
"Systolic_BP_Avg =  102.19768 + (1.82416 * Age_Factor) + (0.12776 * power(Age_Factor,2)) + (0.00249 * power(Age_Factor,3)) - (0.00135 * power(Age_Factor,4))  + (2.73157 * Height_Z) - (0.19618 * power(Height_Z,2)) - (0.04659 * power(Height_Z,3)) + (0.00947 * power(Height_Z,4));",
"",
"Diastolic_BP_Avg =  61.01217 + (0.68314 * Age_Factor) - (0.09835 * power(Age_Factor,2)) + (0.01711 * power(Age_Factor,3)) + (0.00045 * power(Age_Factor,4))  + (1.46993 * Height_Z) - (0.07849 * power(Height_Z,2)) - (0.03144 * power(Height_Z,3)) + (0.00967 * power(Height_Z,4));",
"",
"Systolic_BP_Z =  (Systolic_BP - Systolic_BP_Avg) / 10.7128;",
"",
"Diastolic_BP_Z =  (Diastolic_BP - Diastolic_BP_Avg) / 11.6032;",
"",
"Systolic_BP_Percentile =  ZtoPercentile(Systolic_BP_Z);",
"",
"if (doCalc) Systolic_BP_Percentile_param.value = fixDP(Systolic_BP_Percentile, dp);",
"",
"",
"",
"Diastolic_BP_Percentile =  ZtoPercentile(Diastolic_BP_Z);",
"",
"if (doCalc) Diastolic_BP_Percentile_param.value = fixDP(Diastolic_BP_Percentile, dp);",
"",
"",
"",
"SBP_Threshold =  (2.326348 * 10.7128) + Systolic_BP_Avg + 5;",
"",
"if (doCalc) SBP_Threshold_param.value = fixDP(SBP_Threshold, dp);",
"",
"",
"",
"DBP_Threshold =  (2.326348 * 11.6032) + Diastolic_BP_Avg + 5;",
"",
"if (doCalc) DBP_Threshold_param.value = fixDP(DBP_Threshold, dp);",
"",
"",
"",
"",
"if (doCalc){",
"",
"rrclr();",
"if (Systolic_BP_Percentile < 90){ document.getElementById('rr1_1').bgColor = \"#cccccc\";",
"}",
"if ((Systolic_BP_Percentile >= 90) && (Systolic_BP_Percentile < 95)){ document.getElementById('rr1_2').bgColor = \"#cccccc\";",
"}",
"if (Systolic_BP_Percentile >= 95){ document.getElementById('rr1_3').bgColor = \"#cccccc\";",
"}",
"",
"",
"",
"}",
"",
"if (doCalc){",
"",
"rrclr();",
"if (Systolic_BP_Percentile < 90){ document.getElementById('rr1_1').bgColor = \"#cccccc\";",
"}",
"if ((Systolic_BP_Percentile >= 90) && (Systolic_BP_Percentile < 95)){ document.getElementById('rr1_2').bgColor = \"#cccccc\";",
"}",
"if (Systolic_BP_Percentile >= 95){ document.getElementById('rr1_3').bgColor = \"#cccccc\";",
"}",
"if (Diastolic_BP_Percentile < 90){ document.getElementById('rr2_1').bgColor = \"#cccccc\";",
"}",
"if ((Diastolic_BP_Percentile >= 90) && (Diastolic_BP_Percentile < 95)){ document.getElementById('rr2_2').bgColor = \"#cccccc\";",
"}",
"if (Diastolic_BP_Percentile >= 95){ document.getElementById('rr2_3').bgColor = \"#cccccc\";",
"}",
"",
"",
"",
"}",
"",
"",
"}",
"",
"}",
"",
"function minMaxCheck(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.BloodPressurePercentBoys_form){",
"",
"if (Age_param.value && Age < 2) {",
"Age = 0;",
"Age_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Age is 2 yr.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Age_param.value && Age > 17.99) {",
"Age_param.value = \"\";",
"clrResults();",
"Age = 0;",
"doCalc = false;",
"alert(\"The maximum value for Age is 17.99 yr.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Height_param.value && Height < 50) {",
"Height = 0;",
"Height_param.value = \"\";",
"clrResults();",
"doCalc = false;",
"alert(\"The minimum value for Height is 50 cm.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"if (Height_param.value && Height > 200) {",
"Height_param.value = \"\";",
"clrResults();",
"Height = 0;",
"doCalc = false;",
"alert(\"The maximum value for Height is 200 cm.\\nIf you are specifying a value with a different unit,\\nchange the unit selector first.\");",
"}",
"",
"",
"}",
"",
"}",
"",
"",
"function clrResults(){",
"",
"if (currenttimeout) self.clearTimeout(currenttimeout);",
"",
"with(document.BloodPressurePercentBoys_form){",
"",
"Height_Percentile_param.value = '';",
"Systolic_BP_Percentile_param.value = '';",
"Diastolic_BP_Percentile_param.value = '';",
"SBP_Threshold_param.value = '';",
"DBP_Threshold_param.value = '';",
"",
"rrclr();",
"",
"}",
"",
"}",
"",
"",
"",
"",
"",
"",
"",
"",
"",
"function rrclr(){",
"document.getElementById('rr1_1').bgColor = \"\";",
"document.getElementById('rr1_2').bgColor = \"\";",
"document.getElementById('rr1_3').bgColor = \"\";",
"document.getElementById('rr2_1').bgColor = \"\";",
"document.getElementById('rr2_2').bgColor = \"\";",
"document.getElementById('rr2_3').bgColor = \"\";",
"}",
"",
"",
""].join("\n");
var outline_f9_15_9463=null;
var title_f9_15_9464="Optic neuritis: Pathophysiology, clinical features, and diagnosis";
var content_f9_15_9464=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Optic neuritis: Pathophysiology, clinical features, and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/15/9464/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9464/contributors\">",
"     Benjamin Osborne, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9464/contributors\">",
"     Laura J Balcer, MD, MSCE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/15/9464/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9464/contributors\">",
"     Francisco Gonzalez-Scarano, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9464/contributors\">",
"     Paul W Brazis, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/15/9464/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9464/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/15/9464/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 23, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optic neuritis is an inflammatory, demyelinating condition that causes acute, usually monocular, visual loss. It is highly associated with multiple sclerosis (MS). Optic neuritis is the presenting feature of MS in 15 to 20 percent of patients and occurs in 50 percent at some time during the course of their illness [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/1-4\">",
"     1-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The term optic neuritis is sometimes applied to other inflammatory and infectious conditions affecting the optic nerve. These and other causes of optic neuropathy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/54/4969?source=see_link\">",
"     \"Optic neuropathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The epidemiology, pathophysiology, clinical features, and diagnosis of demyelinating optic neuritis will be covered here. Prognosis and treatment of optic neuritis and other clinical manifestations of multiple sclerosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29944?source=see_link\">",
"     \"Optic neuritis: Prognosis and treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32458?source=see_link\">",
"     \"Epidemiology and clinical features of multiple sclerosis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/15/37112?source=see_link\">",
"     \"Clinically isolated syndromes suggestive of multiple sclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most cases of acute demyelinating optic neuritis occur in women (two-thirds) and typically develop in patients between the ages of 20 and 40 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/5-7\">",
"     5-7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The incidence of optic neuritis is highest in populations located at higher latitudes, in the northern United States and western Europe, and is lowest in regions closer to the equator. In the United States, studies have estimated the annual incidence of optic neuritis to be as high as 6.4 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. In the United States, optic neuritis occurs more frequently in whites than blacks [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/10\">",
"     10",
"    </a>",
"    ]. In Asia, optic neuritis is proportionately more common relative to the incidence of multiple sclerosis than in the United States or western Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common pathologic basis for optic neuritis is inflammatory demyelination of the optic nerve. The pathology is similar to that of acute multiple sclerosis (MS) plaques in the brain, with perivascular cuffing, edema in the myelinated nerve sheaths, and myelin breakdown. Inflammation of the retinal vascular endothelium can precede demyelination and is sometimes visibly manifest as retinal vein sheathing [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/12\">",
"     12",
"    </a>",
"    ]. Myelin loss exceeds axonal loss.",
"   </p>",
"   <p>",
"    It is believed that the demyelination in optic neuritis is immune-mediated, but the specific mechanism and target antigen(s) are unknown. Systemic T cell activation is identified at symptom onset and precedes changes in the cerebrospinal fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/13\">",
"     13",
"    </a>",
"    ]. Systemic changes also normalize earlier (within two to four weeks) than central changes. T cell activation leads to the release of cytokines and other inflammatory agents. B cell activation against myelin basic protein is not seen in peripheral blood but can be demonstrated in the cerebrospinal fluid of patients with optic neuritis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As with MS, a genetic susceptibility for optic neuritis is suspected. This is supported by an over-representation of certain human leukocyte antigen (HLA) types among patients with optic neuritis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/15,16\">",
"     15,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Acute features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optic neuritis is usually monocular in its clinical presentation. In about 10 percent of cases, symptoms occur in both eyes, either simultaneously or in rapid succession [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/17\">",
"     17",
"    </a>",
"    ]. Bilateral optic neuritis is more common in children younger than 12 to 15 years old and also in Asian and black South African patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/17-22\">",
"     17-22",
"    </a>",
"    ]. Because bilateral symptoms are relatively uncommon, they should suggest an alternative cause of optic neuropathy. However, subclinical visual deficits in acuity, contrast sensitivity, color vision, and visual field in the contralateral eye can often be elicited by detailed visual testing in patients with clinically monocular disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/9,23\">",
"     9,23",
"    </a>",
"    ]. Because these deficits usually resolve along with the clinical deficits in the symptomatic eye, it is unlikely that these findings represent prior episodes of optic neuritis.",
"   </p>",
"   <p>",
"    Other clinical features of optic neuritis were systematically characterized in the Optic Neuritis Treatment Trial (ONTT), which enrolled 457 patients, aged 18 to 46 years, with acute unilateral optic neuritis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/7,24\">",
"     7,24",
"    </a>",
"    ]. The two most common symptoms of optic neuritis are vision loss and eye pain:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vision loss typically develops over a period of hours to days, peaking within one to two weeks. Continued deterioration after that time suggests an alternative diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]. Greater than 90 percent of patients in the ONTT had a significant decrease in central visual acuity. In most, the visual acuities ranged from",
"      <span class=\"nowrap\">",
"       20/25",
"      </span>",
"      to",
"      <span class=\"nowrap\">",
"       20/190",
"      </span>",
"      (median visual acuity",
"      <span class=\"nowrap\">",
"       20/60).",
"      </span>",
"      However, some patients had",
"      <span class=\"nowrap\">",
"       20/20",
"      </span>",
"      acuity (11 percent), and, at the other extreme, a few had no light perception (3 percent).",
"     </li>",
"     <li>",
"      Eye pain occurred in 92 percent of patients in the ONTT and often worsened with eye movement [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/7\">",
"       7",
"      </a>",
"      ]. The onset of pain generally coincided with the visual acuity loss and improved along with it.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other common visual symptoms and signs include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An afferent pupillary defect always occurs in optic neuritis if the other eye is uninvolved and otherwise healthy. This is demonstrated by shining a light alternately in one eye and then the other and finding that the direct response to light is more sluggish in the affected eye. The room should be dark, and the patient should fixate on a distant target to prevent miosis due to accommodation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38377?source=see_link&amp;anchor=H35#H35\">",
"       \"The detailed neurologic examination in adults\", section on 'Afferent pupillary defect'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The visual field defect in optic neuritis is typically characterized as a central scotoma [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/1,25\">",
"       1,25",
"      </a>",
"      ]. However, in the ONTT, almost all types of visual field defects were seen, including diffuse vision loss and altitudinal, arcuate, hemianopic, and cecocentral defects. Nonetheless, a defect that extends to the periphery should suggest a compressive lesion, while an altitudinal defect, particularly an inferior altitudinal defect, is more common in anterior ischemic optic neuropathy [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/1,25\">",
"       1,25",
"      </a>",
"      ]. Visual field defects usually resolve; in the ONTT, 56 percent had normalized at one year and 73 percent had normalized at 10 years [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/26,27\">",
"       26,27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Papillitis with hyperemia and swelling of the disk, blurring of disk margins, and distended veins is seen in one-third of patients with optic neuritis (",
"      <a class=\"graphic graphic_picture graphicRef50320 \" href=\"UTD.htm?31/5/31824\">",
"       picture 1",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/7\">",
"       7",
"      </a>",
"      ]. Two-thirds of these patients have retrobulbar neuritis with a normal funduscopic examination (",
"      <a class=\"graphic graphic_picture graphicRef66013 \" href=\"UTD.htm?41/37/42591\">",
"       picture 2",
"      </a>",
"      ). Papillitis is more common in children less than 14 years old and in certain ethnic populations, including black South Africans and Southeast Asians [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/11,18-20\">",
"       11,18-20",
"      </a>",
"      ]. Peripapillary hemorrhages are rare in optic neuritis, but are a common accompaniment to papillitis due to anterior ischemic optic neuropathy [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Photopsias (flickering or flashes of light) are often precipitated with eye movement and were reported by 30 percent of patients in the ONTT [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Loss of color of vision out of proportion to the loss of visual acuity is specific to optic nerve pathology. Abnormal color vision by Ishihara plates was found in 88 percent of involved eyes in the ONTT; this increased to 94 percent with the more sensitive Farnsworth-Munsell 100 hue test [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other signs of ocular inflammation may be observed by the ophthalmologist on funduscopic or slit lamp examination. Perivenous sheathing or periphlebitis retinae can be seen in about 12 percent of patients with optic neuritis and implies a high risk for multiple sclerosis (MS) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/9,12\">",
"       9,12",
"      </a>",
"      ]. Uveitis, cells in the anterior chamber,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pars planitis are uncommonly seen in optic neuritis and are more typical of infections and other autoimmune diseases. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/54/4969?source=see_link\">",
"       \"Optic neuropathies\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Chronic features",
"    </span>",
"    &nbsp;&mdash;&nbsp;Even after clinical recovery, signs of optic neuritis can persist. These signs in a patient without a history of optic neuritis may suggest a previous, subclinical attack. When a patient presents with a possible first attack of MS elsewhere in the central nervous system, these signs are often sought because evidence of other demyelinating episodes separated in \"time and space\" can affect prognosis and treatment decisions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/15/37112?source=see_link\">",
"     \"Clinically isolated syndromes suggestive of multiple sclerosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Chronic signs of optic neuritis can include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persistent visual loss. Most patients with optic neuritis recover functional vision within one year. However, on testing, deficits in color vision, contrast sensitivity, stereo acuity, and light brightness are detectable in most patients at up to two years [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/28\">",
"       28",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29944?source=see_link&amp;anchor=H3#H3\">",
"       \"Optic neuritis: Prognosis and treatment\", section on 'Recovery of vision'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A relative afferent pupillary defect remains in approximately one-fourth of patients two years after presentation [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Color desaturation refers to a qualitative inter-eye difference in color perception that can be tested by comparing vision of a red object with each eye. A patient with monocular \"red desaturation\" may report that the red color appears \"washed out,\" pink, or orange when viewed with the affected eye.",
"     </li>",
"     <li>",
"      Temporary exacerbations of visual problems in patients can occur with increased body temperature (Uhthoff's phenomenon). Hot showers and exercise are classic precipitants.",
"     </li>",
"     <li>",
"      Optic atrophy to at least some degree almost always follows an attack of optic neuritis, despite the return of visual acuity [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/29\">",
"       29",
"      </a>",
"      ]. Normal,",
"      <span class=\"nowrap\">",
"       20/20",
"      </span>",
"      visual acuity requires less than one-half of normal foveal axons [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/30\">",
"       30",
"      </a>",
"      ]. The disc appears shrunken and pale, particularly in its temporal half (temporal pallor). The disk pallor extends beyond the margins of the disk into the peripapillary retinal nerve fiber layer.",
"     </li>",
"     <li>",
"      The pattern-shift visual evoked response remains delayed in most patients, even with visual recovery. Although latencies continue to shorten (improve) up to two years after presentation, abnormalities are seen in most (80 percent) at two years [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/28,31,32\">",
"       28,31,32",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Visual evoked response'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In a young child, infectious and postinfectious causes of optic nerve impairment should be considered as alternatives to optic neuritis, while in an older patient (&gt;50 years), ischemic optic neuropathy (due, for example, to diabetes mellitus or giant cell arteritis) is a more likely diagnosis than optic neuritis.",
"   </p>",
"   <p>",
"    The differential diagnosis of optic nerve diseases is summarized in the Tables and is discussed separately (",
"    <a class=\"graphic graphic_table graphicRef75945 \" href=\"UTD.htm?20/31/20988\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef51786 \" href=\"UTD.htm?42/48/43788\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/54/4969?source=see_link\">",
"     \"Optic neuropathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, optic neuritis is a clinical diagnosis based upon the history and examination findings. Because important findings on funduscopic examination help differentiate typical from atypical cases of optic neuritis, an ophthalmologic examination should be considered an essential feature of the clinical evaluation.",
"   </p>",
"   <p>",
"    Diagnostic testing is directed toward excluding other causes of visual loss in atypical cases and in assessing the risk of subsequent multiple sclerosis (MS).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;A magnetic resonance imaging study (MRI) of the brain and orbits with gadolinium contrast provides confirmation of the diagnosis of acute demyelinating optic neuritis and important prognostic information regarding the risk of developing MS.",
"   </p>",
"   <p>",
"    Innovations in MRI technology (eg, short tau inversion recovery [STIR], fast spin echo [FSE], and fluid-attenuated inversion recovery with fat suppression techniques [FLAIR], diffusion tensor imaging [DTI]) have improved imaging of the optic nerve [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. Optic nerve inflammation can be demonstrated in about 95 percent of patients with optic neuritis with gadolinium contrast-enhanced MRI of the brain and orbits (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef69073 \" href=\"UTD.htm?28/13/28881\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/6,36-38\">",
"     6,36-38",
"    </a>",
"    ]. The longitudinal extent of nerve involvement as seen on MRI correlates with visual impairment at presentation and with visual prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/31,36,38\">",
"     31,36,38",
"    </a>",
"    ]. Gadolinium enhancement persists for a mean of 30 days since onset [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/31\">",
"     31",
"    </a>",
"    ]. The signal abnormality in the nerve can still be seen after recovery of vision, and is also present in as many as 60 percent of patients with MS who do not have a clinical history of optic neuritis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/31,39-41\">",
"     31,39-41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The brain MRI often shows white matter abnormalities characteristic of MS (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef81188 \" href=\"UTD.htm?36/46/37606\">",
"     image 2",
"    </a>",
"    ). Typical lesions are ovoid, periventricular, and larger than 3 mm. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/19/35130?source=see_link&amp;anchor=H5#H5\">",
"     \"Diagnosis of multiple sclerosis in adults\", section on 'Lesion characteristics'",
"    </a>",
"    .) The reported prevalence of white matter abnormalities varies substantially among patients with optic neuritis (23 to 75 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/42\">",
"     42",
"    </a>",
"    ]. In the ONTT, almost 40 percent of patients had MRI lesions, but this trial represents a selected patient group [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/7\">",
"     7",
"    </a>",
"    ]. Small case series of unselected patients have noted a higher coincidence of MRI brain lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/31,43,44\">",
"     31,43,44",
"    </a>",
"    ]. Individuals with white matter abnormalities are at a higher risk of developing MS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29944?source=see_link\">",
"     \"Optic neuritis: Prognosis and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The yield of spinal cord imaging is low in unselected patients. Among 115 patients presenting with optic neuritis, MRI abnormalities in the spinal cord were seen in only four patients with a normal brain MRI [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Lumbar puncture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lumbar puncture is not an essential diagnostic test in optic neuritis, but should be considered in atypical cases (eg, those with bilateral presentation, &lt;15 years in age, or symptoms suggesting infection) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. Approximately 60 to 80 percent of patients with acute optic neuritis have nonspecific abnormalities in the cerebrospinal fluid (CSF), including lymphocytes (10 to 100) and elevated protein [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other CSF findings in optic neuritis can include [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/47\">",
"     47",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Myelin basic protein in about 20 percent",
"     </li>",
"     <li>",
"      IgG synthesis in 20 to 36 percent",
"     </li>",
"     <li>",
"      Oligoclonal bands (OCB) in 56 to 69 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of OCB implies a higher risk of developing MS. However, since OCB are also associated with white matter lesions on brain MRI, their presence is not clearly of independent prognostic importance [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29944?source=see_link\">",
"     \"Optic neuritis: Prognosis and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;When there are relevant clues to an alternative diagnosis (",
"    <a class=\"graphic graphic_table graphicRef51786 \" href=\"UTD.htm?42/48/43788\">",
"     table 2",
"    </a>",
"    ), measurement of the erythrocyte sedimentation rate, antinuclear antibodies, and angiotensin converting enzyme levels and serologic and CSF tests for Lyme disease and syphilis should be obtained [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/45,46\">",
"     45,46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/54/4969?source=see_link\">",
"     \"Optic neuropathies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Fluorescein angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29108?source=see_link\">",
"     Fluorescein",
"    </a>",
"    angiography is not routinely performed in the evaluation of optic neuritis and is often normal. Up to 25 percent demonstrate either dye leakage or perivenous sheathing [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/12\">",
"     12",
"    </a>",
"    ]. These findings may identify patients at somewhat higher risk for developing MS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Visual evoked response",
"    </span>",
"    &nbsp;&mdash;&nbsp;A delay in the P100 of the visual evoked response (VER) is the electrophysiologic manifestation of slowed conduction in the optic nerve as a result of axonal demyelination [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/48\">",
"     48",
"    </a>",
"    ]. This test is not usually helpful in the diagnosis of acute optic neuritis, unless there is a suspicion that the visual loss is functional.",
"   </p>",
"   <p>",
"    Abnormalities in the VER can persist after recovery of full vision. At one year, 80 to 90 percent will be abnormal; 35 percent will return to normal at two years [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/28,31,32\">",
"     28,31,32",
"    </a>",
"    ]. The VER is often employed to find evidence of previous, asymptomatic, episodes of optic neuritis, but the sensitivity and specificity are imperfect [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The multifocal VER is a technical advance that appears to be more sensitive and specific for identifying optic neuritis, but this technology is not generally available [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/1,49\">",
"     1,49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Optical coherence tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optical coherence tomography (OCT) measures the thickness in the retinal nerve fiber layer and detects thinning in most (85 percent) of patients with optic neuritis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/48,50-53\">",
"     48,50-53",
"    </a>",
"    ]. Lower values correlate with impaired visual outcome. However, its utility as a prognostic tool is limited in that abnormal values do not show up until early swelling disappears. In one study, OCT was less sensitive than VER in detecting subclinical optic neuritis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A number of studies have found that a greater severity of optic nerve injury seen on OCT suggests neuromyelitis optica rather than optic neuritis associated with multiple sclerosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/55-57\">",
"     55-57",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Aquaporin-4-specific serum autoantibody",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with recurrent optic neuritis may be particularly at risk for the variant of MS known as neuromyelitis optica or Devic's disease. This is particularly true for patients with a normal brain MRI and those with optic neuritis events in rapid succession [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/58\">",
"     58",
"    </a>",
"    ]. In one study, seropositivity for the aquaporin-4-specific serum autoantibody was predictive of subsequent NMO among patients with recurrent optic neuritis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/59\">",
"     59",
"    </a>",
"    ]. This test has been suggested for individuals with recurrent ON, particularly if MRI is negative [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9464/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?10/30/10722?source=see_link\">",
"       \"Patient information: Optic neuritis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optic neuritis is an acute inflammatory demyelinating injury to the optic nerve.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In typical cases, painful, monocular visual loss evolves over several hours to a few days. One-third of patients have visible optic nerve inflammation on funduscopic examination (papillitis); in the remainder, the inflammation is retrobulbar. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Acute features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Chronic signs of optic neuritis include a relative afferent pupillary defect, color desaturation, and optic atrophy. These often persist despite recovery of normal vision. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Chronic features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Common entities in the differential diagnosis of optic neuritis are presented in the Tables (",
"      <a class=\"graphic graphic_table graphicRef75945 \" href=\"UTD.htm?20/31/20988\">",
"       table 1",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef51786 \" href=\"UTD.htm?42/48/43788\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?4/54/4969?source=see_link\">",
"       \"Optic neuropathies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A gadolinium-enhanced MRI of the brain and orbits provides confirmation of optic neuritis and aids in the assessment of prognosis and treatment decisions. Other tests, including lumbar puncture,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/27/29108?source=see_link\">",
"       fluorescein",
"      </a>",
"      angiography, and visual evoked potentials are used in atypical cases. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/1\">",
"      Balcer LJ. Clinical practice. Optic neuritis. N Engl J Med 2006; 354:1273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/2\">",
"      Foroozan R, Buono LM, Savino PJ, Sergott RC. Acute demyelinating optic neuritis. Curr Opin Ophthalmol 2002; 13:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/3\">",
"      Frohman EM, Frohman TC, Zee DS, et al. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol 2005; 4:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/4\">",
"      Arnold AC. Evolving management of optic neuritis and multiple sclerosis. Am J Ophthalmol 2005; 139:1101.",
"     </a>",
"    </li>",
"    <li>",
"     Liu GT. Visual loss: optic neuropathies. In: Neuro-Ophthalmology: Diagnosis and Management, Liu GT, Volpe NJ, Galetta SL (Eds), WB Saunders, Philadelphia 2001.",
"    </li>",
"    <li>",
"     Wray, SH. Optic neuritis. In: Principles and Practice of Ophthalmology, Albert, DM, Jakobiec, FA (Eds), WB Saunders, Philadelphia 1994. p.2539.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/7\">",
"      The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group. Arch Ophthalmol 1991; 109:1673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/8\">",
"      Percy AK, Nobrega FT, Kurland LT. Optic neuritis and multiple sclerosis. An epidemiologic study. Arch Ophthalmol 1972; 87:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/9\">",
"      Rodriguez M, Siva A, Cross SA, et al. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 1995; 45:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/10\">",
"      Phillips PH, Newman NJ, Lynn MJ. Optic neuritis in African Americans. Arch Neurol 1998; 55:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/11\">",
"      Wakakura M, Minei-Higa R, Oono S, et al. Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Jpn J Ophthalmol 1999; 43:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/12\">",
"      Lightman S, McDonald WI, Bird AC, et al. Retinal venous sheathing in optic neuritis. Its significance for the pathogenesis of multiple sclerosis. Brain 1987; 110 ( Pt 2):405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/13\">",
"      Roed H, Frederiksen J, Langkilde A, et al. Systemic T-cell activation in acute clinically isolated optic neuritis. J Neuroimmunol 2005; 162:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/14\">",
"      S&ouml;derstr&ouml;m M, Link H, Xu Z, Fredriksson S. Optic neuritis and multiple sclerosis: anti-MBP and anti-MBP peptide antibody-secreting cells are accumulated in CSF. Neurology 1993; 43:1215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/15\">",
"      Frederiksen JL, Madsen HO, Ryder LP, et al. HLA typing in acute optic neuritis. Relation to multiple sclerosis and magnetic resonance imaging findings. Arch Neurol 1997; 54:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/16\">",
"      Francis DA, Compston DA, Batchelor JR, McDonald WI. A reassessment of the risk of multiple sclerosis developing in patients with optic neuritis after extended follow-up. J Neurol Neurosurg Psychiatry 1987; 50:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/17\">",
"      de la Cruz J, Kupersmith MJ. Clinical profile of simultaneous bilateral optic neuritis in adults. Br J Ophthalmol 2006; 90:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/18\">",
"      Pokroy R, Modi G, Saffer D. Optic neuritis in an urban black African community. Eye (Lond) 2001; 15:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/19\">",
"      Hwang JM, Lee YJ, Kim MK. Optic neuritis in Asian children. J Pediatr Ophthalmol Strabismus 2002; 39:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/20\">",
"      Wang JC, Tow S, Aung T, et al. The presentation, aetiology, management and outcome of optic neuritis in an Asian population. Clin Experiment Ophthalmol 2001; 29:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/21\">",
"      Lucchinetti CF, Kiers L, O'Duffy A, et al. Risk factors for developing multiple sclerosis after childhood optic neuritis. Neurology 1997; 49:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/22\">",
"      Wilejto M, Shroff M, Buncic JR, et al. The clinical features, MRI findings, and outcome of optic neuritis in children. Neurology 2006; 67:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/23\">",
"      Beck RW, Kupersmith MJ, Cleary PA, Katz B. Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial. Ophthalmology 1993; 100:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/24\">",
"      Beck RW. The Optic Neuritis Treatment Trial. Arch Ophthalmol 1988; 106:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/25\">",
"      Gerling J, Meyer JH, Kommerell G. Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features. Graefes Arch Clin Exp Ophthalmol 1998; 236:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/26\">",
"      Keltner JL, Johnson CA, Spurr JO, Beck RW. Visual field profile of optic neuritis. One-year follow-up in the Optic Neuritis Treatment Trial. Arch Ophthalmol 1994; 112:946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/27\">",
"      Beck RW, Gal RL, Bhatti MT, et al. Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. Am J Ophthalmol 2004; 137:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/28\">",
"      Brusa A, Jones SJ, Plant GT. Long-term remyelination after optic neuritis: A 2-year visual evoked potential and psychophysical serial study. Brain 2001; 124:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/29\">",
"      Cleary PA, Beck RW, Bourque LB, et al. Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment Trial. J Neuroophthalmol 1997; 17:18.",
"     </a>",
"    </li>",
"    <li>",
"     Miller NR, Newman NJ, Biousse V, Kerrison JB. Walsh and Hoyt's Clinical Neuro-ophthalmology, Lippincott, Williams and Wilkins, Philadelphia 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/31\">",
"      Hickman SJ, Toosy AT, Miszkiel KA, et al. Visual recovery following acute optic neuritis--a clinical, electrophysiological and magnetic resonance imaging study. J Neurol 2004; 251:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/32\">",
"      Celesia GG, Kaufman DI, Brigell M, et al. Optic neuritis: a prospective study. Neurology 1990; 40:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/33\">",
"      Barker GJ. Technical issues for the study of the optic nerve with MRI. J Neurol Sci 2000; 172 Suppl 1:S13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/34\">",
"      Jackson A, Sheppard S, Laitt RD, et al. Optic neuritis: MR imaging with combined fat- and water-suppression techniques. Radiology 1998; 206:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/35\">",
"      Naismith RT, Xu J, Tutlam NT, et al. Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities. Neurology 2009; 72:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/36\">",
"      Rizzo JF 3rd, Andreoli CM, Rabinov JD. Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy. Ophthalmology 2002; 109:1679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/37\">",
"      Rocca MA, Hickman SJ, B&ouml; L, et al. Imaging the optic nerve in multiple sclerosis. Mult Scler 2005; 11:537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/38\">",
"      Kupersmith MJ, Alban T, Zeiffer B, Lefton D. Contrast-enhanced MRI in acute optic neuritis: relationship to visual performance. Brain 2002; 125:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/39\">",
"      Youl BD, Turano G, Towell AD, et al. Optic neuritis: swelling and atrophy. Electroencephalogr Clin Neurophysiol Suppl 1996; 46:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/40\">",
"      Miller DH, Newton MR, van der Poel JC, et al. Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology 1988; 38:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/41\">",
"      Davies MB, Williams R, Haq N, et al. MRI of optic nerve and postchiasmal visual pathways and visual evoked potentials in secondary progressive multiple sclerosis. Neuroradiology 1998; 40:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/42\">",
"      Dalton CM, Brex PA, Miszkiel KA, et al. Spinal cord MRI in clinically isolated optic neuritis. J Neurol Neurosurg Psychiatry 2003; 74:1577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/43\">",
"      Jacobs LD, Kaba SE, Miller CM, et al. Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis. Ann Neurol 1997; 41:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/44\">",
"      St&auml;dt D, Kappos L, Rohrbach E, et al. Occurrence of MRI abnormalities in patients with isolated optic neuritis. Eur Neurol 1990; 30:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/45\">",
"      Boomer JA, Siatkowski RM. Optic neuritis in adults and children. Semin Ophthalmol 2003; 18:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/46\">",
"      Beck RW, Trobe JD. What we have learned from the Optic Neuritis Treatment Trial. Ophthalmology 1995; 102:1504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/47\">",
"      Nilsson P, Larsson EM, Maly-Sundgren P, et al. Predicting the outcome of optic neuritis: evaluation of risk factors after 30 years of follow-up. J Neurol 2005; 252:396.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/48\">",
"      Klistorner A, Arvind H, Nguyen T, et al. Axonal loss and myelin in early ON loss in postacute optic neuritis. Ann Neurol 2008; 64:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/49\">",
"      Fraser CL, Klistorner A, Graham SL, et al. Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis. Ophthalmology 2006; 113:323.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/50\">",
"      Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006; 59:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/51\">",
"      Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005; 58:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/52\">",
"      Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006; 113:324.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/53\">",
"      de Seze J, Blanc F, Jeanjean L, et al. Optical coherence tomography in neuromyelitis optica. Arch Neurol 2008; 65:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/54\">",
"      Naismith RT, Tutlam NT, Xu J, et al. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis. Neurology 2009; 73:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/55\">",
"      Naismith RT, Tutlam NT, Xu J, et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 2009; 72:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/56\">",
"      Ratchford JN, Quigg ME, Conger A, et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 2009; 73:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/57\">",
"      Green AJ, Cree BA. Distinctive retinal nerve fibre layer and vascular changes in neuromyelitis optica following optic neuritis. J Neurol Neurosurg Psychiatry 2009; 80:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/58\">",
"      Pirko I, Blauwet LA, Blauwet LK, et al. The natural history of recurrent optic neuritis. Arch Neurol 2004; 61:1401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/59\">",
"      Matiello M, Lennon VA, Jacob A, et al. NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008; 70:2197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9464/abstract/60\">",
"      Petzold A, Pittock S, Lennon V, et al. Neuromyelitis optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry 2010; 81:109.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5251 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-61.234.146.186-B5D3664DDB-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9464=[""].join("\n");
var outline_f9_15_9464=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Acute features",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Chronic features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Lumbar puncture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Fluorescein angiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Visual evoked response",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Optical coherence tomography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Aquaporin-4-specific serum autoantibody",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5251\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5251|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?28/13/28881\" title=\"diagnostic image 1\">",
"      MRI optic neuritis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?36/46/37606\" title=\"diagnostic image 2\">",
"      MRI of CIS presenting as optic neuritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5251|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?31/5/31824\" title=\"picture 1\">",
"      Optic neuritis fundus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?41/37/42591\" title=\"picture 2\">",
"      Normal fundus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5251|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/31/20988\" title=\"table 1\">",
"      Causes of optic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/48/43788\" title=\"table 2\">",
"      Clinical features of common optic neuropathies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/15/37112?source=related_link\">",
"      Clinically isolated syndromes suggestive of multiple sclerosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/19/35130?source=related_link\">",
"      Diagnosis of multiple sclerosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/44/32458?source=related_link\">",
"      Epidemiology and clinical features of multiple sclerosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/15/29944?source=related_link\">",
"      Optic neuritis: Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/54/4969?source=related_link\">",
"      Optic neuropathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?10/30/10722?source=related_link\">",
"      Patient information: Optic neuritis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/30/38377?source=related_link\">",
"      The detailed neurologic examination in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_15_9465="Inguinal and femoral hernia repair: Open techniques";
var content_f9_15_9465=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Inguinal and femoral hernia repair: Open techniques",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/15/9465/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9465/contributors\">",
"     Forrest Dean Griffen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/15/9465/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9465/contributors\">",
"     Richard Turnage, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/15/9465/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9465/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/15/9465/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inguinal hernioplasty is among the most common procedures performed by general surgeons [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/1\">",
"     1",
"    </a>",
"    ]. Indirect inguinal hernias develop at the internal ring, the site where the spermatic cord in males (the round ligament in females) enters the abdominal wall (",
"    <a class=\"graphic graphic_figure graphicRef61841 \" href=\"UTD.htm?7/18/7461\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef73484 \" href=\"UTD.htm?39/12/40128\">",
"     figure 2",
"    </a>",
"    ). The origin is lateral to the inferior epigastric artery, in contrast to direct hernias which originate medial to the inferior epigastric vessels through Hesselbach's triangle. Hesselbach's triangle is an anatomic landmark, bounded by the rectus abdominis muscle medially, the inguinal ligament (Poupart's) inferiorly and the inferior epigastric vessels laterally. Femoral hernias protrude through the femoral ring, which is bounded anteriorly by to the inguinal ligament (ileopubic tract), posteriorly by Cooper&rsquo;s ligament, medially by the lacunar ligament, and laterally by the femoral sheath (",
"    <a class=\"graphic graphic_figure graphicRef55844 \" href=\"UTD.htm?29/47/30453\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The main principles of hernia repair are to reinforce the floor of the inguinal canal and tighten the internal inguinal ring [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/2\">",
"     2",
"    </a>",
"    ]. All hernia surgeons agree that repairs must be tension free to minimize recurrences [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/3\">",
"     3",
"    </a>",
"    ]. In the past, relaxing incisions in the rectus sheath were used to reduce tension [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/4\">",
"     4",
"    </a>",
"    ], but recurrences remained unacceptably high because autogenous tissues weaken over time. Mesh has been incorporated in hernia repairs to reduce tension, leading to a fall in recurrence rates. Although initial infection rates near 6 percent dampened enthusiasm for the use of mesh, use of appropriate antibiotic prophylaxis has significantly lowered the rate of infectious complications [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/5,6\">",
"     5,6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many techniques have been proposed for hernia repair. These can be divided into tissue approximation repairs (such as the Bassini or McVay repair) and tension free repairs using mesh. The most commonly used open approaches include the Lichtenstein open tension-free hernioplasty, a plug and patch, or an open preperitoneal approach [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/7\">",
"     7",
"    </a>",
"    ]. All of these options have their advocates and result in recurrence rates of 1 to 2 percent when performed by surgeons skilled in the technique [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/8-14\">",
"     8-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We focus here on the Lichtenstein open tension-free hernioplasty, as it is considered the \"gold standard\" for open hernia repair [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/7\">",
"     7",
"    </a>",
"    ]. Long-term results favor the Lichtenstein technique because of its low recurrence rate and ease of technical mastery, and because it can be performed in the outpatient setting with local anesthetic [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will cover open repair of inguinal hernias. The diagnosis and general approach to the treatment of groin hernias is addressed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/49/43801?source=see_link\">",
"     \"Overview of abdominal hernias\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/37/31321?source=see_link\">",
"     \"Classification, clinical features and diagnosis of inguinal and femoral hernias in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/57/20373?source=see_link\">",
"     \"Sports-related groin pain or 'sports hernia'\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29000?source=see_link\">",
"     \"Overview of treatment for inguinal and femoral hernias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Please note that some technical details, such as suture choice, presented here reflect the author's preferences and are not meant to imply that these are requirements for successful surgical outcomes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREOPERATIVE EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hernia should be evaluated in the context of a differential diagnosis appropriate to the patient's symptoms. Hernias are so common that their presence may be incidental to the patient's true problem. If symptoms or physical findings are atypical, the possibility of an underlying cause of the hernia, such as a coincident appendiceal cancer, a colon malignancy, or inguinal lymphadenopathy should be considered and excluded, as appropriate, prior to repairing the hernia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/37/31321?source=see_link\">",
"     \"Classification, clinical features and diagnosis of inguinal and femoral hernias in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36074?source=see_link\">",
"     \"Cancer of the appendix and pseudomyxoma peritonei\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=see_link\">",
"     \"Clinical manifestations, diagnosis, and staging of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Any existing comorbidity should be identified and addressed. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/4/10314?source=see_link\">",
"     \"Preoperative medical evaluation of the healthy patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risks and benefits of surgery versus expectant management, as well as potential surgical complications, should be reviewed with the patient. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29000?source=see_link\">",
"     \"Overview of treatment for inguinal and femoral hernias\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risks and benefits of laparoscopic versus open repair should be discussed. There is a steep learning curve for laparoscopic hernia repair. Ideally, these procedures are performed by experienced surgeons or with the assistance of an experienced surgeon. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29000?source=see_link\">",
"     \"Overview of treatment for inguinal and femoral hernias\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     LICHTENSTEIN REPAIR",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Lichtenstein repair is suitable for most inguinal hernias but is not applicable to the repair of femoral hernias. If operative findings do not correspond to the preoperative physical findings, the transversalis fascia must be incised in the area of Hesselbach's triangle to expose and explore the femoral ring. If a femoral hernia is found, the Lichtenstein approach will need to be abandoned in favor of a different technique. (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Femoral hernias'",
"    </a>",
"    below.) &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Patient positioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient is placed in the supine position.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Thromboprophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients, except those who are healthy, thin, and under 40 years of age, receive 5000 units aqueous",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    subcutaneously or its low-molecular-weight heparin equivalent in the holding room. Thigh-length sequential compression devices are applied. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=see_link\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Skin preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients are instructed to take a chlorhexidine bath the night before surgery. In routine cases, the preoperative skin preparation should not include the scrotum, as there is a risk of contaminating the cleaner anterior region of the groin with organisms from the region behind the scrotum. Scrotal preps are reserved for patients with large scrotal hernias in case the scrotum needs to be manipulated to facilitate the return of the testicle into its proper location.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Local anesthesia with conscious sedation is an option for open femoral and inguinal hernia surgery, particularly in high risk patients. General and spinal anesthesia are also acceptable.",
"   </p>",
"   <p>",
"    Local anesthesia can be administered in two ways: as a nerve block of the ilioinguinal and iliohypogastric nerves or as direct infiltration into the proposed incision site. The former may be more difficult to achieve, but has the advantage of not causing significant soft tissue edema. Epinephrine can be added to the local anesthetic at the surgeon's discretion, but it is often omitted in patients with significant cardiac risks. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18042?source=see_link&amp;anchor=H9#H9\">",
"     \"Peripheral nerve block: Techniques\", section on 'Ilioinguinal and Iliohypogastric nerve block'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Local anesthesia is usually given along with monitored sedation. The patient must always be accompanied upon leaving the surgical suite if sedation is used. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19817?source=see_link\">",
"     \"Overview of anesthesia and anesthetic choices\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients receive an appropriate antibiotic, such as 1 g of cefazolin, intravenously after arriving in the operating room before the incision. The efficacy of antibiotic prophylaxis decreases if administered more than one hour before surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hernia surgery is considered clean surgery, meaning surgery with no inflammation and no contact with septic material. There are few controlled clinical trials on the use of antibiotic prophylaxis in hernia surgery and the data are conflicting [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/18\">",
"     18",
"    </a>",
"    ]. While antibiotics are not usually recommended for clean procedures, antibiotic prophylaxis is generally accepted as an imperative when mesh will be used (",
"    <a class=\"graphic graphic_table graphicRef65369 \" href=\"UTD.htm?23/52/24397\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Incision planning",
"    </span>",
"    &nbsp;&mdash;&nbsp;The skin incision is placed over the inguinal canal and angled only slightly cephalad as it progresses laterally. It should be long enough to provide adequate exposure (",
"    <a class=\"graphic graphic_figure graphicRef51599 \" href=\"UTD.htm?0/36/577\">",
"     figure 4",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30265?source=see_link\">",
"     \"Principles of abdominal wall incisions\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Dissection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The subcutaneous layer is divided and the superficial epigastric vessels are ligated. The subcutaneous tissue is sharply dissected from the external oblique aponeurosis to expose the external inguinal ring (",
"    <a class=\"graphic graphic_figure graphicRef61841 \" href=\"UTD.htm?7/18/7461\">",
"     figure 1",
"    </a>",
"    ). The aponeurosis of the external oblique muscle is incised in the direction of its fibers extending laterally from the external inguinal ring. The lateral extent of this incision should be sufficient to expose the internal oblique muscle as it engages the inguinal ligament (",
"    <a class=\"graphic graphic_figure graphicRef82223 \" href=\"UTD.htm?4/17/4377\">",
"     figure 5",
"    </a>",
"    ). This allows for clear identification of the ilioinguinal nerve laterally between the internal and external oblique muscles and before it joins the other cord structures more medially, facilitating the nerve's protection during mesh placement (",
"    <a class=\"graphic graphic_figure graphicRef82223 \" href=\"UTD.htm?4/17/4377\">",
"     figure 5",
"    </a>",
"    ). It also provides exposure for the fixation of mesh laterally.",
"   </p>",
"   <p>",
"    The cord structures are dissected from the underlying transversalis fascia in the region of Hesselbach's triangle and retracted with a Penrose drain. If a direct hernia is present and of sufficient size that it obscures the operative field, a purse-string stitch of 2-0 absorbable suture is placed in the transversalis fascia around the base of the hernia, the attenuated fascia is inverted, and the purse-string is tied (",
"    <a class=\"graphic graphic_figure graphicRef82223 \" href=\"UTD.htm?4/17/4377\">",
"     figure 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef83248 \" href=\"UTD.htm?0/53/855\">",
"     figure 6",
"    </a>",
"    ). This purse-string is then reinforced with a figure-of-eight stitch of 2-0 absorbable suture. This purse-string suture does not strengthen the repair; it simply facilitates exposure during additional dissection and mesh placement.",
"   </p>",
"   <p>",
"    The cord is explored for an indirect hernia sac or cord lipoma. In general, the indirect sac is removed and the peritoneum closed at the level of the internal ring. Alternatively, it is acceptable to free the sac at the internal ring and place it within the adjacent preperitoneal space. If the sac neck is large, a running closure or purse-string may be required. Smaller necks can be transfixed. Cord lipomas (appendages of preperitoneal fat passing through the internal ring and extending along the cord structures) are similarly removed. Except for redundant cremasteric muscle tissue, the cord is not \"skeletonized\" because testicular ischemia might occasionally result.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;A patch of polypropylene mesh, the measurements of which depend upon the anatomy of the hernia, is fashioned from a sheet of the chosen mesh product to cover the inguinal region (",
"    <a class=\"graphic graphic_figure graphicRef82223 \" href=\"UTD.htm?4/17/4377\">",
"     figure 5",
"    </a>",
"    ). The inferior margin of the mesh is sutured into place using running non-absorbable suture (eg, 2-0) to approximate the mesh to the shelving edge of the inguinal ligament from the pubic tubercle to a point that is at least 1 cm lateral to the point at which the arch of the internal oblique muscle meets Poupart's ligament. Similarly, the superior margin of the mesh is sutured to the rectus sheath medially and internal oblique muscle laterally to the point at which the internal oblique meets the inguinal ligament. The mesh defect around the cord is snugged by suturing the two leaves of the mesh together lateral to the spermatic cord. This \"new\" internal inguinal ring is slightly medial to the true internal ring, creating obliquity to the cord in the inguinal canal, which may help prevent recurrence of indirect hernias (",
"    <a class=\"graphic graphic_figure graphicRef82223 \" href=\"UTD.htm?4/17/4377\">",
"     figure 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Other proposed methods of mesh fixation meant to reduce the potential for chronic postoperative pain include the use of absorbable suture and various sutureless techniques, such as tissue glue or self-fixing mesh [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/19-21\">",
"     19-21",
"    </a>",
"    ]. One trial randomly assigned 302 patients to receive mesh fixation with absorbable polyglycolic acid (3-0 Dexon) or 1 mL butyl-2-cyanoacrylate tissue glue [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/22\">",
"     22",
"    </a>",
"    ]. No differences were seen in the duration of the operation, the need for postoperative analgesics, wound infection rates, or hernia recurrence at one year. The rates of foreign body sensation, acute pain, and chronic pain were similar between those with mesh fixation using absorbable suture versus tissue glue.",
"   </p>",
"   <p>",
"    The key technical points in mesh placement are [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/7\">",
"     7",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Medially, the pubic tubercle must be covered with mesh by at least 2 centimeters.",
"     </li>",
"     <li>",
"      The lateral extent of the mesh must cover the arch of the internal oblique as it extends laterally past the conjoined tendon (the fused aponeuroses of the internal oblique and transverse abdominis) to insert on the inguinal ligament.",
"     </li>",
"     <li>",
"      Sutures must not entrap the ilioinguinal, iliohypogastric, or genital branch of the genitofemoral nerves.",
"     </li>",
"     <li>",
"      The tails of the mesh should be sutured together lateral to the spermatic cord to avoid recurrence lateral to the internal ring.",
"     </li>",
"     <li>",
"      Continuous suture may prevent folding and movement of the mesh, which can cause chronic pain and hernia recurrence. Interrupted suture may be preferred if continuous suture appears to entrap the iliohypogastric or ilioinguinal nerves.",
"     </li>",
"     <li>",
"      The lower edge of mesh must be in apposition to the inguinal ligament from the pubic tubercle medially to at least 1 cm past the edge of the internal oblique muscle laterally.",
"     </li>",
"     <li>",
"      The upper edge of mesh must cover a generous portion of the anterior rectus sheath medially and the internal oblique muscle over the upper edge of Hesselbach's triangle more superiorly.",
"     </li>",
"     <li>",
"      There must be no tension on the mesh.",
"     </li>",
"     <li>",
"      The anatomical margins for mesh attachment must be clearly identified by clearing all fat, which sometimes requires cauterizing vessels that lie over the ligamentous tissues in the area of the pubic tubercle.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Avoiding nerve injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;During suturing of mesh laterally across the internal oblique near the inguinal ligament, the ilioinguinal nerve is especially vulnerable. It is easily identified in that location as it passes between the external and internal oblique muscles and across the arching fibers of the internal oblique before joining the other cord structures. This location makes it subject to entrapment during fixation of mesh to the internal oblique laterally. This nerve may also be injured more medially along the cord during dissection of indirect sacs. Freeing the nerve from the cord and retracting it behind a hemostat on the lower leaf of the external oblique aponeurosis during the dissection of indirect sacs may be protective. If entrapment or injury occurs, it is advisable to transect and ligate the nerve at the lateral extent of exposure.",
"   </p>",
"   <p>",
"    The iliohypogastric nerve is at risk for injury when incising the external oblique aponeurosis immediately behind the external oblique and in front of the internal oblique muscles. If the iliohypogastric nerve appears absent, it may be hidden within the fibers of the internal oblique muscle. In these instances, it may be protective if the mesh is fixed at its cephalad margin with very superficial sutures.",
"   </p>",
"   <p>",
"    Fortunately, the genital branch of the genitofemoral nerve, the third nerve in this area and the only one that accompanies the other cord structures through the internal ring, is behind the cord out of the usual area of dissection and out of harm&rsquo;s way. It is virtually always sacrificed in women along with the round ligament without need for selective identification.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Neurectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although simply placing mesh across a nerve does not cause neuralgia, inadvertently entrapping or otherwise injuring a nerve can cause chronic pain [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/23\">",
"     23",
"    </a>",
"    ]. To reduce the incidence of neuralgia, some surgeons empirically transect the ilioinguinal and iliohypogastric nerves laterally [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/24\">",
"     24",
"    </a>",
"    ]. The numbness that occasionally results from this approach has been of surprisingly little consequence. We use neurectomy selectively when the nerve is at risk for entrapment or nerve injury has occurred, and include proximal ligation, hoping to reduce the incidence of sensitive neuromas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Closure",
"    </span>",
"    &nbsp;&mdash;&nbsp;The subcutaneous layer is approximated with a running suture of 3-0 absorbable suture to exclude the mesh from the skin. The skin is closed and a sterile dressing is applied. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10633?source=see_link\">",
"     \"Principles of abdominal wall closure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SPECIAL CONSIDERATIONS IN WOMEN",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indirect inguinal hernia sacs are frequently much more intimately attached to the round ligament in women than are indirect sacs to the cord structures in males. Compared to men, this makes totally preperitoneal laparoscopic repairs somewhat more technically difficult when inadvertent pneumoperitoneum occurs during dissection of the sac from the ligament.",
"   </p>",
"   <p>",
"    In addition, women have frequently had prior lower abdominal surgery that causes adhesions within the preperitoneal space, increasing the risk of unintended organ injury during laparoscopic repairs. The technical aspects of the Lichtenstein tension free herniorrhaphy procedure can be altered slightly in women by removing that segment of the round ligament lying within the inguinal canal and by removing and ligating the ilioinguinal nerve. In doing so, the need to bivalve the mesh is eliminated. The mesh is sutured to the same landmarks described for men above.",
"   </p>",
"   <p>",
"    The surgeon should discuss the pros and cons of both open and laparoscopic repairs with the patient. In particular, the location and length of planned incisions with women patients should be discussed. The incision for an open repair, although longer than the incisions for laparoscopic repairs, may be more cosmetically appealing since it is below the \"bikini line\".",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     ALTERNATIVE OPEN TECHNIQUES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Shouldice repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Shouldice technique is used for open repair of inguinal hernias without mesh [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/25\">",
"     25",
"    </a>",
"    ]. This technique involves division of all layers of the floor of the canal followed by reconstruction in a four layer overlap technique utilizing continuous fine wire sutures [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/26\">",
"     26",
"    </a>",
"    ]. The defect is closed with multiple layers, none of which are placed with inordinate tension and completely obliterates the defect in the canal [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Shouldice and colleagues have reported recurrence rates of less than 2 percent in selected patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/27\">",
"     27",
"    </a>",
"    ]. Their results have not been equaled by any non-prosthetic repair, and the cited low recurrence rates have not been achieved by other surgeons.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Bassini repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;First introduced in 1887, the Bassini repair is a tissue approximation approach to inguinal hernia repair [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/2\">",
"     2",
"    </a>",
"    ]. The essence of the Bassini repair is that the weakened inguinal floor is strengthened by approximating the conjoined tendon to the inguinal ligament from the pubic tubercle medially to the area of the internal ring laterally. Many surgeons use this approach preferentially when treating patients who require bowel resection for an incarcerated or strangulated hernia to avoid the potential complication of infected mesh. The Bassini repair is used more frequently in women who have less strenuous life styles.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     McVay repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;The McVay repair is applicable to the repair of femoral and inguinal hernias, whereas the Bassini repair is applicable to only inguinal hernias [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/4\">",
"     4",
"    </a>",
"    ]. It is somewhat more technically challenging than the Bassini repair. It involves incising transversalis fascia in the region of Hesselbach's triangle to enter the preperitoneal space and expose the pectineal ligament (Cooper's ligament), an extension of the lacunar ligament on the pectineal line of the pubic bone. The conjoined tendon is then sutured to Cooper's ligament from the pubic tubercle medially to the femoral vein as it crosses Cooper's ligament laterally. At that point, a transition stitch is placed incorporating the conjoined tendon, Cooper's ligament, the femoral sheath at the medial aspect of the femoral vein, and the inguinal ligament (occasionally the femoral sheath cannot be identified and can be excluded).",
"   </p>",
"   <p>",
"    The remainder of the inguinal floor is repaired by approximating the conjoined tendon to the inguinal ligament extending laterally to the area of the internal ring. This repair creates considerable tension. To release this tightness, a relaxing incision is required. This involves first exposing the rectus sheath behind the external oblique aponeurosis from the pubic tubercle cephalad for several centimeters. Sparing its external oblique component, the rectus sheath is then incised from the tubercle extending cephalad for approximately 6 centimeters along the fusion of the external oblique aponeurosis with the sheath's other components. This relaxing incision can also be used with other mesh less repairs.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     BILATERAL INGUINAL HERNIAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;During the era before tension-free hernia repairs, bilateral inguinal hernias were repaired one side at a time to avoid increased tension and high recurrence rates. This teaching lingers in many circles today, leading some to conclude that bilaterality is one of the few indications for laparoscopic repair. In fact, open tension-free mesh repairs can be performed bilaterally at the same time [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     FEMORAL HERNIAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Femoral hernias account for &lt;10 percent of all groin hernias, but 40 percent present with emergencies such as incarceration or strangulation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/29\">",
"     29",
"    </a>",
"    ]. Femoral hernias develop in the potential empty space above Cooper's ligament, below the inguinal ligament (",
"    <a class=\"graphic graphic_figure graphicRef55844 \" href=\"UTD.htm?29/47/30453\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef61841 \" href=\"UTD.htm?7/18/7461\">",
"     figure 1",
"    </a>",
"    ). This potential space is called the femoral ring. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/37/31321?source=see_link\">",
"     \"Classification, clinical features and diagnosis of inguinal and femoral hernias in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Traditional surgical repair of femoral hernias was performed using the McVay repair, although this tissue approximation technique can cause postoperative pain and have an increased risk of recurrence due to tension at the suture line. Mesh repairs have decreased both postoperative pain and recurrence rates [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/30\">",
"     30",
"    </a>",
"    ]. Both mesh plugs and flat mesh techniques have been used successfully for femoral hernia repair [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/31\">",
"     31",
"    </a>",
"    ]. We prefer a bilayer mesh repair described below because of its ease and reliability (",
"    <a class=\"graphic graphic_figure graphicRef55844 \" href=\"UTD.htm?29/47/30453\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The Lichtenstein repair is not applicable to femoral hernias since it does not cover the femoral ring. When the operative exploration of the internal inguinal ring and Hesselbach's triangle fail to identify an inguinal hernia, the preperitoneal space must be explored by incising the transversalis fascia over Hesselbach's triangle to allow inspection of the femoral canal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Bilayer mesh repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bilayer mesh repair combines components of the Lichtenstein repair and preperitoneal repair [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/32\">",
"     32",
"    </a>",
"    ]. The two layers of mesh include a preperitoneal portion as well as a transversalis overlay (",
"    <a class=\"graphic graphic_figure graphicRef55844 \" href=\"UTD.htm?29/47/30453\">",
"     figure 3",
"    </a>",
"    ). This repair is applicable for all groin hernias.",
"   </p>",
"   <p>",
"    Follow the same steps as outlined above for the Lichtenstein repair, up to and including freeing the cord structures from the inguinal floor and retracting them with a Penrose drain (in women, the round ligament is removed and the ilioinguinal nerve is transected and ligated). Next, access to the preperitoneal space is required. This can be accomplished through a dilated internal ring or by making an incision in the transversalis fascia over Hesselbach's Triangle. Using the index finger, the preperitoneal space is dissected, separating the peritoneum and preperitoneal fat from the inner aspect of the muscular components of the abdominal wall anteriorly extending as far as the linea alba medially and the anterior superior iliac spine laterally.",
"   </p>",
"   <p>",
"    Dissection continues posteriorly, exposing the symphysis pubis, Cooper's ligament, femoral ring, cord structures, psoas muscle, and external iliac vessels. During this dissection, care is taken to leave the deep epigastric vessels anteriorly with the anterior abdominal wall. The herniated tissues in the femoral ring are reduced under direct vision through the incised transversalis fascia. The sac is not removed. The preperitoneal component of the mesh is then inserted into the preperitoneal space, using the index finger to ensure that it is fully deployed without gathers, folds, or wrinkles. The anterior component of the bilayer mesh is then sutured in place just as in the Lichtenstein technique.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     INCARCERATED AND STRANGULATED HERNIAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Incarceration refers to trapping of a hernia's contents so that it cannot be reduced. Impaired venous and lymphatic drainage leads to swelling of incarcerated tissue. As edema builds, venous and ultimately arterial flow to the contents of the hernia sac may be compromised, resulting in ischemia and necrosis of the entrapped contents, known as strangulation. All types of groin hernias can strangulate. Incarcerated",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    strangulated hernias can present as an acute small bowel obstruction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/37/31321?source=see_link\">",
"     \"Classification, clinical features and diagnosis of inguinal and femoral hernias in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29000?source=see_link\">",
"     \"Overview of treatment for inguinal and femoral hernias\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/38/8807?source=see_link\">",
"     \"Small bowel obstruction: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The operating table is placed in reverse Trendelenburg position during induction to decrease the likelihood that the hernia will reduce spontaneously with the induction of anesthesia. If spontaneous reduction of the hernia does occur in spite of this maneuver, the bowel should be explored by retrieving it through the opened hernia sac. Alternatively, laparoscopy would be required to assure that the bowel is viable and that the hernia has not reduced \"en mass\" with potentially obstructive acute or subacute adhesions. Clear yellow peritoneal fluid is reassuring, but does not necessarily rule out gangrene or adhesive obstruction. The presence of bloody fluid increases the suspicion of strangulated, gangrenous tissues.",
"   </p>",
"   <p>",
"    Occasionally, an incarcerated or strangulated femoral hernia cannot be reduced in spite of traction from above in the preperitoneal space and pressure from below the femoral ring on the anterior thigh. In such cases the lacunar ligament can be incised to enlarge the femoral ring. If even that is not adequate, the inguinal ligament can be transected just above the femoral ring; this maneuver is rarely required.",
"   </p>",
"   <p>",
"    If gangrenous tissue is found, it must be resected. When intestinal gangrene is present, it requires bowel resection and an anastomosis. This can frequently be performed through the groin incision. However, if the groin incision does not provide adequate exposure, a laparotomy will be required.",
"   </p>",
"   <p>",
"    Mesh may safely be used for the repair of incarcerated hernias if the herniated tissue looks normal or is only mildly edematous [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/33\">",
"     33",
"    </a>",
"    ]. Profound edema",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    dusky bowel that normalize in color during observation mitigates against the use of mesh. Mesh should never be used in the presence of gangrenous tissue. When a mesh repair is selected, we prefer the Lichtenstein procedure for inguinal hernias and a bilayer mesh repair for femoral hernias. When mesh is contraindicated, we use a Bassini repair with a McVay relaxing incision for inguinal hernias and a classic McVay repair for femoral hernias.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     SLIDING INGUINAL HERNIAS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A sliding hernia is one in which a portion of the sac is composed of the mesentery of viscera or viscera itself. The visceral component can be ovary, fallopian tube, cecum, appendix, sigmoid colon, bladder, ureter, or only preperitoneal fat adjacent to any of these structures. Direct sliding hernias require no special techniques, since the sac, including the sliding component, can be inverted behind a purse string suture as described above under the Lichtenstein technique. The essence of the repair of sliding inguinal hernias is the peritonealization of the sliding component. Regardless of the size or source of the sliding component of the sac, the approach described here, a modification of the LaRoque technique, is always applicable [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/34,35\">",
"     34,35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Dissection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indirect sac is freed from the adjacent cord structures. Sliding hernias are rarely direct except in the case of the urinary bladder. If all contents of the sac cannot be reduced, adhesions of viscera to the sac or a sliding component must be considered. If the cecum, terminal ileum, appendix, or sigmoid colon contributes to the sac, they present laterally and posteriorly. The urinary bladder and ovary present as medial components of the sac. Although the appendix is expendable, appendectomy is inadvisable; it converts a clean case into a clean-contaminated case, which needlessly increases the risk of infection, rendering the use of mesh risky. The mesenteric vasculature and enteric organ are covered with peritoneum and serosa, respectively, only on the inside of the sac; the outer surface, having been extraperitoneal prior to herniation, has no peritoneal or serosal layer. The sac is opened with caution (",
"    <a class=\"graphic graphic_figure graphicRef76206 \" href=\"UTD.htm?29/15/29943\">",
"     figure 7",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Once the sac is entered, the serosalized surface of the sliding organ is visualized. Next, the sliding component is separated from the rest of the sac, leaving a 1 cm circumferential cuff of adjacent sac attached, which can be used to peritonealize the extraperitoneal surface (",
"    <a class=\"graphic graphic_figure graphicRef76206 \" href=\"UTD.htm?29/15/29943\">",
"     figure 7",
"    </a>",
"    ). This peritonealization is accomplished by everting the cuff and approximating its everted margins edge-to-edge with a running suture beginning at the apex and continuing to the level of the internal ring. The sliding component is now totally peritonealized and ready to assume its intraperitoneal location (",
"    <a class=\"graphic graphic_figure graphicRef76206 \" href=\"UTD.htm?29/15/29943\">",
"     figure 7",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    At this point, the organ is reduced through the internal ring into the abdominal cavity. On rare occasions, its bulk may require ligation of the deep epigastric vessels and enlargement of the internal ring medially. Beginning at the termination of the previously completed peritonealizing suture, the remaining peritoneal defect is closed at the level of the internal ring while, at the same time, any remaining redundant sac is excised. The procedure is completed in typical Lichtenstein fashion.",
"   </p>",
"   <p>",
"    Ovaries frequently incarcerate without sliding. When a true slide is encountered, the sliding component must still be separated from the rest of the sac, but, as with the appendix, peritonealizing the extra-peritoneal surface is not required as long as the base at the level of the internal ring is incorporated in the high ligation of the sac.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     RECURRENT HERNIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;The variability of recurrent inguinal hernias precludes a standard approach. For recurrences after laparoscopic repairs, an open approach is best. Conversely, for recurrences after open repair, a laparoscopic approach is best, depending on the surgeon's scope of practice and assuming there are no other contraindications.",
"   </p>",
"   <p>",
"    When, for any reason, an open approach is chosen for a recurrence after a prior open repair, a classic Lichtenstein repair is best if the original repair was without mesh.",
"   </p>",
"   <p>",
"    The options are more varied when the original repair included mesh. No attempt is made to remove the old mesh unless it is technically beneficial to do so. If the recurrence is limited to a small 1 or 2 centimeter defect, as is sometimes seen next to the pubic tubercle, a plug and patch are used. If multiple direct defects are found, the fibrous bridges between them are transected, providing access for an open bilayer mesh preperitoneal repair. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Bilayer mesh repair'",
"    </a>",
"    above.) A preperitoneal repair is also used when a direct hernia involves the entire floor of the canal. Utilizing these options, it is generally possible, and advisable, to avoid taking down or destroying portions of the previous repair that are intact, except in the case of multiple defects. If the recurrence is indirect, a high ligation of the sac is performed and the ring narrowed in Lichtenstein fashion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the emphasis on tension-free repairs, recurrences are so infrequent in the hands of experienced surgeons that we are now focused more on mitigating the other complications of groin hernioplasty. Mesh infection, chronic orchialgia, neuralgia, other pain syndromes, and testicular ischemia are the most serious complications. Postoperative pain syndromes are so common that many hernia surgeons avoid repair of asymptomatic hernias, even for young, healthy patients [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44360?source=see_link\">",
"     \"Evaluation of the acute scrotum in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/39/21113?source=see_link\">",
"     \"Abdominal surgical incisions: Prevention and treatment of complications\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of mesh infections is discussed separately (",
"    <a class=\"graphic graphic_table graphicRef52962 \" href=\"UTD.htm?42/9/43163\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11268?source=see_link\">",
"     \"Infection in mesh graft following hernia repair: Clinical manifestations, diagnosis, and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative care is individualized. In general, the length of stay is dictated by comorbidities, complications, and the elective or emergent nature of the hernia. Elective cases are usually discharged the same day. Nausea and urinary retention are the most common problems that require an overnight stay. Patients that have mesh repairs may return to full activity as postoperative discomfort abates [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9465/abstract/37\">",
"     37",
"    </a>",
"    ]. Patients that undergo non-mesh repairs are limited in activity for one month and told to increase to full activity from that point over the next two weeks.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/62/42977?source=see_link\">",
"       \"Patient information: Inguinal and femoral (groin) hernias (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The main principles of hernia repair are to reinforce the floor of the inguinal canal and tighten the internal inguinal ring. Repairs must be tension free to mitigate recurrences. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hernia repairs can be described as tissue approximation repairs (such as the Bassini or McVay repair) or tension-free repairs using mesh. The Lichtenstein open tension-free hernioplasty is favored for open inguinal hernia repair because it has a low recurrence rate, can be technically mastered with ease and can be performed in the outpatient setting with local anesthetic. Equivalent surgical results can be obtained with other open or laparoscopic approaches, depending on the experience and expertise of the surgeon. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hernias are so common that they may be incidental to the patient's true problem. If symptoms are atypical, a thorough search should be undertaken for other important causes of the patient&rsquo;s symptoms, such as colorectal cancer. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Preoperative evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The surgical consent process should include discussion of possible complications including the possibility of hernia recurrence, mesh infection, chronic orchialgia, neuralgia, other pain syndromes, and testicular necrosis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Preoperative evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The option of laparoscopic versus open repair should be discussed and the patient is given the opportunity to autonomously choose between them. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Preoperative evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Key elements of the Lichtenstein repair include avoiding tension on the mesh, crossing the tails of the mesh lateral to the cord, overlapping the public tubercle with the mesh, securing the mesh on all edges and protection of the ilioinguinal, iliohypogastric and genital nerves. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Lichtenstein repair'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bilateral open tension-free repairs can be safely performed at the same procedure. (See",
"      <a class=\"local\" href=\"#H21\">",
"       'Bilateral inguinal hernias'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The Lichtenstein repair is not applicable to femoral hernias since it does not close the femoral ring. The presence of a femoral hernia dictates a different approach, such as a bilayer mesh repair. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Femoral hernias'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Incarcerated or strangulated inguinal and femoral hernias should usually be repaired with an open approach. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Incarcerated and strangulated hernias'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The essence of the open repair of sliding inguinal hernias via a groin approach is the peritonealization of the sliding component. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Sliding inguinal hernias'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Repair of recurrent hernias is individualized based on the original repair and the anatomy of the recurrence. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Recurrent hernia'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/1\">",
"      Rutkow IM, Robbins AW. Demographic, classificatory, and socioeconomic aspects of hernia repair in the United States. Surg Clin North Am 1993; 73:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/2\">",
"      Sachs M, Damm M, Encke A. Historical evolution of inguinal hernia repair. World J Surg 1997; 21:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/3\">",
"      EU Hernia Trialists Collaboration. Repair of groin hernia with synthetic mesh: meta-analysis of randomized controlled trials. Ann Surg 2002; 235:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/4\">",
"      McVAY CB, CHAPP JD. Inguinal and femoral hernioplasty; the evaluation of a basic concept. Ann Surg 1958; 148:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/5\">",
"      Polk HC. Prophylactic antibiotics. West J Med 1975; 123:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/6\">",
"      Lichtenstein IL, Shulman AG, Amid PK, Montllor MM. The tension-free hernioplasty. Am J Surg 1989; 157:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/7\">",
"      Amid PK. Groin hernia repair: open techniques. World J Surg 2005; 29:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/8\">",
"      Nienhuijs SW, van Oort I, Keemers-Gels ME, et al. Randomized trial comparing the Prolene Hernia System, mesh plug repair and Lichtenstein method for open inguinal hernia repair. Br J Surg 2005; 92:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/9\">",
"      Voyles CR, Hamilton BJ, Johnson WD, Kano N. Meta-analysis of laparoscopic inguinal hernia trials favors open hernia repair with preperitoneal mesh prosthesis. Am J Surg 2002; 184:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/10\">",
"      Kingsnorth AN, Porter CS, Bennett DH, et al. Lichtenstein patch or Perfix plug-and-patch in inguinal hernia: a prospective double-blind randomized controlled trial of short-term outcome. Surgery 2000; 127:276.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/11\">",
"      Kingsnorth AN, Wright D, Porter CS, Robertson G. Prolene Hernia System compared with Lichtenstein patch: a randomised double blind study of short-term and medium-term outcomes in primary inguinal hernia repair. Hernia 2002; 6:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/12\">",
"      Bringman S, Ramel S, Heikkinen TJ, et al. Tension-free inguinal hernia repair: TEP versus mesh-plug versus Lichtenstein: a prospective randomized controlled trial. Ann Surg 2003; 237:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/13\">",
"      Vironen J, Nieminen J, Eklund A, Paavolainen P. Randomized clinical trial of Lichtenstein patch or Prolene Hernia System for inguinal hernia repair. Br J Surg 2006; 93:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/14\">",
"      Zhao G, Gao P, Ma B, et al. Open mesh techniques for inguinal hernia repair: a meta-analysis of randomized controlled trials. Ann Surg 2009; 250:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/15\">",
"      McGillicuddy JE. Prospective randomized comparison of the Shouldice and Lichtenstein hernia repair procedures. Arch Surg 1998; 133:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/16\">",
"      Fry DE. Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008; 9:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/17\">",
"      Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/18\">",
"      Sanchez-Manuel FJ, Lozano-Garc&iacute;a J, Seco-Gil JL. Antibiotic prophylaxis for hernia repair. Cochrane Database Syst Rev 2007; :CD003769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/19\">",
"      Campanelli G, Champault G, Pascual MH, et al. Randomized, controlled, blinded trial of Tissucol/Tisseel for mesh fixation in patients undergoing Lichtenstein technique for primary inguinal hernia repair: rationale and study design of the TIMELI trial. Hernia 2008; 12:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/20\">",
"      Nowobilski W, Dobosz M, Wojciechowicz T, Mionskowska L. Lichtenstein inguinal hernioplasty using butyl-2-cyanoacrylate versus sutures. Preliminary experience of a prospective randomized trial. Eur Surg Res 2004; 36:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/21\">",
"      Kapischke M, Schulze H, Caliebe A. Self-fixating mesh for the Lichtenstein procedure--a prestudy. Langenbecks Arch Surg 2010; 395:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/22\">",
"      Paajanen H, K&ouml;ssi J, Silvasti S, et al. Randomized clinical trial of tissue glue versus absorbable sutures for mesh fixation in local anaesthetic Lichtenstein hernia repair. Br J Surg 2011; 98:1245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/23\">",
"      Dittrick GW, Ridl K, Kuhn JA, McCarty TM. Routine ilioinguinal nerve excision in inguinal hernia repairs. Am J Surg 2004; 188:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/24\">",
"      Mui WL, Ng CS, Fung TM, et al. Prophylactic ilioinguinal neurectomy in open inguinal hernia repair: a double-blind randomized controlled trial. Ann Surg 2006; 244:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/25\">",
"      Simons MP, Kleijnen J, van Geldere D, et al. Role of the Shouldice technique in inguinal hernia repair: a systematic review of controlled trials and a meta-analysis. Br J Surg 1996; 83:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/26\">",
"      Shouldice, EE. The treatment of hernia. Ontario Med Rev 1953; 20:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/27\">",
"      Glassow F. The Shouldice Hospital technique. Int Surg 1986; 71:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/28\">",
"      Amid PK, Shulman AG, Lichtenstein IL. Simultaneous repair of bilateral inguinal hernias under local anesthesia. Ann Surg 1996; 223:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/29\">",
"      McIntosh A, Hutchinson A, Roberts A, Withers H. Evidence-based management of groin hernia in primary care--a systematic review. Fam Pract 2000; 17:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/30\">",
"      Hachisuka T. Femoral hernia repair. Surg Clin North Am 2003; 83:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/31\">",
"      Scott NW, McCormack K, Graham P, et al. Open mesh versus non-mesh for repair of femoral and inguinal hernia. Cochrane Database Syst Rev 2002; :CD002197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/32\">",
"      Gilbert, AI, Graham, MF, Voigt, WJ. A bilayer patch device for inguinal hernia repair. Hernia 1999; 3:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/33\">",
"      Elsebae MM, Nasr M, Said M. Tension-free repair versus Bassini technique for strangulated inguinal hernia: A controlled randomized study. Int J Surg 2008; 6:302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/34\">",
"      LaRoque, GP. The intra-abdominal method of removing inguinal and femoral hernia. Arch Surg 1932; 24:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/35\">",
"      Williams C. Repair of Sliding Inguinal Hernia Through the Abdominal (Laroque) Approach. Ann Surg 1947; 126:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/36\">",
"      Fitzgibbons RJ Jr, Giobbie-Hurder A, Gibbs JO, et al. Watchful waiting vs repair of inguinal hernia in minimally symptomatic men: a randomized clinical trial. JAMA 2006; 295:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9465/abstract/37\">",
"      Shulman AG, Amid PK, Lichtenstein IL. Returning to work after herniorrhaphy. BMJ 1994; 309:216.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3690 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-83.177.194.223-190351C039-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9465=[""].join("\n");
var outline_f9_15_9465=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREOPERATIVE EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      LICHTENSTEIN REPAIR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Patient positioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Thromboprophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Skin preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Anesthesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Incision planning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Dissection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Avoiding nerve injuries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Neurectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Closure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SPECIAL CONSIDERATIONS IN WOMEN",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      ALTERNATIVE OPEN TECHNIQUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Shouldice repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Bassini repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      McVay repair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      BILATERAL INGUINAL HERNIAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      FEMORAL HERNIAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Bilayer mesh repair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      INCARCERATED AND STRANGULATED HERNIAS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      SLIDING INGUINAL HERNIAS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      RECURRENT HERNIA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      POSTOPERATIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/3690\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/3690|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/18/7461\" title=\"figure 1\">",
"      Groin hernia anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/12/40128\" title=\"figure 2\">",
"      Groin hernias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/47/30453\" title=\"figure 3\">",
"      Femoral hernia repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/36/577\" title=\"figure 4\">",
"      Open hernia groin incision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/17/4377\" title=\"figure 5\">",
"      Lichtenstein hernia repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/53/855\" title=\"figure 6\">",
"      Direct hernia repair",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?29/15/29943\" title=\"figure 7\">",
"      Sliding hernia repair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/3690|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/52/24397\" title=\"table 1\">",
"      Antimicrobial prophylaxis for gastrointestinal surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?42/9/43163\" title=\"table 2\">",
"      Empiric antibiotic therapy for mesh graft infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/39/21113?source=related_link\">",
"      Abdominal surgical incisions: Prevention and treatment of complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36074?source=related_link\">",
"      Cancer of the appendix and pseudomyxoma peritonei",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/37/31321?source=related_link\">",
"      Classification, clinical features and diagnosis of inguinal and femoral hernias in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/33/17946?source=related_link\">",
"      Clinical manifestations, diagnosis, and staging of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/20/44360?source=related_link\">",
"      Evaluation of the acute scrotum in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/0/11268?source=related_link\">",
"      Infection in mesh graft following hernia repair: Clinical manifestations, diagnosis, and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/49/43801?source=related_link\">",
"      Overview of abdominal hernias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19817?source=related_link\">",
"      Overview of anesthesia and anesthetic choices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29000?source=related_link\">",
"      Overview of treatment for inguinal and femoral hernias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/62/42977?source=related_link\">",
"      Patient information: Inguinal and femoral (groin) hernias (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/39/18042?source=related_link\">",
"      Peripheral nerve block: Techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/4/10314?source=related_link\">",
"      Preoperative medical evaluation of the healthy patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10633?source=related_link\">",
"      Principles of abdominal wall closure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/35/30265?source=related_link\">",
"      Principles of abdominal wall incisions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/38/8807?source=related_link\">",
"      Small bowel obstruction: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/57/20373?source=related_link\">",
"      Sports-related groin pain or 'sports hernia'",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_15_9466="Etiology and diagnosis of heart failure in infants and children";
var content_f9_15_9466=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Etiology and diagnosis of heart failure in infants and children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/15/9466/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9466/contributors\">",
"     Rakesh K Singh, MD, MSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9466/contributors\">",
"     TP Singh, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/15/9466/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9466/contributors\">",
"     John K Triedman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/15/9466/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/15/9466/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/15/9466/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 26, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H23884829\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart failure is estimated to affect 12,000 to 35,000 children below 19 years of age in the United States each year [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/1\">",
"     1",
"    </a>",
"    ]. The presentation of pediatric heart failure is diverse because of the numerous underlying cardiac etiologies and varying clinical settings (eg, age at presentation).",
"   </p>",
"   <p>",
"    The etiology, presentation, diagnosis, and initial evaluation of the pediatric patient with heart failure are reviewed here. The management of heart failure in infants and children is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/16/5386?source=see_link\">",
"     \"Management of heart failure in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23884822\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart failure is a clinical condition that results from impairment of the ventricle to fill with or eject blood. Heart failure is caused by ventricular pump dysfunction, or by overload of volume (preload) or pressure (afterload) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/1,2\">",
"     1,2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23884815\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY AND ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causes of pediatric heart failure can be divided into pathophysiologic categories (",
"    <a class=\"graphic graphic_table graphicRef79989 \" href=\"UTD.htm?6/33/6685\">",
"     table 1",
"    </a>",
"    ). This categorization helps in the understanding of the underlying physiology and clinical manifestations of the different causes of pediatric heart failure, and guides the approach to management. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/16/5386?source=see_link\">",
"     \"Management of heart failure in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ventricular pump dysfunction &mdash; Ventricular dysfunction results in reduced ventricular contractility that leads to impaired ejection of blood from the ventricle. Ventricular dysfunction can occur in both children born with structurally normal hearts and those with congenital heart disease. Children born with a congenital heart lesion may have ventricular pump dysfunction at presentation, but more commonly develop pump dysfunction and heart failure several years (or even decades) following surgical repair of their cardiac defect (ie, &ldquo;burnt-out&rdquo; congenital heart disease). (See",
"      <a class=\"local\" href=\"#H180717383\">",
"       'Ventricular pump dysfunction'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Volume overload with preserved ventricular contractility &mdash; Volume overload (increased preload) resulting in heart failure is due to congenital heart lesions with significant left-to right shunt of blood from the systemic to the pulmonary circulation or less commonly, valvular insufficiency. (See",
"      <a class=\"local\" href=\"#H23884808\">",
"       'Preserved ventricular pump function with volume overload'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Pressure overload with preserved ventricular contractility &mdash; Pressure overload (increased afterload) is due to congenital heart disease with severe ventricular outflow obstruction that impedes ejection of blood from the heart resulting in inadequate cardiac output.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H180717383\">",
"    <span class=\"h2\">",
"     Ventricular pump dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cardiac causes of ventricular pump dysfunction can be separated into children with structurally normal hearts and those born with congenital heart disease (",
"    <a class=\"graphic graphic_table graphicRef79989 \" href=\"UTD.htm?6/33/6685\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H180717491\">",
"    <span class=\"h3\">",
"     Structurally normal heart",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cardiac causes of ventricular dysfunction in children with structurally normal hearts include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiomyopathy &mdash; The most common cause of heart failure in children with a structurally normal heart is cardiomyopathy. The incidence of pediatric cardiomyopathy in the United States is 1.13 cases per 100,000, estimated from a prospective registry in two large US regions [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/3\">",
"       3",
"      </a>",
"      ]. When categorized according to type, 51 percent in the registry had dilated cardiomyopathy, 42 percent had hypertrophic cardiomyopathy, 3 percent had restrictive or other known types of cardiomyopathy, and 4 percent were unspecified.",
"      <br/>",
"      <br/>",
"      Heart failure symptoms were treated with medications in 58 percent of all children with cardiomyopathy; and most children treated for heart failure had dilated cardiomyopathy. Heart failure is rare in children with hypertrophic cardiomyopathy as most patients have preserved ventricular pump function. Of note, infants with hypertrophic cardiomyopathy that have ventricular dysfunction and early manifestations of heart failure are at-risk for a poor outcome. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30777?source=see_link\">",
"       \"Definition and classification of the cardiomyopathies\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Myocarditis &mdash; Inflammation of the myocardium (myocarditis) is usually due to a viral infection, and often results in ventricular pump dysfunction and heart failure. Acute myocarditis may be followed by either a complete recovery of left ventricular function or a secondary dilated cardiomyopathy with chronic heart failure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=see_link\">",
"       \"Clinical manifestations and diagnosis of myocarditis in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Myocardial",
"      <span class=\"nowrap\">",
"       ischemia/infarction",
"      </span>",
"      &mdash; Anomalous left coronary arteries may rarely lead to myocardial ischemia followed by ventricular dysfunction and heart failure. In particular, anomalous left coronary artery arising from the pulmonary artery (ALCAPA) may present with myocardial ischemia during the first few months of life after the physiologic decline in pulmonary vascular resistance, which may cause severe left ventricular dysfunction. Surgical coronary re-implantation is the definitive therapy and usually results in a dramatic improvement in ventricular function and heart failure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14218?source=see_link&amp;anchor=H13#H13\">",
"       \"Congenital and pediatric coronary artery abnormalities\", section on 'Variations of coronary artery origin from the pulmonary artery'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Arrhythmias &mdash; The following arrhythmias may lead to ventricular pump dysfunction and pediatric heart failure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Neonatal complete heart block (seen in association with congenital heart disease or from maternal autoimmune collagen vascular disease) may lead to heart failure if the junctional escape rhythm is not fast enough for the body&rsquo;s needs. It is treated with a permanent pacemaker placement. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?23/57/24474?source=see_link&amp;anchor=H24#H24\">",
"       \"Neonatal lupus\", section on 'Congenital complete heart block'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/24/33161?source=see_link&amp;anchor=H24#H24\">",
"       \"Bradycardia in children\", section on 'AV Heart block'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/52/17226?source=see_link&amp;anchor=H181202983#H181202983\">",
"       \"Atrial arrhythmias (including AV block) in congenital heart disease\", section on 'Congenital AV block'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Atrial arrhythmias such as supraventricular tachycardia, atrial flutter, atrial fibrillation, ectopic atrial tachycardia, or paroxysmal junctional reciprocating tachycardia, if incessant and not recognized for",
"      <span class=\"nowrap\">",
"       hours/days",
"      </span>",
"      after onset, may result in ventricular dysfunction and heart failure. Similarly, junctional or ventricular tachycardia may also lead to progressive heart failure. It may be difficult to ascertain in a child presenting with ventricular dysfunction and a concurrent tachyarrhythmia whether the arrhythmia is the primary diagnosis (with secondary ventricular dysfunction) or is secondary to an underlying",
"      <span class=\"nowrap\">",
"       cardiomyopathy/ventricular",
"      </span>",
"      dysfunction. Control of arrhythmia with medications or ablative methods may lead to improved ventricular function. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43623?source=see_link\">",
"       \"Irregular heart rate (arrhythmias) in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/35/39481?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and evaluation of narrow QRS complex tachycardias\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/54/31593?source=see_link\">",
"       \"Supraventricular tachycardia in children: AV reentrant tachycardia (including WPW) and AV nodal reentrant tachycardia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/19/31034?source=see_link\">",
"       \"Approach to the diagnosis and treatment of wide QRS complex tachycardias\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <span class=\"nowrap\">",
"       Drug/toxins",
"      </span>",
"      &mdash; Pediatric cancer patients who have been treated with chemotherapy agents, especially anthracyclines, carry a life-long risk of developing ventricular dysfunction and heart failure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41706?source=see_link\">",
"       \"Cardiotoxicity of anthracycline-like chemotherapy agents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Non-cardiac causes of heart failure due to ventricular dysfunction are rare and include sepsis (release of cytokines)",
"     </li>",
"     <li>",
"      Renal failure (occurs despite normal preload and afterload)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H180717533\">",
"    <span class=\"h3\">",
"     Congenital heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ventricular dysfunction may develop in a child who was born with complex congenital heart disease and underwent surgical correction in early childhood. Although impaired ventricular function is most frequently detected by the onset of symptoms during adolescence and young adulthood, it may be detected earlier in the first decade of life on routine echocardiographic imaging in asymptomatic patients. The progression of ventricular dysfunction is variable depending on the underlying pathophysiology of the corrected cardiac defect. These patients with &ldquo;burnt-out&rdquo; congenital heart disease are expected to represent a growing cause of chronic heart failure in the general population [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23884808\">",
"    <span class=\"h2\">",
"     Preserved ventricular pump function with volume overload",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3449490\">",
"    <span class=\"h3\">",
"     Cardiac causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Volume overload occurs due to a moderate or large communication (shunt) between systemic and pulmonary circulations and may occur with the following cardiac lesions (",
"    <a class=\"graphic graphic_table graphicRef79989 \" href=\"UTD.htm?6/33/6685\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Ventricular septal defect (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=see_link\">",
"       \"Pathophysiology and clinical features of isolated ventricular septal defects in infants and children\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Patent ductus arteriosus (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/52/35656?source=see_link\">",
"       \"Clinical manifestations and diagnosis of patent ductus arteriosus\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Atrial septal defect, rarely (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26201?source=see_link\">",
"       \"Classification and clinical features of isolated atrial septal defects in children\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Aortopulmonary window",
"     </li>",
"     <li>",
"      Atrioventricular septal defect",
"     </li>",
"     <li>",
"      Single ventricle physiology with unobstructed pulmonary blood flow",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The magnitude of left-to-right shunting across a congenital heart defect is not significant early after birth due to high pulmonary vascular resistance. During the first six to eight weeks after birth, the physiologic decline in pulmonary vascular resistance leads to a progressive increase in shunting with increase in pulmonary blood flow, pulmonary venous return, and left (systemic) ventricular preload resulting in symptoms and signs of heart failure. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4344?source=see_link\">",
"     \"Pathophysiology of left to right shunts\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Volume overload may also occur with valvular insufficiency from:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Aortic regurgitation, seen in some children with bicuspid aortic valves (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/33/1559?source=see_link\">",
"       \"Aortic regurgitation in children\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Mitral regurgitation",
"     </li>",
"     <li>",
"      Pulmonary regurgitation, seen in some children as a long-term complication following tetralogy of Fallot repair (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28794?source=see_link&amp;anchor=H9#H9\">",
"       \"Overview of the management of tetralogy of Fallot\", section on 'Chronic pulmonary regurgitation'",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3449497\">",
"    <span class=\"h3\">",
"     Noncardiac causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Non-cardiac causes of heart failure due to volume overload with preserved ventricular pump function include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Arteriovenous malformation (extra-cardiac shunting)",
"     </li>",
"     <li>",
"      Renal failure (fluid overload)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23884801\">",
"    <span class=\"h2\">",
"     Preserved ventricular pump function with pressure overload",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ventricular outflow obstruction leads to pressure overload. Mild outflow obstruction is asymptomatic; however, severe obstruction often presents acutely with heart failure (low cardiac output) in early infancy.",
"    <span class=\"nowrap\">",
"     Moderate/severe",
"    </span>",
"    outflow obstruction may also lead to heart failure from chronically elevated filling pressures. The obstructive lesions associated with heart failure include (",
"    <a class=\"graphic graphic_table graphicRef79989 \" href=\"UTD.htm?6/33/6685\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Aortic stenosis, seen in some children with bicuspid aortic valves (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/28/38345?source=see_link&amp;anchor=H6#H6\">",
"       \"Valvar aortic stenosis in children\", section on 'Critical AS'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Coarctation of the aorta (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link&amp;anchor=H8#H8\">",
"       \"Clinical manifestations and diagnosis of coarctation of the aorta\", section on 'Manifestations according to age'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Pulmonary stenosis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/62/39910?source=see_link\">",
"       \"Clinical manifestations and diagnosis of pulmonic stenosis\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Systemic hypertension results in pressure overload of the heart. The ventricular pump function is usually preserved, but dysfunction may occur with severe hypertension. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/7/42105?source=see_link\">",
"     \"Epidemiology, risk factors, and etiology of hypertension in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23884787\">",
"    <span class=\"h1\">",
"     STAGING AND CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart failure has been categorized either to describe its natural history after exposure to a risk factor for heart failure (&ldquo;stages of heart failure&rdquo;) or to describe the severity of symptoms on a given day (&ldquo;classes of heart failure&rdquo;).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H180717674\">",
"    <span class=\"h2\">",
"     Staging of the progression of HF",
"    </span>",
"    &nbsp;&mdash;&nbsp;A task force representing the American College of Cardiology and the American Heart Association developed a staging system (stages A to D) to describe the development and progression of the heart failure in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/5\">",
"     5",
"    </a>",
"    ]. These stages have been modified for infants and children by the International Society of Heart and Lung Transplantation (",
"    <a class=\"graphic graphic_table graphicRef60553 \" href=\"UTD.htm?6/37/6748\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/28/39369?source=see_link&amp;anchor=H2#H2\">",
"     \"Evaluation of the patient with heart failure or cardiomyopathy\", section on 'Definition and classification'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H180717685\">",
"    <span class=\"h2\">",
"     Classification of HF severity",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H55853967\">",
"    <span class=\"h3\">",
"     NYHA class",
"    </span>",
"    &nbsp;&mdash;&nbsp;The New York Heart Association (NYHA) Classes (I to IV) is most commonly used to quantify the degree of functional limitation imposed by heart failure in adults and may be used in adolescents (",
"    <a class=\"graphic graphic_table graphicRef52683 \" href=\"UTD.htm?3/2/3117\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33546?source=see_link&amp;anchor=H3#H3\">",
"     \"Predictors of survival in heart failure due to systolic dysfunction\", section on 'NYHA functional class'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H180717751\">",
"    <span class=\"h3\">",
"     Ross classification",
"    </span>",
"    &nbsp;&mdash;&nbsp;In 1992, the Ross Heart Failure Classification adapted the NYHA system for describing heart failure severity in infants under six months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/8\">",
"     8",
"    </a>",
"    ]. It assigned infants to four different classes of heart failure severity (no, mild, moderate, or severe heart failure) based on feeding history",
"    <span class=\"nowrap\">",
"     (formula/feed,",
"    </span>",
"    feeding time, diaphoresis, tachypnea), growth parameters, and physical findings (tachypnea, tachycardia, perfusion, edema, diastolic filling sounds, and hepatomegaly).",
"   </p>",
"   <p>",
"    The Ross criteria were subsequently modified to be used for children of all ages and are based on a history of feeding intolerance, growth problems, exercise intolerance, and physical findings [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The numeric score generated by these criteria is comparable to the NYHA classification for adults (",
"    <a class=\"graphic graphic_table graphicRef74339 \" href=\"UTD.htm?14/36/14923\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of the Ross classification in infants was validated by two prospective studies that used physiologic measures of heart failure severity (ie, plasma levels of norepinephrine and peripheral lymphocytic beta-adrenergic receptor density) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H180717758\">",
"    <span class=\"h3\">",
"     NYU Pediatric HF Index",
"    </span>",
"    &nbsp;&mdash;&nbsp;The New York University Pediatric Heart Failure Index classified heart failure severity using physiologic indicators and medical regimen [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/13\">",
"     13",
"    </a>",
"    ]. In a small study of 20 children undergoing surgery for rheumatic heart disease, this index had better correlation with radiologic, echocardiographic, electrocardiographic, and biologic markers compared with the Ross and NYHA classification scores [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/14\">",
"     14",
"    </a>",
"    ]. However, this index has not been further validated and is not widely used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23884780\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms and physical findings in children with heart failure reflect the patient&rsquo;s inability to adequately increase cardiac output (eg, exercise intolerance and easy fatigue)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    pulmonary or systemic fluid overload (eg, shortness of breath at rest or with effort due to pulmonary interstitial edema or hepatomegaly).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H180717807\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of heart failure vary with the age of the patient as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants &ndash; The most common symptoms are tachypnea and diaphoresis during feeds, easy fatigability, irritability, decreased volume of feeds, and poor weight gain.",
"     </li>",
"     <li>",
"      Young children &ndash; In young children, the symptoms may be mistaken for common childhood illnesses such as gastroenteritis, reflux, asthma or even behavioral issues. They include gastrointestinal symptoms (abdominal pain, nausea, vomiting, and poor appetite), failure to thrive, easy fatigability, and recurrent or chronic cough with wheezing.",
"     </li>",
"     <li>",
"      Older children &ndash; Older children may present with exercise intolerance, anorexia, wheezing, dyspnea, edema, palpitations, chest pain, or syncope.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A family history of congenital heart disease or cardiomyopathy in a sibling or parent may suggest a similar diagnosis in the child being evaluated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23884766\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Physical findings vary depending on the reduction of cardiac output, and degree of volume overload with signs of pulmonary",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    systemic venous congestion.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tachycardia is a response to decreased cardiac output in patients with depressed myocardial contractility. Tachycardia is defined as the presence of a heart rate value greater than expected for age (",
"      <a class=\"graphic graphic_table graphicRef78097 \" href=\"UTD.htm?27/37/28252\">",
"       table 5",
"      </a>",
"      ). The following values are published for specific age groups for clinical use (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/38/9832?source=see_link&amp;anchor=H8#H8\">",
"       \"Approach to the child with tachycardia\", section on 'Physical exam'",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Infants (&lt;2 years): &gt;160 BPM (beats per minute)",
"     </li>",
"     <li>",
"      Children between 2 to 6 years: &gt;140 BPM",
"     </li>",
"     <li>",
"      Children between 6 to 12 years: &gt;120 BPM",
"     </li>",
"     <li>",
"      Adolescents and adults: &gt;100 BPM (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/38/9832?source=see_link&amp;anchor=H8#H8\">",
"       \"Approach to the child with tachycardia\", section on 'Physical exam'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Poor perfusion as a result of diminished cardiac output is manifested by cool and mottled extremities, decreased capillary refill, decreased peripheral pulses, and lowered systemic blood pressure.",
"     </li>",
"     <li>",
"      An S3 gallop may be present in children with diminished cardiac output or volume overload.",
"     </li>",
"     <li>",
"      Pulmonary congestion is manifested primarily with changes in respiratory status.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Tachypnea is the most common finding of pulmonary congestion. Normal respiratory rate varies with age (",
"      <a class=\"graphic graphic_table graphicRef78097 \" href=\"UTD.htm?27/37/28252\">",
"       table 5",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Other signs of respiratory distress seen in patients with heart failure include retractions, use of accessory respiratory muscles, and in infants, grunting with nasal flaring.",
"     </li>",
"     <li>",
"      Ausculatory findings include wheezing and rales are more commonly seen in older children as compared with infants.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Systemic congestion may be manifested by the following findings:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Hepatomegaly is the most common finding of systemic venous congestion.",
"     </li>",
"     <li>",
"      Other findings may include jugular venous distension (not generally observed in infants and young children) and peripheral edema.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other findings are suggestive of the underlying etiology for heart failure as demonstrated by the following examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      High blood pressure limited to upper extremities",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      feeble pulses in lower extremities are suggestive of aortic coarctation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=see_link&amp;anchor=H1088178828#H1088178828\">",
"       \"Clinical manifestations and diagnosis of coarctation of the aorta\", section on 'Blood pressure and pulses'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The presence of a systolic murmur may be seen in patients with outflow obstruction in hypertropic cardiomyopathy or aortic stenosis, congenital heart defects with left to right shunting (eg, ventricular septal defects), or mitral regurgitation. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/7/12409?source=see_link&amp;anchor=H26#H26\">",
"       \"Suspected heart disease in infants and children: Criteria for referral\", section on 'Murmurs'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Precordial examination may reveal a &ldquo;thrill&rdquo; in patients with shunt lesions, whereas those with a long-standing cardiomyopathy may have a &ldquo;heave&rdquo; with a laterally displaced point of maximal impulse.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H180717846\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of heart failure in children is based on a combination of characteristic signs and physical findings of impaired cardiac output (eg, exercise and feeding intolerance, tachycardia, poor perfusion with cool extremities, decreased peripheral pulses, and delayed capillary refill), respiratory distress (eg, tachypnea and dyspnea), and poor growth [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/6,15\">",
"     6,15",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H23884780\">",
"     'Clinical manifestations'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Laboratory studies and imaging studies generally are used to confirm the diagnosis of heart failure when there is clinical uncertainty, assess the severity of failure, and determine the underlying cause.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258994897\">",
"    <span class=\"h1\">",
"     INITIAL EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H544135\">",
"    <span class=\"h2\">",
"     Overview",
"    </span>",
"    &nbsp;&mdash;&nbsp;Laboratory testing and noninvasive imaging studies are initially obtained to ascertain the severity of heart failure, determine the underlying cause, and in some cases, confirm the diagnosis. The initial evaluation generally includes chest radiography, electrocardiogram, echocardiography, and blood tests.",
"   </p>",
"   <p>",
"    However, evaluation should only proceed if the patient is clinically stable. In patients who have significant cardiorespiratory compromise (ie, shock or pending shock), rapid initiation of treatment to restore adequate perfusion is required to decrease mortality and morbidity (",
"    <a class=\"graphic graphic_algorithm graphicRef77079 \" href=\"UTD.htm?41/12/42178\">",
"     algorithm 1",
"    </a>",
"    ) prior to undergoing an evaluation to determine the underlying cause of heart failure. In addition, neonates presenting with unexplained shock should be started on prostaglandin infusion, which should be continued until a ductal-dependent cardiac defect is excluded using echocardiography. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26762?source=see_link\">",
"     \"Initial management of shock in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=see_link&amp;anchor=H27#H27\">",
"     \"Diagnosis and initial management of cyanotic heart disease in the newborn\", section on 'Prostaglandin E1'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23884687\">",
"    <span class=\"h2\">",
"     Chest radiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chest radiography is helpful to assess for cardiomegaly and pulmonary congestion, and monitor the effectiveness of heart failure treatment. Pulmonary interstitial edema and pleural effusion are common findings in newly diagnosed heart failure (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef88511 \" href=\"UTD.htm?31/50/32544\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The presence of cardiomegaly is seen in a number of specific cardiac diseases as illustrated by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In children with left-to-right shunt defects, cardiomegaly reflects the presence of a moderate to large shunt, volume overload, and subsequent atrial and ventricular dilatation.",
"     </li>",
"     <li>",
"      Cardiomegaly in children with dilated cardiomyopathy reflects the dilatation of left ventricle (",
"      <a class=\"graphic graphic_diagnosticimage graphicRef63664 \" href=\"UTD.htm?23/61/24529\">",
"       image 2",
"      </a>",
"      ). In myocarditis, ventricular dilation is usually not as severe, and the cardiothoracic silhouette may be normal.",
"     </li>",
"     <li>",
"      Right ventricular dilation may sometimes be seen in children with arrhythmogenic right ventricular dysplasia.",
"     </li>",
"     <li>",
"      Biatrial enlargement may be seen in children with restrictive cardiomyopathy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a prospective cohort of 95 children referred to a pediatric cardiology clinic, cardiomegaly on chest x-ray had a specificity of 92.3 percent and a negative predictive value of 91.1 percent in predicting ventricular dilation on echocardiogram [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258995466\">",
"    <span class=\"h2\">",
"     Electrocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sinus tachycardia is a common electrocardiographic finding in children with heart failure as it is a physiologic compensation for reduced stroke volume. In addition, the electrocardiogram (ECG) is an important diagnostic tool in the evaluation of a child with heart failure as it may point toward an underlying cause.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Varying degrees of heart block may sometimes be observed in patients with rheumatic or lyme carditis, or in patients with neonatal lupus.",
"     </li>",
"     <li>",
"      Bi-atrial enlargement may be present in restrictive cardiomyopathy.",
"     </li>",
"     <li>",
"      Increased QRS voltage that meets criteria for ventricular hypertrophy may be seen in hypertrophic or dilated cardiomyopathy (",
"      <a class=\"graphic graphic_waveform graphicRef53365 \" href=\"UTD.htm?5/52/5959\">",
"       waveform 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Decreased QRS voltage may suggest myocardial edema or pericardial effusion, and may be present in children with myocarditis (",
"      <a class=\"graphic graphic_waveform graphicRef63132 \" href=\"UTD.htm?27/20/27974\">",
"       waveform 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      ST segment and T wave abnormalities are common in all forms of cardiomyopathy and myocarditis.",
"     </li>",
"     <li>",
"      A deep q wave in inferior and lateral leads (I, aVL, and V5-V6) with ST segment and T wave changes is suggestive of a myocardial infarct and is a classic finding in infants with anomalous left coronary arising from the pulmonary artery (ALCAPA) (",
"      <a class=\"graphic graphic_waveform graphicRef51869 \" href=\"UTD.htm?1/33/1560\">",
"       waveform 3",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23884680\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;An echocardiogram is the primary imaging modality to establish whether the child has a structurally normal heart or underlying structural congenital heart disease, and assess ventricular size and function.",
"   </p>",
"   <p>",
"    In a child with congenital heart disease, an echocardiogram is useful to elucidate the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Cardiac anatomy",
"     </li>",
"     <li>",
"      Arterial and venous connections",
"     </li>",
"     <li>",
"      Presence and amount of shunting",
"     </li>",
"     <li>",
"      Presence and amount of valvular stenosis and regurgitation",
"     </li>",
"     <li>",
"      Atrial and ventricular sizes",
"     </li>",
"     <li>",
"      Diastolic function",
"     </li>",
"     <li>",
"      Estimation of right ventricular and pulmonary artery pressures",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The use of echocardiogram in establishing the cause of heart failure and assessing the clinical status of the patient is illustrated in the following examples.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Echocardiography can demonstrate the origin of coronary arteries from the aortic root if close attention is paid to this aspect of imaging. It has an important role in the diagnosis of anomalous origin of the left coronary artery from pulmonary artery (ALCAPA). These infants often have severe left ventricular dysfunction and mitral regurgitation at presentation, the latter due to papillary muscle infarction. Reversal of color flow in the left coronary artery is highly suggestive of the diagnosis.",
"     </li>",
"     <li>",
"      Non-compaction cardiomyopathy, a rare type of cardiomyopathy, derives its name from the echocardiographic appearance of left ventricular endocardial surface which, instead of being smooth, has deep trabeculations and multiple deep inter-trabecular recesses communicating with the ventricular cavity. In one retrospective study of 23 children with this form of cardiomyopathy, 19 (83 percent) had evidence of ventricular dysfunction, and 9 (39 percent) had heart failure [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In patients with myocarditis and dilated cardiomyopathy, echocardiogram provides accurate assessment of left ventricular dilation, mass, and function. Left atrial and ventricular size may be helpful in determining chronicity as their dilation and ventricular wall-thinning usually suggest long-standing dilated cardiomyopathy rather than acute myocarditis (",
"      <a class=\"graphic graphic_waveform graphicRef53365 \" href=\"UTD.htm?5/52/5959\">",
"       waveform 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258995135\">",
"    <span class=\"h2\">",
"     Initial blood tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial blood tests obtained in a child with heart failure include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Complete blood count &ndash; The presence of anemia may contribute to heart failure in a predisposed patient (eg, one with a moderate to severe ventricular septal defect), or exacerbate the severity of failure in a patient with preexisting heart failure. In addition, an elevated white blood cell count may be indicative of infection, which may also contribute to heart failure or be seen in patients with septic shock (who may present with similar symptoms to that of patients with heart failure).",
"     </li>",
"     <li>",
"      Serum electrolytes, blood urea nitrogen and creatinine.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Hyponatremia may be seen in patients with severe heart failure.",
"     </li>",
"     <li>",
"      Renal impairment may be a contributing factor for heart failure or exacerbate pre-existing failure.",
"     </li>",
"     <li>",
"      Baseline electrolytes are needed prior to initiating therapy with diuretics or angiotensin converting enzyme inhibitors to avoid potential side effects of these drugs.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Liver function tests &ndash; Liver function studies may be elevated due to hepatic congestion with right-sided heart failure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258995695\">",
"    <span class=\"h1\">",
"     FURTHER EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Further testing includes imaging by magnetic resonance imaging or cardiac catheterization for enhanced delineation of cardiac anatomy and function, and additional blood tests to determine the underlying etiology, severity of heart failure, and potentially, monitor response to therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23884673\">",
"    <span class=\"h2\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Occasionally, the information from echocardiography is insufficient because of altered geometry, particularly in the assessment of right ventricular and single ventricular function in children with complex congenital heart disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/1\">",
"     1",
"    </a>",
"    ], or in patients with inflammation. In these settings, cardiac magnetic resonance imaging (MRI) can provide accurate and detailed information regarding cardiac anatomy, ventricular function, myocardial inflammation, and infiltration by fat and fibrous tissues [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation of anatomic details in complex congenital heart disease and for providing quantitative assessment of shunts and right ventricular function.",
"     </li>",
"     <li>",
"      Distinguishing restrictive cardiomyopathy from constrictive pericarditis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29752?source=see_link\">",
"       \"Differentiating constrictive pericarditis and restrictive cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Non-invasive assessment of myocardial inflammation in patients with suspected myocarditis and demonstrates good correlation with biopsy results [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/19\">",
"       19",
"      </a>",
"      ]. The three MRI criteria of myocardial inflammation are edema,",
"      <span class=\"nowrap\">",
"       hyperemia/capillary",
"      </span>",
"      leak (early gadolinium enhancement), and cell injury (late gadolinium enhancement). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=see_link&amp;anchor=H10#H10\">",
"       \"Clinical manifestations and diagnosis of myocarditis in children\", section on 'Magnetic resonance imaging'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=see_link&amp;anchor=H20#H20\">",
"       \"Clinical manifestations and diagnosis of myocarditis in adults\", section on 'Cardiovascular magnetic resonance'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evaluation of right ventricular function, dilation, and fatty infiltration in patients with arrhythmogenic right ventricular dysplasia, a rare cardiomyopathy characterized by fibrofatty replacement of the right ventricle that presents as right-sided heart failure and life-threatening ventricular arrhythmias in previously healthy young subjects [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/20\">",
"       20",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/22/32106?source=see_link\">",
"       \"Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Assessing the extent of non-compacted myocardium in non-compaction cardiomyopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/21\">",
"       21",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41784?source=see_link\">",
"       \"Isolated left ventricular noncompaction\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      MRI with late gadolinium enhancement allows a quantitative assessment of myocardial fibrosis. The amount of fibrosis in adults with dilated and hypertrophic cardiomyopathy has been independently associated with ventricular arrhythmias, hospitalizations, and mortality. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=see_link&amp;anchor=H24#H24\">",
"       \"Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy\", section on 'Cardiovascular magnetic resonance'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23884666\">",
"    <span class=\"h2\">",
"     Cardiac catheterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac catheterization may help in establishing the etiology of heart failure, if the underlying cause remains unclear after noninvasive testing with echocardiography or MRI. In particular, endomyocardial biopsy remains the gold standard for diagnosing myocarditis and is obtained from the right ventricular aspect of the interventricular septum using a bioptome. The risk of serious complications during biopsy such as cardiac perforation or arrhythmias in critically-ill children with myocarditis is small but is not zero [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/22\">",
"     22",
"    </a>",
"    ]. Cardiac catheterization with endomyocardial biopsy may also be used to differentiate restrictive cardiomyopathy from constrictive pericarditis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=see_link&amp;anchor=H13#H13\">",
"     \"Clinical manifestations and diagnosis of myocarditis in children\", section on 'Endomyocardial biopsy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29752?source=see_link&amp;anchor=H15#H15\">",
"     \"Differentiating constrictive pericarditis and restrictive cardiomyopathy\", section on 'Cardiac catheterization'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cardiac catheterization is used to guide the need and timing of cardiac transplantation in children with heart failure by assessing their hemodynamic status (intracardiac pressures, pulmonary artery pressure, pulmonary vascular resistance, and cardiac output). Coronary angiography is also helpful in the diagnosis of coronary anomalies if echocardiography findings are equivocal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258996187\">",
"    <span class=\"h2\">",
"     Additional blood tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based on the initial evaluation, additional blood tests may be obtained to elucidate the underlying etiology, especially in a child with a normally structured heart.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258996270\">",
"    <span class=\"h3\">",
"     Troponin and creatine kinase",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac troponin and creatine kinase MB fraction (CK-MB) are biomarkers of myocardial injury. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=see_link\">",
"     \"Troponins and creatine kinase as biomarkers of cardiac injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiac troponin T (cTnT) is a highly sensitive biomarker for myocyte injury. cTnt levels are elevated in patients with myocardial ischemia or who have myocarditis. Among children presenting with left ventricular dysfunction, an elevated cTnT level may suggest acute myocarditis rather than dilated cardiomyopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      CK-MB is also a biomarker for myocardial injury. Levels are elevated in patients with myocardial ischemia or who have myocarditis, and are elevated earlier than cTnT levels.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258996277\">",
"    <span class=\"h3\">",
"     Inflammatory markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both C-reactive protein (CRP), a protein associated with the secretion of various inflammatory cytokines including interleukin-6, tumor necrosis factor, and interleukin-1, and erythrocyte sedimentation rate (ESR) are markers of inflammation. In children presenting with left ventricular dysfunction, elevated CRP",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ESR may suggest the diagnosis of myocarditis and may help in differentiating it from dilated cardiomyopathy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258996284\">",
"    <span class=\"h3\">",
"     Genetic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;All children with newly diagnosed heart failure due to cardiomyopathy should be evaluated by a clinical geneticist. Overall, 30 percent of all children with cardiomyopathy may have a genetic origin, especially those with hypertrophic cardiomyopathy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/24\">",
"     24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/41/39576?source=see_link\">",
"     \"Genetics of dilated cardiomyopathy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/44/29386?source=see_link\">",
"     \"Genetics of hypertrophic cardiomyopathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258995873\">",
"    <span class=\"h3\">",
"     BNP and NT-proBNP",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pro-brain natriuretic peptide (proBNP) is a cardiac hormone secreted by the ventricular cells in response to increased wall stress in volume- or pressure-overload [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/25\">",
"     25",
"    </a>",
"    ]. It is cleaved into the active peptide (BNP) and the inactive N-terminal fragment (NT-proBNP). BNP and pro-BNP levels have been extensively studied in adults and are used to assist in the diagnosis and monitoring of heart failure, and as prognostic markers. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19818?source=see_link\">",
"     \"Natriuretic peptide measurement in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, the role of BNP and proBNP is uncertain in children because of the difference in ventricular impairment and morphology between adult and pediatric cardiac diseases, and the lack of normative pediatric standards because of variation of levels due to assay methods and age [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/15\">",
"     15",
"    </a>",
"    ]. BNP and NT-proBNP levels are higher at birth and decrease rapidly during the first days of life [",
"    <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Nevertheless, several small studies in infants and children have proposed a potential role of BNP and NT-proBNP to screen for pediatric cardiovascular disease.",
"   </p>",
"   <p>",
"    Higher BNP levels have been demonstrated:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      To correlate with the presence and amount of shunting through a patent ductus arteriosus in premature babies [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/27\">",
"       27",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      To discriminate serious cardiovascular causes from non-cardiac causes in newborns admitted with respiratory distress to an intensive care unit early after birth [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      To discriminate children with heart failure from those with primary pulmonary disease among those presenting with respiratory distress [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/29\">",
"       29",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      To discriminate children with and without a significant cardiovascular disease among those referred to a cardiologist [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      To discriminate serious from non-serious disease among children with newly diagnosed cardiac disease [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In addition, other studies in children with heart failure have shown:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In children with ventricular pump dysfunction, BNP and NT-proBNP levels correlate negatively with ejection fraction and positively with modified Ross class [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/32,33\">",
"       32,33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      BNP and NT-proBNP levels are higher in children with newly diagnosed heart failure compared with children with compensated heart failure or those with acute exacerbations of chronic heart failure [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/34\">",
"       34",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Higher BNP levels in children with chronic systolic left ventricular dysfunction have been associated with worse outcomes on follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/35,36\">",
"       35,36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Improved BNP is associated with improvement in heart failure class and left ventricular function [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In children who have undergone palliative surgery for complex single ventricle, BNP is predictive of HF (eg, ventricular dysfunction) regardless of the stage of palliation [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/38,39\">",
"       38,39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      BNP could play a role as a marker of anthracycline-induced cardiac toxicity [",
"      <a class=\"abstract\" href=\"UTD.htm?9/15/9466/abstract/40-42\">",
"       40-42",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In our institutions, BNP measurements are used to assess the severity of heart failure and monitor response to therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3449744\">",
"    <span class=\"h3\">",
"     Other studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following studies are obtained based on the initial clinical evaluation and are used to determine an underlying etiology:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Rheumatological tests include anti-streptolysin titers (rheumatic heart disease) and anti-nuclear antibody testing (collagen vascular diseases including systemic lupus erythematous).",
"     </li>",
"     <li>",
"      Studies to determine the etiology of cardiomyopathy include (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/0/19465?source=see_link&amp;anchor=H4#H4\">",
"       \"Causes of dilated cardiomyopathy\", section on 'Etiology'",
"      </a>",
"      ):",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Thyroid function tests to screen for hyperthyroidism-induced cardiomyopathy",
"     </li>",
"     <li>",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?22/11/22710?source=see_link\">",
"       Carnitine",
"      </a>",
"      levels to screen for carnitine deficiency-induced cardiomyopathy",
"     </li>",
"     <li>",
"      Urine organic acids and serum amino acids to screen for metabolic causes of cardiomyopathy (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1351?source=see_link\">",
"       \"Inherited syndromes associated with cardiac disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blood and urine tests to detect infectious causes of cardiomyopathy and myocarditis (",
"      <a class=\"graphic graphic_table graphicRef56995 \" href=\"UTD.htm?35/10/36014\">",
"       table 6",
"      </a>",
"      ). These include Ebstein-Barr virus, cytomegalovirus, parvovirus B19, adenovirus, coxsackie A and B virus, Human herpes virus 6, Mycoplasma pneumoniae, and titers for Lyme disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H258994852\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart failure is differentiated from the following non-cardiac conditions, which share similar presenting complaints, based on its constellation of characteristic clinical manifestations, and in some cases, echocardiography. (See",
"    <a class=\"local\" href=\"#H180717846\">",
"     'Diagnosis'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H23884680\">",
"     'Echocardiography'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Causes of respiratory distress",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Neonates &ndash; Respiratory distress syndrome, transient tachypnea of the newborn, meconium aspiration, congenital diaphragmatic hernia, pneumothorax, pneumonia, and pulmonary hypoplasia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31511?source=see_link\">",
"       \"Overview of neonatal respiratory distress: Disorders of transition\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Older infants and children &ndash; Pneumonia, asthma, and gastro-esophageal reflux.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diseases that present with poor weight gain and failure to thrive. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38233?source=see_link\">",
"       \"Poor weight gain in children older than two years of age\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=see_link&amp;anchor=H11#H11\">",
"       \"Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years\", section on 'Etiology'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Gastrointestinal causes include protein-milk allergy, cystic fibrosis, and celiac disease",
"     </li>",
"     <li>",
"      Chronic infections",
"     </li>",
"     <li>",
"      Hyperthyroidism",
"     </li>",
"     <li>",
"      Metabolic disorders",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fatigue in older children may be due to sleep apnea, depression, or deconditioning.",
"     </li>",
"     <li>",
"      Peripheral edema may be caused by renal failure, venous thrombosis, or adverse drug effects. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/39/1657?source=see_link&amp;anchor=H8#H8\">",
"       \"Pathophysiology and etiology of edema in children\", section on 'Etiology'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Shock may be due to overwhelming sepsis or hypovolemia. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/49/14104?source=see_link&amp;anchor=H3#H3\">",
"       \"Initial evaluation of shock in children\", section on 'Pathophysiology'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23884658\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart failure is defined as the inability of the ventricles to adequately fill with or eject blood. It is estimated to affect 12,000 to 35,000 children in the United States each year. (See",
"    <a class=\"local\" href=\"#H23884822\">",
"     'Definition'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The causes of pediatric heart failure can be divided into the following pathophysiologic categories (",
"      <a class=\"graphic graphic_table graphicRef79989 \" href=\"UTD.htm?6/33/6685\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H23884815\">",
"       'Pathophysiology and etiology'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Ventricular pump dysfunction may occur in both patients with a structurally normal heart (eg, cardiomyopathy, myocarditis, and complete heart block) and those with complex congenital heart disease (CHD). Although heart failure in patients with CHD may occur at the time of diagnosis, it generally is a long-term complication following surgical cardiac repair. (See",
"      <a class=\"local\" href=\"#H180717383\">",
"       'Ventricular pump dysfunction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Volume overload with preserved ventricular contractility is most commonly due to CHD with significant left-to-right shunting of blood from the systemic to pulmonary circulation. (See",
"      <a class=\"local\" href=\"#H23884808\">",
"       'Preserved ventricular pump function with volume overload'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pressure overload with preserved ventricular contractility is most commonly due to CHD with ventricular outflow obstruction. (See",
"      <a class=\"local\" href=\"#H23884801\">",
"       'Preserved ventricular pump function with pressure overload'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pediatric heart failure has been classified to describe its natural history after exposure to a risk factor for heart failure (&ldquo;stages of heart failure&rdquo;) (",
"      <a class=\"graphic graphic_table graphicRef60553 \" href=\"UTD.htm?6/37/6748\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef74339 \" href=\"UTD.htm?14/36/14923\">",
"       table 4",
"      </a>",
"      ) and the severity of symptoms on a given day (&ldquo;classes of heart failure&rdquo;) (",
"      <a class=\"graphic graphic_table graphicRef74339 \" href=\"UTD.htm?14/36/14923\">",
"       table 4",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H23884787\">",
"       'Staging and classification'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Symptoms and physical findings reflect a limited ability to adequately increase cardiac output (eg, exercise intolerance, easy fatigue, or GI symptoms),",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pulmonary (eg, respiratory distress with tachypnea) or systemic (eg, hepatomegaly) fluid overload. Clinical features also vary with age at presentation. (See",
"      <a class=\"local\" href=\"#H23884780\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of heart failure in children is based on the combination of characteristic signs and physical findings of inadequate cardiac output and growth failure. (See",
"      <a class=\"local\" href=\"#H180717846\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial evaluation consists of laboratory and imaging studies that confirm the diagnosis of heart failure when there is clinical uncertainty, assess the severity of failure, and determine the underlying cause. However, evaluation should only proceed if the patient is clinically stable. In patients who have significant cardiorespiratory compromise (ie, shock or pending shock), rapid initiation of treatment to restore adequate perfusion is required to decrease mortality and morbidity (",
"      <a class=\"graphic graphic_algorithm graphicRef77079 \" href=\"UTD.htm?41/12/42178\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26762?source=see_link\">",
"       \"Initial management of shock in children\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Initial studies include chest radiography, electrocardiogram, echocardiography, and blood tests (eg, complete blood count, liver function tests, and serum electrolytes, blood urea nitrogen, and creatinine). Echocardiography is the primary imaging modality for establishing whether the child has a structurally normal heart or whether there is an underlying cardiac lesion, and assessing ventricular size and function. (See",
"      <a class=\"local\" href=\"#H258994897\">",
"       'Initial evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Further testing includes imaging testing by magnetic resonance imaging or cardiac catheterization for enhanced delineation of cardiac anatomy and function, and additional blood tests to primarily determine the underlying etiology. Although the clinical role for using brain natriuretic peptide (BNP) measurements is still evolving, we use BNP levels to determine the severity of pediatric heart failure and monitor the response to therapy. (See",
"      <a class=\"local\" href=\"#H258995695\">",
"       'Further evaluation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/1\">",
"      Hsu DT, Pearson GD. Heart failure in children: part I: history, etiology, and pathophysiology. Circ Heart Fail 2009; 2:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/2\">",
"      Madriago E, Silberbach M. Heart failure in infants and children. Pediatr Rev 2010; 31:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/3\">",
"      Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003; 348:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/4\">",
"      Book WM. Heart failure in the adult patient with congenital heart disease. J Card Fail 2005; 11:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/5\">",
"      Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119:1977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/6\">",
"      Rosenthal D, Chrisant MR, Edens E, et al. International Society for Heart and Lung Transplantation: Practice guidelines for management of heart failure in children. J Heart Lung Transplant 2004; 23:1313.",
"     </a>",
"    </li>",
"    <li>",
"     Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th ed. Little, Brown &amp; Co., Boston 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/8\">",
"      Ross RD, Bollinger RO, Pinsky WW. Grading the severity of congestive heart failure in infants. Pediatr Cardiol 1992; 13:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/9\">",
"      Reithmann C, Reber D, Kozlik-Feldmann R, et al. A post-receptor defect of adenylyl cyclase in severely failing myocardium from children with congenital heart disease. Eur J Pharmacol 1997; 330:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/10\">",
"      L&auml;er S, Mir TS, Behn F, et al. Carvedilol therapy in pediatric patients with congestive heart failure: a study investigating clinical and pharmacokinetic parameters. Am Heart J 2002; 143:916.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/11\">",
"      Ross RD, Daniels SR, Schwartz DC, et al. Plasma norepinephrine levels in infants and children with congestive heart failure. Am J Cardiol 1987; 59:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/12\">",
"      Wu JR, Chang HR, Huang TY, et al. Reduction in lymphocyte beta-adrenergic receptor density in infants and children with heart failure secondary to congenital heart disease. Am J Cardiol 1996; 77:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/13\">",
"      Connolly D, Rutkowski M, Auslender M, Artman M. The New York University Pediatric Heart Failure Index: a new method of quantifying chronic heart failure severity in children. J Pediatr 2001; 138:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/14\">",
"      Tissi&egrave;res P, Aggoun Y, Da Cruz E, et al. Comparison of classifications for heart failure in children undergoing valvular surgery. J Pediatr 2006; 149:210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/15\">",
"      Hsu DT, Pearson GD. Heart failure in children: part II: diagnosis, treatment, and future directions. Circ Heart Fail 2009; 2:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/16\">",
"      Satou GM, Lacro RV, Chung T, et al. Heart size on chest x-ray as a predictor of cardiac enlargement by echocardiography in children. Pediatr Cardiol 2001; 22:218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/17\">",
"      Pignatelli RH, McMahon CJ, Dreyer WJ, et al. Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 2003; 108:2672.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/18\">",
"      Attili AK, Parish V, Valverde I, et al. Cardiovascular MRI in childhood. Arch Dis Child 2011; 96:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/19\">",
"      Gagliardi MG, Bevilacqua M, Di Renzi P, et al. Usefulness of magnetic resonance imaging for diagnosis of acute myocarditis in infants and children, and comparison with endomyocardial biopsy. Am J Cardiol 1991; 68:1089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/20\">",
"      Tandri H, Castillo E, Ferrari VA, et al. Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle. J Am Coll Cardiol 2006; 48:2277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/21\">",
"      Thuny F, Jacquier A, Jop B, et al. Assessment of left ventricular non-compaction in adults: side-by-side comparison of cardiac magnetic resonance imaging with echocardiography. Arch Cardiovasc Dis 2010; 103:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/22\">",
"      Pophal SG, Sigfusson G, Booth KL, et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol 1999; 34:2105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/23\">",
"      Soongswang J, Durongpisitkul K, Nana A, et al. Cardiac troponin T: a marker in the diagnosis of acute myocarditis in children. Pediatr Cardiol 2005; 26:45.",
"     </a>",
"    </li>",
"    <li>",
"     Pediatric Cardiomyopathy, 3rd, Singh RK, Gersony WM, Addonizio LJ (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2010.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/25\">",
"      Favilli S, Frenos S, Lasagni D, et al. The use of B-type natriuretic peptide in paediatric patients: a review of literature. J Cardiovasc Med (Hagerstown) 2009; 10:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/26\">",
"      Mir TS, Marohn S, L&auml;er S, et al. Plasma concentrations of N-terminal pro-brain natriuretic peptide in control children from the neonatal to adolescent period and in children with congestive heart failure. Pediatrics 2002; 110:e76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/27\">",
"      Holmstr&ouml;m H, Hall C, Thaulow E. Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 2001; 90:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/28\">",
"      Ko HK, Lee JH, Choi BM, et al. Utility of the rapid B-type natriuretic peptide assay for detection of cardiovascular problems in newborn infants with respiratory difficulties. Neonatology 2008; 94:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/29\">",
"      Koulouri S, Acherman RJ, Wong PC, et al. Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 2004; 25:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/30\">",
"      Law YM, Hoyer AW, Reller MD, Silberbach M. Accuracy of plasma B-type natriuretic peptide to diagnose significant cardiovascular disease in children: the Better Not Pout Children! Study. J Am Coll Cardiol 2009; 54:1467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/31\">",
"      Maher KO, Reed H, Cuadrado A, et al. B-type natriuretic peptide in the emergency diagnosis of critical heart disease in children. Pediatrics 2008; 121:e1484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/32\">",
"      Sugimoto M, Manabe H, Nakau K, et al. The role of N-terminal pro-B-type natriuretic peptide in the diagnosis of congestive heart failure in children. - Correlation with the heart failure score and comparison with B-type natriuretic peptide -. Circ J 2010; 74:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/33\">",
"      Mangat J, Carter C, Riley G, et al. The clinical utility of brain natriuretic peptide in paediatric left ventricular failure. Eur J Heart Fail 2009; 11:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/34\">",
"      Fried I, Bar-Oz B, Perles Z, et al. N-terminal pro-B-type natriuretic peptide levels in acute versus chronic left ventricular dysfunction. J Pediatr 2006; 149:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/35\">",
"      Price JF, Thomas AK, Grenier M, et al. B-type natriuretic peptide predicts adverse cardiovascular events in pediatric outpatients with chronic left ventricular systolic dysfunction. Circulation 2006; 114:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/36\">",
"      Auerbach SR, Richmond ME, Lamour JM, et al. BNP levels predict outcome in pediatric heart failure patients: post hoc analysis of the Pediatric Carvedilol Trial. Circ Heart Fail 2010; 3:606.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/37\">",
"      Nasser N, Perles Z, Rein AJ, Nir A. NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis. Pediatr Cardiol 2006; 27:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/38\">",
"      Law YM, Ettedgui J, Beerman L, et al. Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. Am J Cardiol 2006; 98:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/39\">",
"      Lowenthal A, Camacho BV, Lowenthal S, et al. Usefulness of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide as biomarkers for heart failure in young children with single ventricle congenital heart disease. Am J Cardiol 2012; 109:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/40\">",
"      Hayakawa H, Komada Y, Hirayama M, et al. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer. Med Pediatr Oncol 2001; 37:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/41\">",
"      Pinarli FG, O��uz A, Tunao��lu FS, et al. Late cardiac evaluation of children with solid tumors after anthracycline chemotherapy. Pediatr Blood Cancer 2005; 44:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/15/9466/abstract/42\">",
"      Aggarwal S, Pettersen MD, Bhambhani K, et al. B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children. Pediatr Blood Cancer 2007; 49:812.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14373 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-190.92.87.115-3AD7EB5AF7-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9466=[""].join("\n");
var outline_f9_15_9466=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H23884658\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23884829\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23884822\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23884815\">",
"      PATHOPHYSIOLOGY AND ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H180717383\">",
"      Ventricular pump dysfunction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H180717491\">",
"      - Structurally normal heart",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H180717533\">",
"      - Congenital heart disease",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23884808\">",
"      Preserved ventricular pump function with volume overload",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3449490\">",
"      - Cardiac causes",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3449497\">",
"      - Noncardiac causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23884801\">",
"      Preserved ventricular pump function with pressure overload",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23884787\">",
"      STAGING AND CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H180717674\">",
"      Staging of the progression of HF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H180717685\">",
"      Classification of HF severity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H55853967\">",
"      - NYHA class",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H180717751\">",
"      - Ross classification",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H180717758\">",
"      - NYU Pediatric HF Index",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23884780\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H180717807\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23884766\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H180717846\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H258994897\">",
"      INITIAL EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H544135\">",
"      Overview",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23884687\">",
"      Chest radiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258995466\">",
"      Electrocardiogram",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23884680\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258995135\">",
"      Initial blood tests",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H258995695\">",
"      FURTHER EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23884673\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23884666\">",
"      Cardiac catheterization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H258996187\">",
"      Additional blood tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H258996270\">",
"      - Troponin and creatine kinase",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H258996277\">",
"      - Inflammatory markers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H258996284\">",
"      - Genetic testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H258995873\">",
"      - BNP and NT-proBNP",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3449744\">",
"      - Other studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H258994852\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23884658\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/14373\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/14373|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?41/12/42178\" title=\"algorithm 1\">",
"      Initial management of shock in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/14373|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?31/50/32544\" title=\"diagnostic image 1\">",
"      Infant coarctation of the aorta and heart failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?23/61/24529\" title=\"diagnostic image 2\">",
"      Chest x-ray - Dilated cardiomyopathy in 13 yo boy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/14373|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/33/6685\" title=\"table 1\">",
"      Pediatric causes of heart failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/37/6748\" title=\"table 2\">",
"      Stages of pediatric heart failure and therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/2/3117\" title=\"table 3\">",
"      Methods to assess cardiovascular disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/36/14923\" title=\"table 4\">",
"      Ross heart failure classification for children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?27/37/28252\" title=\"table 5\">",
"      Normal respiratory rate and heart rate in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/10/36014\" title=\"table 6\">",
"      Causes of myocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/14373|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?5/52/5959\" title=\"waveform 1\">",
"      ECG - Dilated cardiomyopathy in 13 yo boy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?27/20/27974\" title=\"waveform 2\">",
"      ECG - Myocarditis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?1/33/1560\" title=\"waveform 3\">",
"      ECG - ALCAPA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/33/1559?source=related_link\">",
"      Aortic regurgitation in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/38/9832?source=related_link\">",
"      Approach to the child with tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/19/31034?source=related_link\">",
"      Approach to the diagnosis and treatment of wide QRS complex tachycardias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/52/17226?source=related_link\">",
"      Atrial arrhythmias (including AV block) in congenital heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/24/33161?source=related_link\">",
"      Bradycardia in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/46/41706?source=related_link\">",
"      Cardiotoxicity of anthracycline-like chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/0/19465?source=related_link\">",
"      Causes of dilated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26201?source=related_link\">",
"      Classification and clinical features of isolated atrial septal defects in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/22/32106?source=related_link\">",
"      Clinical manifestations and diagnosis of arrhythmogenic right ventricular cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/53/23385?source=related_link\">",
"      Clinical manifestations and diagnosis of coarctation of the aorta",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/16/26889?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/53/34647?source=related_link\">",
"      Clinical manifestations and diagnosis of myocarditis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/52/35656?source=related_link\">",
"      Clinical manifestations and diagnosis of patent ductus arteriosus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/62/39910?source=related_link\">",
"      Clinical manifestations and diagnosis of pulmonic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/35/39481?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of narrow QRS complex tachycardias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/56/14218?source=related_link\">",
"      Congenital and pediatric coronary artery abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/3/30777?source=related_link\">",
"      Definition and classification of the cardiomyopathies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/2/43048?source=related_link\">",
"      Diagnosis and initial management of cyanotic heart disease in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/3/29752?source=related_link\">",
"      Differentiating constrictive pericarditis and restrictive cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/7/42105?source=related_link\">",
"      Epidemiology, risk factors, and etiology of hypertension in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/12/14538?source=related_link\">",
"      Etiology and evaluation of failure to thrive (undernutrition) in children younger than two years",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/28/39369?source=related_link\">",
"      Evaluation of the patient with heart failure or cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/41/39576?source=related_link\">",
"      Genetics of dilated cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/44/29386?source=related_link\">",
"      Genetics of hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/20/1351?source=related_link\">",
"      Inherited syndromes associated with cardiac disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/49/14104?source=related_link\">",
"      Initial evaluation of shock in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/8/26762?source=related_link\">",
"      Initial management of shock in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/38/43623?source=related_link\">",
"      Irregular heart rate (arrhythmias) in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41784?source=related_link\">",
"      Isolated left ventricular noncompaction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/16/5386?source=related_link\">",
"      Management of heart failure in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/22/19818?source=related_link\">",
"      Natriuretic peptide measurement in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/57/24474?source=related_link\">",
"      Neonatal lupus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31511?source=related_link\">",
"      Overview of neonatal respiratory distress: Disorders of transition",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/7/28794?source=related_link\">",
"      Overview of the management of tetralogy of Fallot",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=related_link\">",
"      Pathophysiology and clinical features of isolated ventricular septal defects in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/39/1657?source=related_link\">",
"      Pathophysiology and etiology of edema in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/15/4344?source=related_link\">",
"      Pathophysiology of left to right shunts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/21/38233?source=related_link\">",
"      Poor weight gain in children older than two years of age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/48/33546?source=related_link\">",
"      Predictors of survival in heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/54/31593?source=related_link\">",
"      Supraventricular tachycardia in children: AV reentrant tachycardia (including WPW) and AV nodal reentrant tachycardia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/7/12409?source=related_link\">",
"      Suspected heart disease in infants and children: Criteria for referral",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/38/39530?source=related_link\">",
"      Troponins and creatine kinase as biomarkers of cardiac injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/28/38345?source=related_link\">",
"      Valvar aortic stenosis in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_15_9467="ECOG performance scale";
var content_f9_15_9467=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F72901&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F72901&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Eastern Cooperative Oncology Group (ECOG, Zubrod, WHO) performance scale",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Performance status",
"       </td>",
"       <td class=\"subtitle1_single\">",
"        Definition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        0",
"       </td>",
"       <td>",
"        Fully active; no performance restrictions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        1",
"       </td>",
"       <td>",
"        Strenuous physical activity restricted; fully ambulatory and able to carry out light work",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        2",
"       </td>",
"       <td>",
"        Capable of all selfcare but unable to carry out any work activities. Up and about &gt;50 percent of waking hours.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        3",
"       </td>",
"       <td>",
"        Capable of only limited selfcare; confined to bed or chair &gt;50 percent of waking hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        4",
"       </td>",
"       <td>",
"        Completely disabled; cannot carry out any selfcare; totally confined to bed or chair",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Excerpted from: Oken MM, et al. Am J Clin Oncol 1982; 5:649.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9467=[""].join("\n");
var outline_f9_15_9467=null;
var title_f9_15_9468="Major causes of hyperkalemia";
var content_f9_15_9468=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F58157&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F58157&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Major causes of hyperkalemia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Increased potassium release from cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pseudohyperkalemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Metabolic acidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Insulin deficiency, hyperglycemia, and hyperosmolality",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased tissue catabolism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Beta blockers",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Exercise",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hyperkalemic periodic paralysis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Overdose of digitalis or related digitalis glycosides",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Red cell transfusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Succinylcholine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Arginine hydrochloride",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Activators of ATP-dependent potassium channels (eg, calcineurin inhibitors, diazoxide, minoxidil, and some volatile anesthetics)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Reduced urinary potassium excretion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduced aldosterone secretion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reduced response to aldosterone",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Reduced distal sodium and water delivery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Effective arterial blood volume depletion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute and chronic kidney disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Other",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Selective impairment in potassium secretion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Gordon's syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ureterojejunostomy",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9468=[""].join("\n");
var outline_f9_15_9468=null;
var title_f9_15_9469="Hypotensive herbal ingredients";
var content_f9_15_9469=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F69652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F69652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Hypotensive herbal ingredients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Agrimony",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asafoetida",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Avens",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Calamus",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Celery",
"       </td>",
"       <td>",
"        Hypotensive, human and in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cohoswh, black",
"       </td>",
"       <td>",
"        Hypotensive, human",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cornsilk",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cowslip",
"       </td>",
"       <td>",
"        Hypotensive, then hypertensive in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Devil's Claw",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Elecampane",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fenugreek",
"       </td>",
"       <td>",
"        Hypotensive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fucus",
"       </td>",
"       <td>",
"        Hypotensive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fumitory",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Garlic",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ginger",
"       </td>",
"       <td>",
"        Hypotensive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ginseng, Panax",
"       </td>",
"       <td>",
"        Hypotensive, human and in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Goldenseal",
"       </td>",
"       <td>",
"        Hypotensive, alkaloid effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hawthorn",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Horehound, white",
"       </td>",
"       <td>",
"        Vasodilator, oil",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Horseradish",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mistletoe",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nettle",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parsley",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plantain",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pokeroot",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prickly Ash, northern",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Prickly Ash, southern",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sage",
"       </td>",
"       <td>",
"        Hypotensive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shepherd's purse",
"       </td>",
"       <td>",
"        Hypotensive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Squill",
"       </td>",
"       <td>",
"        Vasodilator, oil",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        St. John's Wort",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vervain",
"       </td>",
"       <td>",
"        Hypotensive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wild carrot",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yarrow",
"       </td>",
"       <td>",
"        Hypotensive, in vivo",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals, The Pharmaceutical Press, London 1996, p. 277.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9469=[""].join("\n");
var outline_f9_15_9469=null;
var title_f9_15_9470="Carotid artery stenosis by MRA";
var content_f9_15_9470=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F79993&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F79993&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Carotid artery stenosis assessed by magnetic resonance angiography",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 284px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A magnetic resonance angiogram (MRA)&nbsp;in the same patient who underwent carotid duplex ultrasonography shows marked narrowing and stenosis at the origin of the right internal carotid artery (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9470=[""].join("\n");
var outline_f9_15_9470=null;
var title_f9_15_9471="Ulcerating esoph CA EGD";
var content_f9_15_9471=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F78958&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F78958&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ulcerating malignant esophageal mass in distal esophagus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 264px; height: 247px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ulcerating malignant esophageal mass in distal esophagus seen on endoscopy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Brugge, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_15_9471=[""].join("\n");
var outline_f9_15_9471=null;
